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SUMMARY
This thesis describes the different forms of AC produced by B. pertussis, B. 
parapertussis, B. bronchiseptica and those expressed in E. co li. The work was 
done with both crude and purified preparations of AC and also with whole cells of 
B. pertussis. Immunoblot analysis with various antisera, including anti-AC 
monoclonal, monospecific, and polyclonal antibodies, revealed the production of 
two different forms of AC with different electrophoretic mobilities i.e., 210 and 200 
kDa as the major cell- associated forms in B. pertussis and B, bronchiseptica. In3
B. parapertussis and E. coli, the predominant form was 210 kDa. These fomymay 
represent the toxic and non-toxic forms observed by Rogel et a l (1989).
Production of the holotoxic AC was not observed in culture supernates under the 
growth conditions used. Only low MW forms of 45-50 kDa were observed and these 
forms also appeared to be produced by proteolysis of AC during storage and other 
experimental manipulations.The breakdown was partially prevented by using a 
protease inhibitor. The enzymic activity of AC was found to be unstable in purified 
and crude forms of AC in the absence of urea. Thus,urea seemed to be beneficial in 
protecting loss of activity of AC during storage.
A noteworthy observation of the present study was that the different Bordetellae, 
including B. pertussis Tn5-insertion mutants deficient in individual virulence 
factors, and a recombinant B. pertussis strain, produced different amounts of AC 
enzymic and toxic activities under the same set of condition which indicate that the 
production varied from strain to strain . The highest yields of enzymically-active 
and toxic AC were obtained from recombinant strain B. pertussis BP348 (pRMBl) 
and from B. pertussis Tn5- insertion mutant BP357 (deficient in a functional PT 
gene). On the other hand, B. pertussis Tohama and Tn5 mutant BP353 showed the 
lowest AC enzymic and toxic activities of the B. pertussis strains examined. B. 
bronchiseptica produced an intermediate level of AC enzymic and toxic activities 
compared to those of the B. pertussis strains.
Enzymically and biologically- active AC was obtained from the E. coli 
constructs. However, the toxic activity was approximately half than that of native 
AC. E. coli strains harbouring the cloned B. pertussis cyaA, B, D genes together 
with C genes either from P. vulgaris, E. coli, or B. pertussis on separate plasmids, 
showed production of CyaA (AC), as assessed by immunoblotting and the Salomon 
assay,and its activation by C genes, as assessed by inhibition of chemiluminescence.
Various attempts were made to develop more convenient, economical, and 
sensitive methods for detection of AC and determination of its enzymic and toxic
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activities. An alternative method for detection of AC by calmodulin- affinity probing 
of a Western blot was found to be reproducible and suitable for use when specific 
anti-AC antibodies were not available. This is the first report of such a use for 
calmodulin. A microplate assay was developed for detection of AC enzymic activity 
and this proved economical, reproducible, and convenient for preliminary screening 
of AC-producing strains and as a semi-quantitative assay. The method has some 
advantages over conventional assays, such as the Salomon assay and the Binding 
protein assay , in that it does not require radioisotope and it is rapid. Further 
development of this assay as a diagnostic test for pertussis may be possible.
A comparative study was made of different assays for determination of toxic 
effects of AC on a variety of target cells . These included : haemolysis of sheep and 
rabbit RBCs, CHO cell elongation, arborization of BHK cells, inhibition of the 
nitroblue tétrazolium reduction capacity of rabbit neutrophils, and inhibition of the 
chemiluminescence response of neutrophils to various stimuli. The study indicated 
that CL inhibition by AC toxin was a sensitive assay and could detect ACT in crude 
preparations at the level of l}Xg protein /lO^ cells and purified ACT at 5 nmol 
cAMP/min/ml AC enzymic activity applied to 10^ cells. The much lower 
concentration of 0.05 pmol cAMP /min/ml AC enzymic activity caused a stimulation 
rather than an inhibition of CL response which could provide an extremely sensitive 
assay for sub-toxic concentrations of ACT.
This stimulatory effect also provides further evidence that ACT is a member of 
the RTX family of toxins since a similar effect at sub-lytic concentration has been 
observed very recently with E. coli alpha haemolysin (Bhakdi and Martin, 1991). An 
immunological relationship of AC to other RTX toxins i.e., Pasteurella haemolytica 
leukotoxin (LktA), Actinobacillus actinomycetemcomitans leukotoxin (AktA), and 
E. coli alpha haemolysin (HlyA) was also supported by an immunoblot study of 
these toxins.These toxins reacted with anti- AC monoclonal 9D4 at their appropriate 
MW. This is the first report providing the demonstration of an immunological 
relatedness among these toxins, and provides a novel method for detection and 
identification of the newly recognized leukotoxin from A ctinobacillus  
actinomycetemcomitans , an important human pathogen.
A time-dependent suppression of CL response was observed when rabbit 
neutrophils were exposed to live, AC-producing B. pertussis . This impairment of 
host immune effector cell functions indicates that ACT may account for the survival 
and proliferation of B, pertussis during the disease.
AC toxin appears to be an important antigen of B. pertussis since antibodies 
against it were detected by immunoblotting of human pertussis convalescent sera. 
These findings substantiate the recently published studies by Farfel et al. (1990).
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However, in the present study, the antisera were found to be capable of neutralization 
of AC enzymic and toxic activities which does not agree with the findings of Farfel et 
al. (1990). Another anti-AC antiserum (Msl), raised during this study, was also 
capable of neutralizing AC enzymic and toxic activities. This antiserum was raised 
against nitrocellulose -bound AC using a novel method for production of highly 
specific anti-AC antibodies. This antiserum was used in passive protection tests in 
mice against intranasal challenge with B. pertussis 18323 and a partial protection was 
observed.
INTRODUCTION
PART I  -  1 -  INTRODUCTION
THE BORDETELLAE
The genus Bordetella includes four species: B. pertussis , B, parapertussis,
B. bronchiseptica , andB, avium. All these species are obligate pathogens and cause 
upper respiratory tract infections in mammalian or avian species.
Bordetella pertussis
B, pertussis was first discovered as the causative agent of the severe 
respiratory disease ' whooping cough ' by Bordet and Gengou in 1906. Since the 
isolation was carried out on a medium containing glycerated potato extract and 50% 
(v/v) blood, the organism was placed in the genus Haemophilus because of its 
presumed requirement for blood in the culture medium and termed Haemophilus 
pertussis. Later , it was revealed that blood was not obligatory for growth and the 
organism was able to grow in relatively simple media containing only a few amino 
acids, growth factors and salts, with either charcoal, soluble starch or anionic 
exchange resins to neutralize the growth inhibitors (Hornibrook, 1939; Kawajima et 
al., 1957). Subsequently, the genus Bordetella was proposed and the 'whooping 
cough bacillus' was placed in this genus (Moreno-Lopez, 1952,cited by Wardlaw, 
1988) and the species is now known as Bordetella pertussis.
Peptone, colloidal sulphur, peroxides, manganese, fatty acids and some structural 
analogues of vitamin B-complex are inhibitory to the growth of B,pertussis (Field 
and Parker 1979; McPheat and Wardlaw, 1982). The addition of charcoal, ion 
exchange resins or blood may overcome this effect. B. pertussis can now be grown 
relatively easily on a large scale in chemically- defined media such as Stainer and 
Scholte medium (Stainer and Scholte,1971).This medium was modified by Imaizumi 
et al. (1983), in particular by the addition of heptakis (2, 6 -O-dimethyl ) 
B-cyclodextrin, which rendered the medium suitable for the growth, even from small 
inocula and, as a solid medium, gave rise to the same number of colonies and growth 
rate as Bordet -Gengou medium (BG). However, with various modifications, BG is 
still widely used for primary isolation and maintenance of B. pertussis .
B. pertussis is a Gram-negative, strictly aerobic, minute cocco-bacillus (0.3-0.5 x 
0.5-1mm ) . It is chemoorganotrophic, and requires organic nitrogen in the form of 
amino acids e.g., glutamate, and organic sulphur in the form of cysteine, plus 
nicotinamide or nicotinic acid. Growth on BG gives smooth, raised, pinpointed
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colonies with a slight metallic lustre and a narrow diffuse zone of haemolysis. 
Incubation for 72 h is usually required for the appearance and development of colonies 
and upon prolonged incubation the colonies acquire opaque and brownish centres.
In liquid media under constant agitation , B. pertussis grows as a uniform cloudy 
suspension but in two to three days, the culture develops a ropy, mucoid mass . The 
cells from liquid cultures are usually longer than those from solid media. L-forms 
have also been observed and spheroplasts may be produced in special media 
(Mason, 1966). In vivo , growth of B.pertussis appears to be highly selective. 
Growth occurs on and among the cilia of the human upper respiratory tract and does 
not invade the parenchyma (Bromberg, 1989). However, an intracellular state has 
recently been reported in which B, pertussis cells have been found within 
pulmonary macrophages of infected animals or inside tissue culture cells ( Bromberg 
e ta l, 1991).
Other Bordetellae
The other three species of the genus Bordetella are also respiratory tract 
pathogens. B. parapertussis was isolated and identified as the causative agent of a 
mild type of pertussis (parapertussis) in humans (Lautrop, 1971).
B. bronchiseptica causes respiratory diseases in various mammals e.g., kennel 
cough in dogs and atrophic rhinitis in swine (Goodnow, 1980).
B. avium is a more recent addition to the genus and was first proposed as a 
species by Kersters et al, (1984) for the agent that causes turkey coryza (turkey 
rhinotracheitis or bordetellosis) and other respiratory diseases in birds (Kersters et al., 
1984). All bordetellae were formerly classified under different names, before the 
introduction of the genus Bordetella  by Moreno-Lopez (1952,cited by 
Wardlaw, 1988). The four species have common features: all are obligate parasites of 
the resphatory tract where they localize on ciliated epithelial cells.
The genetic relatedness of the species within the genus Bordetella has been 
explored by various investigators. According to a study of DNA - DNA hybridization 
, a high degree of homology between the chromosomal DNA of B.pertussis ,B . 
parapertussis andB. bronchiseptica has been observed (Kloos et al., 1981) and the 
G+C content (67-69 mole%) of their DNA is very similar (Table 1) whereas B. avium 
is more distantly related (61-62 mole%). A repeat sequence with at least 20 
copies/genome has been identified in B. pertussis, but shown to be present in low
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copy number (1 copy/genome) in B. parapertussis and B. bronchiseptica, and absent 
from B. avium (McPheat and MacNally, 1987).
In a survey, by multilocus enzyme electrophoresis, of 60 strains of the mammalian 
bordetellae obtained from world-wide sources, Musser et aL (1986) reported that only a 
limited degree of diversity occurs between these species.However,S. pertussis 18323, 
a strain used for vaccine potency testing and vaccine production, appeared to be more 
closely related to B, bronchiseptica and B. parapertussis than to B. pertussis . Arico 
et al. (1987) and Gross et al. (1989) have proposed a phylogenetic tree (Fig.l) of the 
genus Bordetella, based on the nucleotide sequence of pertussis toxin (FT) operon. 
Both B. parapertussis and B. bronchiseptica possess the mutated (silent) PT toxin 
genes, but B. pertussis strains alone express and produce pertussis toxin. Sequencing 
of the FT operon of B. pertussis, B. parapertussis, and B. bronchiseptica revealed a > 
95% DNA homology between these species (Arico and Rappuoli, 1987).Other 
characterstic features of the species are given in Table 1.
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Fig . l
Phylogenetic Tree of the Genus Bordetella
The phylogenetic tree proposed by Gross et al. ( 1989), based on the sequencing of 
the pertussis toxin operon. The figure indicates the acquisition of the pertussis toxin 
operon by B. parapertussis and B. bronchiseptica after being dissociated from B. 
avium (l).The gain of pertussis toxin expression by B. pertussis and B. pertussis 
18323 (2) suggests an evolutionary link between B. parapertussis and B. 
bronchiseptica which possess silent genes for pertussis toxin.
s.2
(0
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Phylogenetic tree of Bordetellae
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Table.l Characterises of Bordetella Species
Phenotype Bp Bpp Bb Ba
Flagella _ + 4-
Nitrate reduction + ?
Urease activity + +
Oxidase activity V + ?
Catalase utilization _ V 4- V
Growth on BG (days) 3 1-2 1 1
Growth on MA _ + 4- 4-
Browning pigment +
LPS + H- 4- 4-
HLT + + 4- 4-
TCT + + 4- 4-
ACT + + 4-
PT +
FHA + 4- 4- ?
AGGs + + 4- 4-
Species specific
1 + _ ?
14 + ?
12 4- ?
Strain specific
2,3,4,5,6,13 + ?
8,9,10 + ?
8,9,10,11,13 _ 4- ?
G+C (mole%) 67,7-68 68,1-69 68.2-69,5 61.6
Data from: Eldering et al. (1957); Pittman (1984); Kersters et al. (1984); Goldman 
(1988); and Wardlaw (1988).
Bp=5. pertussis, Bpp=^. parapertussis, Bb=B. bronchiseptica,Ba.~B. avium. 
BG=Bordet-Gengou medium» MA=MacConkeys agar, LPS= lipopolysaccharide, 
HLT=heat labile toxin, ACT= adenylate cyclase toxin, PT= pertussis toxin, FHA= 
filamentous haemagglutinin, AGGs = agglutinogens.
+= present, - = absent, V= variable, ?=not known.
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ANTIGENIC VARIATION IN B. PERTUSSIS
B. pertussis produces a variety of biologically active components which directly or 
indirectly contribute to its pathogenicity and thus may be termed 'virulence factors'.
The established virulence factors are:
Heat labile toxin (HLT), Tracheal cytotoxin (TCT), Endotoxin or lipopolysaccharide 
(LPS), Pertussis toxin (PT), Filamentous haemagglutinin (FHA), Agglutinogens 
(AGGs), Pertactin (P-69) outer membrane protein, and Adenylate cyclase toxin (ACT). 
Detailed description of these virulence factors is given on page 15.
A significant phenomenon in B. pertussis is its capacity to undergo antigenic variation 
in which expression of these virulence factors is altered. Three types of variation have 
been described; 1) Antigenic modulation, 2) Phase variation, 3) Serotype variation. 
These phenomena in B. pertussis are reviewed by Coote and Brownlie (1988) and 
Coote (1991).Similar variation processes probably occur in the oih&x Bordetella species 
but these have been less well characterized.
1) Antigenic Modulation
Lacey (1960) observed a change of antigenic expression when B. pertussis cells 
were grown under different conditions. He designated the resulting cells 'C'-mode 
from the bluish (cyanic) appearance of the confluent growth on media containing MgSO/  ^
instead of NaCl. The opposite of this was X-mode for the yellowish (Xanthic) colour of 
the confluent growth of cells on normal media at 37^C where cells possessed all the 
features of freshly isolated virulent strains. The variation process also involved a 
change in the surface of B. pertussis from hydrophobic to hydrophilic (Robinson et al., 
1986) and altered adherence to mouse lung tissue (Burns and Freer ,1982) and unciliated 
human tissue culture cells (Gorringe et al., 1985). In addition, C-mode cells are unable 
to bind the dye Congo red (Parton, 1988) and have lost virulence factors such as 
agglutinogens (McPheat et al, 1983), haemolysin and haemagglutinin (Lacey, 1960), 
pertussis toxin (Wardlaw e ta l, 1976), heat-labile toxin (Livey etal., 1978), adenylate 
cyclase toxin (Parton and Durham, 1978) and certain outer membrane proteins (Parton 
and Wardlaw, 1975).Other workers have confirmed and extended the findings of Lacey 
(1960) and have shown that growth in the presence of other factors e.g., nicotinic acid 
(Pusztai and Joo, 1967), quinaldic acid and other pyridines (Schneider and Parker, 
1982), sodium sulphate, sodium acetate and sodium tartarate (Brownlie et al., 1985) can 
also induce modulation.
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2) Phase Variation
Leslie and Gardner (1931) first observed the loss of virulence in B. pertussis after 
repeated subculturing. They noted four antigenically distinct phases i.e., I and II being 
virulent and III and IV being relatively avirulent, and termed this process 'Phase 
Variation'. Phase IV strains have an increased resistance to certain antibiotics 
(Bannatyne and Cheung, 1984), and fatty acids (Peppier and Schrumpf, 1984) and are 
capable of growing on media not supplemented with blood, charcoal or cyclodextrin 
(Peppier, 1982). Phase IV variants can also be distinguished from Phase I strains by 
their inability to take up Congo Red from media containing the dye (Parton, 1988). An 
alternative classification has been proposed by Weiss and Falkow (1984) for phase 
variants i.e., virulent (Vir+) for the isolates of B, pertussis which possess all the 
virulence factors and avirulent (Vir") for those which have lost these factors including 
PT, ACT, FHA, HLT and the fimbrial AGGs (page 15). Genes encoding these 
virulence factors were found to be regulated by a trans-acting factor produced by a single 
locus which Weiss & Falkow (1984) designated v ir . A single Tn5 insertion into this 
region of the B. pertussis chromosome was able to create the avirulent phenotype as in 
BP347. This strain, however, was not equivalent to a Phase IV strain since it was not 
able to grow on nutrient agar.
Relatedness between phase variation and antigenic modulation.
Mutations in the B. pertussis genetic locus previously designated as a vir , now 
more commonly known as bvg (bordetella virulence genes) (Miller et a/.,1990), cause 
loss of expression of AC, FHA, PT, and AGGs. The same locus is involved in the 
down regulation of virulence factor expression by environmental factors such as low 
temperature (28°C) or 40 mM MgSO^ (Knapp and Mekalanos.,1988).
The nucleotide sequence of bvg DNA revealed two open reading frames : bvgA 
which codes for a 23 kDa protein BvgA and bvgS which codes for a 140 kDa protein, 
BvgS (Scarlato et at., 1990). BvgA is located in the cytoplasm and BvgS in the 
membrane fraction. Regions of nucleotide homology with other two component 
sensor/regulator systems (Arico et.al, 1989) suggests BvgS to be the signal sensor and 
transmitter molecule and BvgA as a signal receiver and DNA binding protein. The bvg 
locus thus encodes a transmembrane transcriptional control system (Braun and Focareta, 
1991). BvgS may act as a transmembrane protein with a periplasmic N-terminal receiver 
domain which senses external signals and transmits them to the second component,
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BvgA via phosphorylation which allows BvgA to regulate specific loci (Coote, 1991).It 
has been suggested that excess phosphate may interfere with the phosphorylation 
mechanisms whereby BvgS transmits external signals to BvgA (Melton and Weiss,
1989), Recent results suggest that BvgA, upon modification by BvgS, binds to specific 
promoter sequences to activate or repress transcription (Roy and Falkow, 1991).A direct 
involvement of the Bvg locus in modulation has become evident from the report of 
Miller et aL (1992) who showed that a single amino acid substitution in BvgS resulted in 
an insensitivity to the environmental signals such as MgSO^, nicotinic acid, and 28 “C 
temp for growth, thus confirming the role of the bvg locus in signal transmission. It 
seems that the two processes (antigenic modulation and phase variation) have a common 
switch mechanism that regulates the simultaneous expression of several virulence factors 
of B. pertussis, and it is revealed from these data that the phase I and X-mode organisms 
may be essentially the same, as are the phase IV and C-mode cells. The difference is that 
the X-mode-C-mode changes are environmentally regulated, affect all the cells in the 
culture, and are freely reversible, whereas the phase I - phase IV changes are fairly rare 
mutational events which require subsequent clonal selection for recognition and are 
usually permanent. However, in some instances, phase variation has been shown to be 
reversible and caused by insertion or deletion of a cytosine residue in a run of six 
cytosine residues within the bvgS gene (Stibitz et a l, 1989). In other cases, stable 
variants have been found to posses small deletions or additions in the bvg locus 
(Monack et a l, 1989).
The possible role of these phenomena during the disease was summarized by 
Wardlaw and Parton (1988). Colonization, by avirulent B. pertussis of children and 
adults may provide carriers in a 'pertussis cycle' and antigenic modulation may aid in 
the process of transmission of the disease. Recent studies suggest a possibility of 
modulation in vivo . A mutant strain of B. pertussis expressing ACT independent of 
the control of bvg continued to produce AC enzymic activity, whereas the parent strain 
showed a reduction of the AC enzymic activity when the bacteria were located in 
macrophages (Masure and Barrett, 1991), suggesting the involvement of modulation 
during this phenomenon. As well as virulence activated- genes (vag ) such as those 
encoding PT, AC, FHA, AGG, and P-69, other genes have been identified, by 
Tn5phoA insertions, as vrg (vir-repressed genes) (Knapp and Mekalanos, 1988).
>>
3) Serotype Variation
Serotype variation in 15. pertussis was first described by Cameron (1967) who
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observed that pure cultures of B. pertussis can display serotype heterogeneity. Variants 
of a single clone of B, pertussis can independently gain or lose AGGs 2 and 3 with a 
frequency between lO"  ^to 10"  ^ (Stanbridge and Preston, 1974), a range of frequencies 
similar to those reported by Stocker (1949) for flagella variation in Salmonella 
typhimurium.. Serotype variation can occur in experimental animals (Preston et al., 
1980) and in the infected child (Preston and Stanbridge, 1972).
The contribution of serotype variation to the disease is not clear ; however, it is 
thought that changes in AGGs may allow the bacteria to evade the host immune system. 
Robinson et al. (1989) reported that in mice immunized with AGG3 , a B. pertussis 
challenge strain of serotype 1,2,3 underwent a change first to 1,2,0 than to 1,0,0 
suggesting that selective pressure occurs against organisms expressing the homologous 
AGGs .Willems et al. (1990) have produced evidence that serotype variation may occur 
due to insertion/deletion events within the cytosine-rich region located 70 bp upstream of 
each of the j^m genes.
PERTUSSIS,THE DISEASE
Whooping cough or pertussis is a non-invasive, acute infection of ciliated cells of 
the upper respiratory tract which mainly affects infants and young children. Muller et al. 
(1986) estimated that the vast majority of the world's unvaccinated children acquire the 
infection by the age of 5 years and life threatening cases occur in very young children 
(under 6  months). However, persons of all ages are susceptible, and although 
outbreaks in adults are uncommom (Linnemann and Nasenbury,1977) there is 
increasing evidence that adults serve as an important reservoir of infection (Muller et al., 
1986). Mortality from pertussis in developing countries can be as high as 1 in 100 . In 
developed countries, mortality is much lower ( from 1 in 1 0 , 0 0 0  to 1 in 1 0 0 , 0 0 0  ) but 
the disease still persists (Rappuoli et al., 1991). Each year there are 60 million cases 
and over 1 million deaths world-wide, due to pertussis (Muller et. al., 1986 ).
In most countries the disease is endemic with epidemics erupting every 3 to 4 
years, depending on the number of susceptibles in the population (Cherry et ah, 1988). 
Transmission is usually due to droplet infection from infected carriers and the attack rate 
may be high even in immunized individuals, when they are exposed within a closed 
environment (Long et ah, 1990). There is no evidence for the existence of true (i.e., 
long-term, asymptomatic ) carriers (Bass and Weiss, 1990) and no natural, non-human 
host, reservoir or vector has been reported.
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Clinical Aspects of Pertussis
The severity, duration and likelihood of complications in pertussis vary with age, 
general health, and immune status of the individual (Parton, 1991). Pertussis can be a 
very severe disease in infants but in grown ups, the disease may be a mild, sometimes 
asymptomatic, atypical type of pertussis. Typical pertussis can be divided into three 
symptomatic stages, 1) catarrhal, 2) paroxysmal and 3) convalescent (Cherry et ah, 
1988; Walker,1988).
Catarrhal stage . After an incubation period of 6  to 20 days (Lapin, 1943),the 
symptoms begin with a mild cough which resembles any ordinary respiratory infection. 
The chances of recovery of the organism are high at this stage (Weiss and 
Hewlett, 1986). The catarrhal stage lasts 1-2 weeks and then the disease enters into its 
second, paroxysmal stage (Olson,1975).
Paroxysmal stage . In this stage the cough is initially more frequent at night, and 
progresses with time to become more frequent by day. In severe cases, 15-20 episodes 
of coughing may occur in a day. Each forceful cough eventually ends when air is rapidly 
inspired into the lungs and often causes the characteristic 'whoop'.As the paroxysm 
ends, the patient often vomits (Pittman,1970),
Sometimes, due to prolonged episodes of coughing, the patients may suffer anoxia, 
and cyanosis. Weight loss, dehydration and malnutrition are quite common in young 
children of substandard nutritional status. Most complications and deaths occur in this 
stage. Respiratory complications and central nervous system damage are relatively 
common and are mainly due to hypoxia and apnoea (Cherry et at., 1988).Other 
long-term complications attributed to pertussis, such as impaired lung function and 
predisposition towards other respiratory complications, have not been proved in recent 
studies (Krantz et al., 1990). The paroxysmal stage lasts 1-4 weeks and, in severe 
cases, up to 20 weeks (Cherry et al;, 1988, Walker, 1988).
Convalescent stage . The convalescent stage approaches with a reduction in the 
number and frequency of paroxysms, but these can occur sporadically for as long as 6  
months after the infection is over (Lawrence, 1965) and may recur with subsequent 
respiratory infections (Fine and Clarkson, 1982).
Diagnosis.
The catarrhal phase of the disease represents the period of maximal proliferation 
and transmission of B. pertussis (Olson, 1975). Different diagnostic methods for
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pertussis have been reviewed by Friedman (1988). The 'gold standard' for diagnosis of 
B. pertussis infection is recovery of the organism from nasopharyngeal swabs by 
culturing (Onorato et al., 1987). The organism is however, difficult to recover from 
previously immunized persons and patients treated with antibiotics (Baraff et al, 1978). 
An alternative method for diagnosis, a fluorescent antibody test has been used and was 
claimed to be more sensitive than culture (Olson, 1975) while other studies found 
culture more sensitive (Field and Parker, 1977). However false positive results may 
occur due to nonspecific binding to background material in respiratory specimens or due 
to cross-reactivity with other organisms sharing common antigenic determinants 
(Onorato et al, 1987). Other serological methods such as agglutination (Manclark et al, 
1986), immunofluorescence and complement fixation (Bradstreet et a l, 1973) have been 
used. However, none of these methods shows high diagnostic sensitivity (Onorato et 
al, 1987). The ELISA technique for diagnosis of pertussis (Finger and Koenig, 1985 ) 
has been shown to be a useful aid to the original culture method. Recently, Mertsola et 
at. (1990) have reported diagnosis of pertussis by measuring anti-pertussis toxin IgA 
responses in patients sera and have proposed this technique to be used as an additional 
tool, with culturing, for diagnosis and confirmation of pertussis.
Another method for diagnosis of pertussis is the exploitation of the components of 
B. pertussis produced during the course of disease. A method for detection of B. 
pertussis AC in vitro was accomplished by incubating alginate swabs coated with B. 
pertussis in a medium containing ATP and calmodulin and cAMP production was 
measured (Confer and Eaton, 1985). Recently this method has been applied to clinical 
specimens (Confer a/., 1990).
A diagnostic method for pertussis based on DNA recombinant technology, using 
DNA probes has been proposed by Friedman (1988). This method has been used for 
screening of enterogenic E. coli (Moseley et a l, 1982).
Treatment
Treatment of pertussis with antibiotics has a negligible effect for preventing the 
progression, clinical course, or the establishment of disease (Bass et a l, 1969). 
However antibiotic treatment is useful as a prophylactic measure for the prevention of 
secondary infections (Altmeier and Ayoub, 1977). Erythromycin may reduce infectivity 
(Bass, 1983) and has been used along with glucocorticoids (Zoumbovlakis et al, 1973) 
which have been reported to ease the coughing and shorten the duration of paroxysm
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Barrie, 1982). Hyperimmune human gamma globulin is still used occasionally but there 
are no reliable data on its efficacy.
PERTUSSIS VACCINES
Whole-Cell Vaccine
An effective vaccine against whooping cough was developed in the 1940s (cited by 
Rappuoli et ah, 1991). This vaccine was composed of whole B. pertussis cells, killed 
by formalin and treated at 56^C for 30 min.With few modifications, this conventional 
pertussis vaccine is still in general use except in Japan.In the United Kingdom, this 
cellular vaccine is usually administered in combination with diphtheria and tetanus 
toxoids (DTP), adsorbed to a carrier like aluminium hydroxide and with thiomersal as a 
preservative (Health Department, 1990).
The development and efficacy of whole-cell vaccines for pertussis has been reviewed 
by Griffiths (1988). The methods to standardize the vaccine potency include :1) the use 
of standard opacity units in the cell suspensions and 2 ) the intracerebral mouse 
protection test (Kendrick et a/., 1947). The whole-cell pertussis vaccine has been shown 
to protect against whooping cough. However, a high fi*equency of adverse reactions and 
a temporal relationship with serious neurological events have been observed following 
administration of this vaccine (Miller et a/., 1981). Adverse effects ranging from 
transient local reactions to permanent brain damage have been reported (Cherry et a l, 
1988; Griffith, 1988 ; Golden, 1990).
The concern about these reactions, in many Western countries, led to a sharp 
decrease in vaccine acceptance (from 90% to 30% in some areas) and a reappearance of 
pertussis epidemics (Cherry et a l, 1988). However, in a recent review it was 
concluded that if pertussis vaccine does cause brain damage, it must be a very rare 
event and it may never be demonstrated conclusively (Marcuse and Wentz, 1989). 
Therefore, although whole-cell pertussis vaccines may cause some transient local and 
systemic effects, there is no convincing evidence that they cause permanent neurological 
disorders. It now seems to be generally accepted that the benefits of the whole-cell 
vaccine are greater than the risks, and the uptake rate of whole-cell pertussis vaccine in 
the U.K has returned to its former level of 80% (Parton, 1991). The World Health 
Organization recommended continuing vaccination with whole-cell vaccine, while 
focussing research on the development of new vaccines devoid of side effects.
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Acellular Vaccines Containing Chemically Toxoided B. pertussis 
Components
Whole-cell pertussis vaccines are undoubtedly reactogenic and different preparations 
may differ in their reactogenicity. Mild common reactions like swelling and redness at 
the site of injection, high fever or uncontrollable crying may occur after the 
administration of whole-cell vaccine (Cherry et al, 1988). In an effort to reduce these 
reactions and to increase the vaccine acceptance and efficacy, acellular pertussis vaccines 
containing purified specific bacterial components are being developed. The first of these 
vaccines essentially contained filamentous haemagglutinin (FHA) and pertussis toxoid 
(PTd), and have been shown to confer protection in animal models (Sato et a i, 1981) 
and in man ( Biritwum et al., 1985; Isomura et al., 1985 ).
Acellular pertussis vaccines have been used to immunize children in Japan since 
1981 (Kimura et al., 1990). They are composed mainly of toxoided PT and FHA in 
equal amounts (Biken type) or FHA and toxoided PT (9:1) along with small amounts of 
AGGs and 69kDa protein (P-69) (Takeda type). These vaccines are reported to be 
protective in children (Biritwum et at., 1985; Isomura et al, 1985) and less reactogenic 
than whole-cell vaccine (Kimura and Hikino, 1985).
In Sweden, a large scale, double blind placebo- controlled clinical trial was started in 
1986. Two acellular vaccines; the two-component Biken type and toxoided PT alone 
were field tested. According to the reports of the Ad Hoc group for the study of 
pertussis vaccine (1988), the acellular vaccines had somewhat lower efficacy in 
protecting children against pertussis than would have been expected for a whole-cell 
vaccine. Both vaccines however, gave good protection (80%) against severe pertussis
The mono-component vaccine containing PT toxoid alone did not prevent infection, 
whereas the Tadeka-type vaccine gave some protection against infection, suggesting that 
inclusion of FHA was helpful (Storsaeter et al., 1990).
The results of the Swedish vaccine trials of pertussis toxoid alone or pertussis toxoid 
in combination with FHA suggests that other antigens may be needed to confer full 
protection.
A new British vaccine containing individually-purified PT, FHA and AGGs has 
been developed at the Centre for Applied Microbiology and Research, Porton Down and 
is currently under consideration for future Phase-III clinical trials .
PART I  - 1 4  INTRODUCTION
Acellular Vaccine Containing G enetically-Detoxified B .p e r tu s s is  
Components
During the clinical trials of acellular vaccines in Sweden, PT toxoid prepared with 
formaldehyde showed some reversion to toxicity on storage at 37 (Kimura and 
Kuno, 1990). In order to avoid the possible risks of such reversion, other methods of 
toxoiding have been investigated. With the application of modem molecular genetic and 
immunological techniques, a genetically inactivated PT is currently being evaluated as a 
candidate vaccine antigen (Nencioni et aL, 1990). A Phase-II clinical trial to determine 
the safety and immunogenicity of this material has recently been performed on a group 
of 250 infants.Preliminary results show that the vaccine is safe and highly immunogenic 
(Rappuoli et al., 1991). Furthermore, in a phase I clinical trial on adult volunteers, 
acellular pertussis vaccine composed of genetically detoxified P T , FHA and P-69 outer 
membrane protein was able to produce a marked humoral response against these 
antigens, and a vaccine-acquired cellular immunity was also observed after the second 
dose (Podda et al., 1991).
Several of the virulence-associated genes of B. pertussis have now been cloned and 
sequenced. DNA sequencing has allowed the deduction of amino-acid sequences and 
the identification of potential epitopes. For the production of new acellular vaccines, the 
known epitopes of cloned genes could be manipulated to provide protective but 
non-toxic components. Increased expression of cloned genes could also prove 
advantageous for vaccine production. Expression of the vimlence genes in E. coli has 
proved difficult so far because of the requirements for the trans-activating virulence 
regulatory genes (Weiss and Falkow, 1984). However in B. pertussis, overproduction 
of genetically-inactivated PT by strains containing multiple copies of tox Lys  ^-Gly^^P 
[been reported very recently by 2Lealey et al. (1992).
PART I  - 1 S INTRODUCTION
VIRULENCE FACTORS
A virulence factor can be defined as 'any bacterial component that promotes 
pathogenicity by enabling the organism to infect the host and cause disease' (Wardlaw, 
1988). The virulence factors of B. pertussis are:
Heat Labile Toxin (HLT)
Tracheal Cytotoxin (TCT)
Endotoxin or Lipopolysaccharide (LPS)
Pertussis Toxin (PT)
Filamentous Haemagglutinin (FHA)
Agglutinogens (AGGs)
P-69 outer-membrane protein 
Adenylate Cyclase Toxin (ACT)
Heat Labile Toxin (HLT)
HLT is a dermonecrotic toxin present in all bordetellae. The levels of HLT do not 
vary much between different phase I strains, but phase IV and C-mode strains have 
reduced HLT (Livey et ah, 1978). This toxin has proved very difficult to purify on 
account of its instability and no purification method has yet had independent 
confirmation (Nakase and Endoh, 1988). Estimations of molecular weight have also 
varied : 89kDa (Livey and Wardlaw, 1984), 102 kDa (Endoh et ah, 1986) and 130 kDa 
(Zhang et ah, 1985). HLT is mainly cytoplasmic but may be partially secreted on the 
cell surface (Livey and Wardlaw, 1984). Exogenous agents incorporated during the 
preparation of crude HLT have been shown to have an impact on the dermonecrotic 
reaction of the toxin and therefore the reliablity of this assay involving the measurement 
of skin lesions seems questionable (Endoh et ah, 1990).
The toxin is found to be lethal and causes vasoconstriction in experimental animals. 
This results in ischaemia, haemorrhage, leukocytic influx and spleen atrophy (Cowell et 
ah, 1979; Nakase and Endoh, 1985). A Tn5 mutant deficient in HLT production, 
BPM1809 (Weiss et al., 1989) has been found to be unimpaired in its ability to cause 
lethal infection suggesting that this toxin does not contribute significantly to the disease 
process at least in mice.
Since HLT is inactivated upon heating at 56"C for 10 min (Manclark and Cowell, 
1984), it is destroyed during the conventional method of pertussis vaccine preparation.
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This suggests a non-essential role for HLT in protection.
Tracheal Cytotoxin (TCT)
TCT is produced by all four species of Bordetella  (Goldman, 1988). 
Chemically, TCT is a disaccharide tetrapeptide derived from the peptidoglycan of the 
bacterial cell wall and thus has a low MW , estimated to be only 921 Da(Goldman,
1988).
The role of TCT in pathogenicity involves destruction of ciliated cells followed by 
extrusion of these cells from the epithelium.This activity has been noted in hamster 
tracheal organ-cultures. In non-ciliated cells, a reduction of DNA synthesis has been 
observed (Goldman and Baseman, 1980). These effects may reflect a hidden toxicity of 
this virulence factor and may explain the persistence of respiratory tract abnormality in 
pertussis long after bacteria have left the host. The destruction of ciliated cells may also 
contribute to the secondary bacterial infections which may account for complications and 
predisposition to secondary infections (Wardlaw, 1988). However, TCT appears to be 
non-immunogenic (Goldman, 1988).
Endotoxin (Lipopolysaccharide)
Endotoxin or lipopolysaccharide (LPS) is produced by all the four species of 
Bordetella and it comprises around 2% of the dry weight of the bacterial cells. 
Bordetella LPS, besides sharing the common features of adjuvant action, pyrogenicity 
and the Shwartzman reactivity with other Gram-negative LPS, has a unique property of 
generating non-specific antiviral activity (Winters et aL, 1985). Purified B. pertussis 
LPS is also reported to activate mononuclear phagocytes (Haeffner-Cavaillon et al., 
1984).
B. pertussis strains contain two immunologically and chemically distinct 
molecular components, LPS I and LPS II ( (Aprile and Wardlaw, 1973; Chaby and 
Caroff, 1988). In B. pertussis, both LPS I and II lack the long chain polysaccharide 
O-antigens, characteristic of LPS of enteric bacteria, and they have been termed lipo 
oligosaccharide (Ayme et al., 1980). Recent comparison of LPS from phase variants of 
different strains of B. pertussis has shown a difference in their composition, 
antigenicity and reactogenicity. Phase I strains contained LPS I whereas phase IV had 
LPS II (Ray et al., 1991). B. pertussis LPS produces a typical lipooligosaccharide 
electrophoretic pattern whereas B. parapertussis andB. bronchiseptica produce a 
smooth LPS. B. bronchiseptica LPS is antigenically different from LPS I and LPS II of
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B. pertussis (Ray e? a/., 1991).
Regarding the role of LPS in pathogenicity, a comparative study of B. pertussis, B. 
parapertussis and B. bronchiseptica LPS has recently been reported by Byrd et ah, 
(1991).In this report, survival of the Bordetella strains (other than B. pertussis) against 
complement-mediated killing was observed which, it was suggested, was due to the 
presence of high MW O-side chains and described that this structure of LPS was 
responsible for the inactivation of the complement complex (C5 - C9) and blocking its 
access to outer cell membrane, thereby preventing cell lysis.
Despite the presence of LPS in the whole-cell vaccine, it is considered not to be a 
protective antigen (Pittman, 1984). However, Standfast (1958) reported the protective 
role of boiled pertussis vaccine against lethal intranasal challenge with B. pertussis in a 
mouse model. Moreover, high titres of anti-LPS antibody have been reported in 
tracheobronchial washings from mice but not in serum (Wardlaw and Stevenson, 1894)
On the other hand, the reactogenicity of the commercial whole-cell vaccine may be 
largely due to the presence of LPS and the reactogenicity is one of the major reasons for 
developing an acellular vaccine. In recent trials in the U.S.A., whole-cell vaccine was 
compared with acellular vaccine having 95% less LPS. The reactogenic symptoms like 
fever, local reactions, and other common reactions were significantly less with the 
acellular vaccine (Cherry et al., 1988).
Pertussis Toxin (PT)
Unlike oth&r Bordetella virulence factors, the production of pertussis toxin (PT) is 
restricted to B. pertussis . This product is considered to play a major role in the 
pathogenesis of whooping cough (Pittman, 1979; Irons and Gorringe, 1988). Before 
the term 'Pertussis toxin' was proposed by Pittman (1979), the toxin was known as 
histamine-sensitizing factor (HSF), leukocytosis and lymphocytosis promoting factor 
(LPF), islet activating protein (lAP) (Yajima et al., 1978) or pertussigen (Munoz and 
Bergman, 1977).
PT has been the subject of several reviews including Wardlaw and Parton (1983), 
Sekura et al. (1985), Ui (1988), Furman et al. (1988), Munoz (1988) and Irons and 
Gorringe (1988).
PT is a protein complex of MW ~ 105 kDa which is made of six protein sub-units, 
two of which are identical. The toxin resembles cholera toxin in that it is an A-B subunit 
toxin where the A-subunit protomer consists of a single polypeptide chain containing a 
disulphide bond which must be reduced for activity. The B- subunit is an oligomer
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consisting of two dimers (S2-S4 and S3-S4) connected by S5.
It has been demonstrated that the A-subunit, SI is an enzyme active as an 
ADP-ribosyl transferase and also as an NAD-glycohydrolase. The B-subunit is 
responsible for binding the intact toxin to susceptible cells.
PT causes an acute increase in cellular cAMP levels by ADP-ribosylation of 
components of the host cell's adenylate cyclase enzyme complex. However, unlike 
cholera toxin where adenylate cyclase is stimulated by modification of the 
GTP-dependent regulatory component responsible for stimulation of the adenylate 
cyclase (the alpha-subunit of Ng), pertussis toxin acts by ADP-ribosylation of the 41 
kDa GTP-dependent regulatory component responsible for inhibition of the adenylate 
cyclase system (Nj). When the alpha {component binds to GTP, it is activated and the 
adenylate cyclase enzyme is inactivated. It seems that ADP-ribosylation of the alpha i 
subunit of Nj by PT leads to a permanent inactivation of the component by preventing
GDP from being replaced at the nucleotide binding site by GTP. Thus PT causes an 
intracellular increase in cAMP by inhibiting hormonally-controlled deactivation of AC 
with a consequent disturbance to normal cell function. Studies of the biological 
activities of A and B components of PT revealed that although many diverse effects of 
PT depend on A-subunit activity, others such as T-cell mitogen activity are mediated by 
the cross-linking effect of B-subunit on mammalian membrane proteins. In addition to 
its toxic activities, pertussis toxin functions as an adhesin (Tuomanen, 1988).
Transposon-insertion mutagenesis has shown that PT is an essential virulence 
determinant in a mouse model of infection.For example, B. pertussis strain BP357 (PT 
deficient) was found to be severely impaired in the abihty to cause lethal infection in the 
infant mouse model (Weiss et al., 1984; Weiss and Goodwin, 1989; Goodwin and 
Weiss, 1990). The ability of PT to act as a protective antigen has been referred to on 
page 13 & 14. Molecular cloning of PT genes (Locht and Keith, 1986; Nicosia et al., 
1986) has revealed that similar genes are also carried by B. parapertussis andB. 
bronchiseptica, but not by B. avium. However, these genes are not expressed in these 
species mainly because of defective promoter regions (Marchitto et al., 1987).
PART I  - 1 9- INTRODUCTION
Filamentous Haemagglutinins (FHA).
FHA is produced by B. pertussis, B. parapertussis and B. bronchiseptica , but has 
not been reported in B. avium.
B. pertussis produces 3 distinct haemagglutinins namely filamentous haemagglutinin 
(FHA), pertussis toxin and an ornithine containing lipid (Kawai et al, 1982). Among 
these, FHA is the most potent (Sato et al, 1983).
FHA has a highly hydrophobic fine filamentous structure, measuring 2 nm in 
diameter, and 40-100 nm in length (Arai and Sato, 1976). It appears to be a non-fimbrial 
surface protein (Ashworth et a l, 1982). SDS-PAGE and Western blot analysis of 
purified FHA has revealed a major component of MW 220kDa (Domenighini et al., 
1990).
The role of FHA in pathogenesis of pertussis seems to be as an adhesin that anchors 
the bacteria against the mucociliary stream in the respiratory tract. However, the strong 
adhesion of B. pertussis to ciliary tufts of human respiratory tract cells in vitro required 
both FHA and PT (Tuomanen, 1988). Both molecules are thought to act in concert as 
adhesins. PT and FHA, in the soluble form, have been reported to adhere either to B. 
pertussis itself or to unrelated bacteria e.g. ,Streptococcus pneumoniae, or Haemophilus 
influenzae which thereby become sticky and attach to cilia. This phenomenon termed 
'piracy' of adhesins has been suggested as an explanation for the prevalence of 
secondary infections in childhood pertussis (Tuomanen, 1988). Transposon insertion 
mutants of B. pertussis lacking either FHA or PT (BP353 and BP357 respectively) 
showed decreased adherence to rabbit and human ciliated cells (Tuomanen et al, 1983). 
However,Weiss and Goodwin (1989) have shown that a Tn5 mutant, unable to produce 
FHA, was as virulent as the wild-type strains in a mouse model. Moreover, the recovery 
rates were also similar to those obtained with wild-type strains (Goodwin and Weiss, 
1990). Studies in the rabbit with another FHA Tn5 mutant showed that there was lack 
of efficient localization to cilia which resulted in more severe lesions in the lungs than 
with the wild- type strain (Tuomanen et a l, 1985). This suggests that attachment to the 
human respiratory tract could halt entry of organism into the lungs and the subsequent 
development of lethal pneumonia.
FHA generates humoral and cellular immune responses in humans during natural 
disease. In an adult mouse model, FHA proved to be a protective antigen and the 
animals showed reduced lung colonization after immunization with FHA (Kimura et al, 
1990), followed by intranasal aerosol challenge with B. pertussis. The use of FHA in 
acellular pertussis vaccines is mentioned on pages 13 &14 .
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The gene for FHA has been cloned into E. coli (Domenighini et a l, 1990), Stibitz 
et aL (1988) cloned into E. coli slB. pertussis DNA fragment carrying the bvg locus 
together with the fha locus. Immunologically detectable FHA was expressed by E. coli. 
There was no FHA expressed however when a plasmid carryhing the fha locus alone 
was used, confirming the importance of trans-acting bvg locus gene products.
Agglutinogens (AGGs)
Agglutinogens (AGGs) are surface antigens capable of eliciting cell agglutinating 
antibodies (agglutinins) and which determine the serotypes of isolates (Preston et al.,
1982). There are 14 agglutinogens reported in the genus Bordetella (Eldering et al., 
1957). AGGs 8-12 and 14 are not produced by B . pertussis . B. pertussis strains 
produce 8  AGGs, of which 2-6 and 13 are strain specific, 1 is species specific , AGG 7 
is shared with B. parapertussis and AGG 13 with B. bronchiseptica AGGs 1-3 are 
major antigens and AGG 4-6 are minor (Preston et al., 1982).The four widely 
recognized serotypes of B. pertussis are : 1.2.3, 1.2, 1.3, and 1.0, of which only the 
first three infect man (Preston and Stanbridge, 1972; Preston, 1988), AGG 2 and AGG 
3 are fimbrial proteins (Irons et. al., 1985).
Mooi et al. (1987) studied the amino acid sequences of the fimbrial subunits from 
B. pertussis and found that AGGs 2 and 3 are closely related. The amino terminal 
amino acid sequence shared 50% homology with that of E. coli K99 fimbrial subunits. 
A genejftm 2 encoding AGG 2 has been cloned and sequenced by Livey et al. (1987) 
and the fim  3 gene has been isolated (Mooi et al., 1987) and sequenced (Mooi et al., 
1990). Another gene, distinct from the above, fim  X, has been characterized by 
Pedroni et al. (1988). The three genes do not appear to be linked on the chromosome 
(Pedroni et al., 1988). Expression of AGG2 and AGG3 are controlled by the bvg locus 
(McGregor et al., 1991).
The role of AGGs in pathogenicity is still unclear. However, a role in the initial 
attachment of bacteria to ciliated epithelial cells of the respiratory tract for establishment 
of infection has been suggested by Gorringe et al. (1985). Monoclonal antibodies to 
type 2 or type 3 fimbriae blocked the adhesion of B . pertussis to Vero cells (Gorringe et 
al, 1985). However, B. pertussis cells without fimbriae adhered well to human ciliated 
cells (Tuomanen and Weiss, 1985).Thus Tuomanen (1988) has argued that there is little 
evidence for a role of AGGs as adhesins to ciliated cells of the human respiratory tract.
Following the epidemiological studies of Preston (1963) and his recommendations 
that pertussis vaccine should contain AGGs 1, 2 and 3, a mixture of strains of
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representative serotypes is generally used to prepare vaccines (World Health 
Organization Committee on Biological Standards, 1979). There is some evidence that 
whole-cell vaccines should contain these components in order to protect adequately 
against all strains of B. pertussis (Preston, 1988).
Protein - 69 Outer-Membrane Protein
A recently identified AGG (Brennan et al., 1988) is a non-fimbrial outer membrane 
protein P-69, the gene for which has been cloned and sequenced (Charles et al., 1989). 
An antigenically related protein is also produced by B. parapertussis and B. 
bronchiseptica (Novotny etal., 1985; Kobisch and Novotny, 1990).
P-69 is a bvg -regulated protein and is synthesized as a polypeptide of 93 kDa, which 
is then processed to a 69 kDa form in the outer-membrane (Charles et al., 1989). 
Purified P-69 has been shown to enhance binding of cultured eukaryotic cells to plastic 
surfaces.The name'pertactin' has been proposed for P-69 to reflect its adhesive 
properties (Leininger et fl/., 1990).
Roberts et al. (1991) have reported construction of P-69 mutants which produced 
noimal levels of other bvg -regulated factors except P-69. The ability of these mutants to 
adhere and invade HEp2 cells was not significantly different from that of the parent 
strain. However, a greater reduction of adhesion and invasion was observed in a P-69, 
FHA" double mutant. Arginine-glycine-aspartic acid (RGD) sequences in eukaryotic 
extracellular matrix proteins are involved in binding to integrin receptors of mammalian 
cells. The RGD sequence has also been found in both FHA and P-69 (Leininger et al.,
1990) thus supporting the view that these component have a role in binding of B. 
pertussis to mammalian cells.
ADENYLATE CYCLASE TOXIN (ACT)
Adenylate cyclase toxin is produced by three species i.e., B. pertussis, B. 
parapertussis and B . bronchiseptica but not by B. avium (Gentry-Weeks gf (%/., 1987; 
Hewlett and Gordon, 1988).B. pertussis AC activity was first observed in the supernate 
of a whole-cell pertussis vaccine (Wolff and Cook, 1973). It was later purified from B. 
pertussis culture supernates and whole-ceU extracts by Hewlett and Wolff (1976).
The enzymic activity of AC is increased several hundred-fold in the presence of the 
eukaryotic calcium-binding protein calmodulin (CaM) which is absent in B. pertussis 
(Wolff et al., 1980). Calmodulin is a small heat- stable protein (MW 16,700), which
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activates a large number of enzymes in a Ca++ dependent, 2-step mechanism 
(Klee et a l 1980).
Calmodulin (CaM) + Calcium ( Ca++)---------- > CaM - Ca++ Complex (1)
Inactive enzyme + CaM-Ca++ Complex > CaM-Ca++- active enzyme (2)
However, Greenlee et a l (1982) found CaM-mediated activation of B. pertussis AC to 
be unique in that there was no requirement for Ca++ for the majority of the activation 
observed.
B. pertussis ACT has been identified in two forms. 1) The AC-enzymic form (AC) 
and 2) AC-toxic form (ACT). The enzymic AC is able to generate cAMP from ATP in 
vitro, whereas the AC toxic form has the ability to penetrate target eukaryotic cells, 
where it interacts with host-cell CaM and generates supra-physiological levels of cAMP 
from endogenous ATP (Confer and Eaton,1982; Hanski and Farfel,1985).These 
uncontrolled, high levels of cAMP impair the ability of polymorphonuclear leukocytes 
and macrophages to undergo chemotaxis, phagocytosis, superoxide generation and 
microbial killing (Confer and Eaton, 1982; Weiss and Hewlett, 1986; Friedman et a l, 
1987 b; Hanski, 1989).
Bacillus anthracis, a Gram-positive bacillus that causes anthrax also produces 
extracytoplasmic CaM-dependent AC which upon entry into target cells generates cAMP 
from host cell ATP (Leppla, 1982). However, this protein is unrelated to ACT (Gordon 
et a l, 1989). Several other bacterial toxins also elicit their effect by alteration of 
intracellular concentrations of cAMP in animal cells and act by means of 
ADP-ribosylation of GTP-binding proteins that regulate the host membrane- bound AC 
system (Gilman, 1984).These include, cholera toxin, pertussis toxin and E. coli 
heat-labile enterotoxin. All these toxins are A-B type toxins and enter the target cell via 
endocytic vesicles. However, AC from B. pertussis is different from these toxins in its 
structure, mechanism of penetration into target cells and duration of its toxic signal 
within the host (Gordon et al, 1988; 1989; Gilboa et al, 1989; Hanski, 1989).
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The structural - functional relationships o f ACT
AC has been isolated and purified by many workers, either from B. pertussis 
culture supernates as soluble AC or from bacterial cell extracts (Table 2).
Many different forms of AC have been associated with B. pertussis.. These include 
polypeptides of various molecular masses ranging from 43 kDa to 660 kDa (Hanski,
1989). Because of this multiplicity of forms , it was not clear whether the larger forms 
of the enzyme represented aggregates of the catalytic form, either with itself or with 
other polypeptides, or multiple molecular mass forms of the enzyme.The 
structural-functional relationship became clearer when Ladant et al. (1986) isolated and 
purified thr&c species of AC enzyme of molecular mass 43, 45 and 50 kDa and found 
them to be structurally related. Furthermore, purified AC from concentrated bacterial 
extracts revealed two forms of AC, of 200 kDa and 47 kDa molecular mass (Rogel et 
al., 1989). These forms were shown to have immunologically related domains because 
polyclonal antiserum raised against the smaller (47 kDa) form of AC cross-reacted with 
the 200 kDa form (Rogel et a l, 1989). It was concluded thatflow MW form which was 
non-toxic, was probably formed by proteolytic cleavage of the high MW 200 kDa toxic 
form of AC. Bellalou et al. (1990 a) have produced evidence that production of the 
40-50 kDa form (s) may not occur under physiological conditions. They showed that 
under certain conditions, the 200 kDa polypeptide could be secreted into the external 
medium of virulent strains of B. pertussis without any proteolytic processing.
The AC locus has been cloned and expressed in E. coli (Glaser et. a l, 1988; 
Brownlie et.al., 1988).These studies revealed that the CyaA protein (AC) is synthesized 
as a large precursor of 1706 anxijno acid. The calmodulin-stimulated catalytic(resides in 
the amino- terminal 400 amino acids whereas the 1300 amino acid carboxy -terminal part 
of the precursor possesses haemolytic activity. Biochemical analysis indicated that the 
ATP- and CaM-binding sites lay within the first 450 a ^  N-terminal region .Tryptic 
fragments of this region show that amino acids 1-235/237 form the ATP binding site 
whereas residues 235/237-399 constitute a CaM binding site (Glaser et al., 1989).
CKLCdi
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Table 2 Isolation and Characterization of AC by Different Investigators
Investigator & Year Source Mr Enzymic activity Toxic activity
Hewlett & Wolff (1976) CS,C 70k 142*
Confer & Eaton (1982) UE,C 1000* 1800 pmol/min/mgT
Wolff gf a/. (1984) BE,C 39k 2000pmol/107Tc
Hewlett et al. (1985) UE,C >350&70k 1000 pmol/min/mgT
Hanski &Faifel (1985) UE,C >600,190&50k 4500pmol/107Tc
Shattuck & StoiTU (1985) CS,C 300-800 pmol/lOSTc
Shattuck <3 / (1985) CS,C 43.4k 608000*
Kessin & Franke (1986) c s 700, 60-70k 100,000* _
Ladant gr a/ (1986) c s 45,43k 1600,000*
Weiss et al. (1986) UE 2000,200,60k 3034* 1278 pmol/min/mgT
Friedman et al. (1987 a) UE,P 200,60k 52.6* 47 pmol/lO'^Tc
Pearson er tz/. (1987) UE 360,000* 9400 pmol/min/mgT
Glaser et al. (1988 b) CS 45k lOOnmol/min/ml
Rogel et al .(1988) UE,P 200,70k 460,1685 |Limol*
Glaser etal. (1989) CS,P 2 0 0 0  qmol*
Masure &Storm (1989) UE,P 215k &45 2 . 8  qm/107 cpm
Rogel etal. (1989) UE,P 2 0 0  k 2-4 qmoF 206pmol/mgT
Hewlett etal. (1989) UE,P 216 k 589 pmol*
Gentüe et a/.(1990) UE,P 2 2 0  k 0.4 mm- 0.5pmol/mgT
Bellalou e ta l (1990 a) UE,P 2 0 0  k 100-150 nmol* _
Bellalou et al. (1990 b) CS,P 2 0 0  k ? ?
Leusch et al{l99Q) UE,P 2 0 0  k 17000 limol* 6,250nmol/2xlQ6Tc
Rogel etal. (1991) UE,P 2 0 0  k 10-30 [Xmol* ?
CS=culture supernate,UE=urea extracts from bacterial cells, C=crude , P=purified, k= 
kilodalton,T = target cell protein,Tc= target cells, • = qmol/min/mg protein, or otherwise 
stated, * = nmol/min/mg protein, " mmol/min/mg protein .The data taken from Hewlett and 
Gordon (1988) and updated.
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Generation of two fragments : 28 kDa and 19 kDa by further cleavage of the 400 - 
residue domain has been reported recently by Munier et al. (1991) . The 28 kDa 
fragment corresponding to the N-tefeninal has been shown to have ATP-binding 
capacity even after dissociation whereas^9 kDa fragment was shown to possess the 
CaM binding site. Both fragments were found susceptible to dénaturation in dissociated 
form and regained their activity when associated.
The C-terminal amino acids are essential for invasiveness and haemolytic activity 
(Rogel et. al., 1989; Hewlett et.al., 1990; Bellalou et al., 1990 b), and share 25% 
sequence homology with alpha -haemolysin (HlyA) of E. coli (Glaser et al., 1988 b). 
This homology serves to explain the capacity of ACT to act as a weak haemolysin. 
(Bellalou et al, 1990 b ; Rogel et a l, 1991; Ehrmann et al., 1991).It was suggested 
therefore, that the 200 kDa form of AC represented the full length transcript, whereas 
the 45-50 kDa form represented the 450 N-terminal aa product.
Three open reading frames have been identified downstream from the cyaA gene, 
cyaB, cyaD and cyaE, encoding polypeptides of 712, 440 and 474 aa residues, 
respectively. The gene products of cyaB and cyaD are highly similar to HlyB and 
HlyD of E. coli, known to be essential for the transport of HlyA across the cell 
envelope and for its release into the external medium. Complementation and functional 
studies indicate that the B. pertussis AC is secreted by a mechanism similar to that 
described for E. coli alpha -haemolysin, but requiring in addition to cyaB and cyaD 
gene products, the presence of a third gene product specified by cyaE gene (Glaser et 
al., 1988 b). Schematic representation of the cyaA gene structure and the cya operon 
is given in Fig.2 . CyaE, the third secretory component of B. pertussis AC has 
obvious sequence similarity with Prtf (one of several products involved in the secretion 
of proteases B and C by Erwinia chrysanthemi ) which has shown homology with 
TolC protein (an outer membrane protein of E. coli ) (Wandersman and Delepelaire ,
1990). Within the prtf operon, the transport genes prtD and prtE have significant 
homology with hlyB and hlyD of E. coli (Letoffe et a l, 1990). Since tolC mutations 
have a pleotropic effect on the expression of outer membrane proteins,this protein 
(TolC) may interact in the outer membrane with the HlyB and HlyD complex to aid 
translocation of HlyA to the cell surface.This suggests that CyaE may function in B. 
pertussis as a TolC protein analogue. This is supported by the fact that CyaA can be 
transported from E. coli (constitutive for TolC) when hlyB and hlyD are provided in 
trans (Masure et al, 1990) and not secreted/exported by B. pertussis in the absence of 
CyaE (Glaser et a l, 1988 b).
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Fig.2
Schematic Representation of the cyaA  Gene Structure and the cya  
Operon.
A) The cyaA gene structure showing the catalytic N-terminal moiety (first 450 
amino acids) with the ATP and CaM binding sites and the C-terminal portion 
responsible for binding to the target cell and haemolytic activities of AC. The figure 
is based on tlie data of Glaser et al. (1988 a).
B) The cya operon showing the organization of different genes responsible for the 
production of active AC . C represents the cyaC gene ; A represents the structural 
gene for AC : B, D, E represent the secretion and transport genes cyaB, cyaD, and 
cyaE respectively. Symbols for the endonucleases are : B, Bam HI; Bg, Bglll; E, 
EcoRl. The arrow shows the direction of transcription. The figure is based on the 
data from Glaser et al. (1988 b) and Barry et al. (1991),
A) I I
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Normally in Gram-negative bacteria, the secretion of proteins occurs by an N-terminal 
leader peptide-dependent two-step process involving translocation of protein to the 
periplasm and loss of the leader peptide and then transfer of protein across the outer 
membrane by a specific export mechanism (Hirst and Welch, 1988). AC however, is 
assumed to be secreted without the formation of a periplasmic interaction in a similar 
manner to HlyA of E. coli. (Coote,1992).
Transcription of the cya determinants starts 115 bp upstream of cyaA and 
transcribes a 4.8 kb cyaA transcript along with a low level production of a 10 kb cyaB, 
D, E transcript (Laoide and Ullmann,1990).An active hvg locus is essential for 
transcription from this promoter.However, another much weaker initiation site for 
transcription has been identified in the intragenic cyaA-cyaB region.This is located 30 
bp upstream of cyaB and its activity is constitutive,and not dependent on the bvg locus.
ACT production is lost along with other virulence factors during the phenomena of 
phase-variation and antigenic modulation (Parton and Durham, 1978) .Activation of the 
AC precursor is a pre-requisite for its interaction with target cell s.Recently a cyaC 
gene, located upstream of cyaA and in the opposite orientation has been shown to be 
necessary fot haemolytic and invasive activities of the cyaA gene product (Ban*y et al,
1991).This gene is homologous to the hlyC gene of E. coli required for the activation 
of the hlyA gene product. Electrophoresis under denaturing conditions did not reveal 
any difference in size between active and non-active ACT, but they have shown 
differences in mobility under partially-denatured conditions, and different aggregation 
properties after gel filtration (Rogel et al., 1989). However, the active form of CyaA 
has been found to be unstable (Rogel et ah, 1991).
Mode o f Action o f ACT
ACT has little target cell specificity (Hanski and Farfel, 1985; Hewlett and Gordon, 
1988).The fact that ACT penetration of target cells raises the internal cAMP 
concentration provides a sensitive assay for ACT with a wide range of eukaryotic 
cells. The exact mechanism involved in cell invasion by ACT is not known. Agents that 
interfere with endocytosis have no effect on the penetration of the toxin (Farfel et 
a/., 1987;Gordon 1988;Gentile et. al., 1988).
Penetration is presumably determined by folding of the toxin which facilitates its 
interaction with cell receptors and/or its ability to create pores in cell membranes.For 
CyaA,there is some evidence that a glycoconjugate receptor may be involved(Gordon et
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al, 1989). An indication that the target cell receptor for CyaA might be a ganglioside had 
come from earlier reports that toxin (ACT) penetration into human neutrophils was blocked 
by bovine brain gangliosides or by treatment of neutrophils with neuraminidase to remove 
sialic acid residues (Gable et at, 1985; Farfel etaL, 1987).
Two types of receptors are involved in bacterial toxin entry, a) glycoprotein receptors 
which are responsible for receptor-mediated endocytosis, and b) glycolipids which allow 
toxin entry by an alternative mechanism.Cholera toxin, for example, reacts/binds with the 
oligosaccharide moiety of ganglioside GM%, via its B-subunit and creates a pore through
which the A-subunit enters (Ribi et aL, 1988). A similar mechanism may be active in ACT 
entry. Analysis of the kinetics of B. pertussis ACT entry into target cells showed almost 
instant accumulation of cAMP which then proceeds to a constant level within 10-40 min 
(Friedman et.al., 1987; Farfel at.al., 1987). This level rapidly declined, presumably due 
to intracellular inactivation of ACT (Gilboa et ah, 1989), when target cells were transferred 
to an enzyme-free medium (Farfel et aL, 1987; Gilboa et.al., 1989). The CyaA protein 
possesses haemolytic activity which is closely associated with the capacity of the protein to 
penetrate target cells (Bellalou et aL, 1990 b; Rogel et al., 1991; Ehrman et al., 1991). 
Studies on haemolytic activity of ACT have suggested that the lytic process has features 
which distinguish it from the penetrative activity which results in elevated cAMP levels. 
Unlike immediate accumulation of cAMP in target cells, the onset of haemolytic activity 
takes at least 60 min (Rogel et a l, 1991; Ehrman et a l ., 1991). The half maximal activity 
of toxin required for haemolysis was at least 1 0 -fold higher than that required for invasive 
activity (Bellalou etal., 1990 b; Rogel etal., 1991).
CaM has been shown to inhibit the entry of ACT into erythrocytes ( Shattuck and 
Storm, 1985; Gentile et a l, 1988). Haemolysis however, either remained unaffected or 
was increased by CaM (Rogel et a l, 1991; Ehrman et a l, 1991). Thus with bound CaM, 
the configuration of the N-terminal portion of ACT may prevent access to the cell interior, 
but pore formation still takes place and causes cell lysis (Rogel e ta l, 1991).
Truncated AC, produced by in-phase deletion of a hydrophobic membrane- spanning 
region of CyaA, did not raise cAMP levels in target cells , but retained 12-50% of 
haemolytic activity (Bellalou e ta l, 1990 b). This suggests a possible mechanism of entry of 
ACT where the C-terminal portion of CyaA would create a pore through which the catalytic 
portion (N-terminus) could enter the cytosol. A simplified view of possible events involved 
in invasion of target cells is given in Fig.3 .
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Fig .3
Possible Mode of Action of ACT.
A proposed view of the mode of action of ACT . (A) Binding of ACT to its receptor 
via its C- terminal moiety , (B) pore formation and penetration of the catalytic and 
CaM - binding sites (N-terminal moieties) into the cell interior through the pore , 
(C) activation via interaction with CaM and uncontrolled generation of cAMP. 
Abbreviations : BS = binding site for cell surface receptor(R), CS = catalytic site, 
CaM = calmodulin binding site , R = cell surface receptor .
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Influence o f calcium on ACT
The role of calcium in the catalytic and invasive activities of ACT has been investigated 
by several workers. Masure et a l (1988) reported that calcium influenced several properties 
of ACT, including its chromatographic behaviour, the Stokes radius of the enzyme, the 
mobility of the protein on SDS-PAGE and the effectiveness of ACT to elevate cAMP in 
target cells.A greater Mj. in the presence of calcium was noted. It was suggested that AC 
interacts directly with calcium which affects its physical and enzymatic properties. Hanski 
and Faifel (1985) observed that on fractionation of AC toxin by ultrogel the peak with toxin 
activity had an apparent size of 190 kDa in the presence of calcium and 340 kDa in the 
absence of calcium .The presence of calcium is not an essential feature for the enzymic 
activity of AC since the activity was shown both in the presence and absence of calcium 
(Greenlee et al, 1988). Gentile et al. (1990) have substantiated this finding and reported 
that calcium is not an absolute requirement for catalytic activity but an indispensible cofactor 
for the invasive activity of ACT.
There is some evidence that calcium might be involved in attachment of ACT to target 
cells. E. coli alpha haemolysin requires calcium for its action (Boehm et al, 1990). The 
presence of 11 tandemly- repeated sequences each consisting of 9 amino acids have been 
found necessary for the binding of E. coli haemolysin to the erythrocyte membrane and 
these sequences appear to bind calcium (Boehm et al, 1990). Similar sequences have been 
identified on B. pertussis ACT (Glaser et a l, 1988 b). Very recently, Hewlett et a l (1991) 
have also shown a role for calcium in ACT structure and function in that calcium binding 
caused a conformational change in ACT. The exposure of purified ACT to free calcium at 
concentrations between 1 - 1 0  qM resulted in a conformational alteration as viewed by 
negative staining and electron microscopy.Calcium induced conformational changes in the 
ACT molecule from folded to linear, which was found necessary for the insertion of ACT 
into target cells and for delivery of its catalytic domain to the cell interior.
The effect of calcium on the haemolytic activity of ACT has been reported recently. 
Bellalou et al. (1990 b) have shown that the haemolytic activity of ACT was calcium- 
dependent. However, in another report, exclusion of calcium and addition of a calcium 
chelating agent (EDTA) did not prevent the binding and haemolytic activity of AC (Rogel et 
a l,  1991). This group has shown a distinct dissociation of haemolytic and cAMP 
accumulation activities of ACT by manipulating the calcium concentration in the incubation 
medium for sheep RBCs. Recently, it has been shown that haemolytic activity of E. coli 
grown in the absence of calcium was calcium- dependent and grown in the presence of
P A R T I  -31" INTRODUCTION
calcium was calcium - independent (Boehm et al., 1990).
A similar possibility of calcium- dependent haemolytic activity could be anticipated for B. 
pertussis ACT.
Influence o f calmodulin on ACT
Wolff et al. (1980) discovered that B. pertussis AC was stimulated by calmodulin 
(CaM) and the stimulation of cell bound AC was 100- fold higher than the AC recovered 
from culture supernates. The half-maximal stimulation of AC associated with intact cells 
occurred at a concentration of 45 nM CaM (Masure et al., 1987). CaM regulation of B. 
pertussis AC differs from CaM stimulation of mammalian AC in several respects. Calcium 
is an obligatory requirement for CaM-stimulation of brain AC but not the bacterial AC and 
the addition of EGTA to the CaM - stimulated B. pertussis AC did not readily reverse the 
stimulation of the enzyme (Wolff gf al., 1980). In fact B. pertussis AC is stimulated by 
CaM both in the presence and absence of calcium (Greenlee et al., 1982 ; Kilhoffer et al.,
1983).
In contrast to the stimulation of AC enzymic activity by CaM, the toxic activity of AC 
may be inhibited by exogenous calmodulin.lt has been demonstrated that addition of qM 
CaM prevented the formation of cAMP in target cells catalyzed by partially purified AC 
(Shattuck and Storm, 1985). Rogel et al. (1989) reported the CaM- mediated inhibition of 
purified ACT activity and showed that the inhibitory effect of CaM was dose dependent.
Exogenous CaM has recently been shown to potentiate the haemolytic activity of ACT. 
The lag time for haemolysis was shortened and the extent of lysis was considerably 
increased in the presence of exogenous CaM. Under similar conditions, CaM almost 
completely blocked intracellular cAMP generation in target cells (Rogel et al., 1991; Ehrman 
et a l, 1991). Thus with bound CaM, the configuration of the N-terminus of ACT prevents 
access of the toxin to the cell interior, but pore formation still takes place and causes cell 
lysis (Rogel et a l, 1991). However, the blocking effect seems to be target cell specific, 
depending upon the type and nature of the cells, since in Chinese hamster ovary (CHO) 
cells, accumulation of cAMP was unaffected when CaM was added (Gentile et al, 1990).
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ACT as a virulence factor.
ACT is believed to be a major virulence factor of B. pertussis and presumably 
of B. parapertussis andB. bronchiseptica on the basis of the following arguments:
(1) ACT, after being activated by a host cell protein, calmodulin, can raise internal cAMP 
levels of many eukaryotic cells. Neutrophils and macrophages attain cAMP levels high 
enough to paralyse those functions that are effective in combating infection (Confer and 
Eaton, 1982; Hanski and Farfel, 1985; Friedman et ah, 1987 b; Pearson etal., 1987).
(2) B. pertussis Tn5- insertion mutants lacking ACT are avirulent in a mouse model (Weiss 
et al., 1984).
(3) The cloned ACT gene was able to restore virulence to an ACT-deficient Tn5 insertion 
mutant of B. pertussis when introduced on a plasmid (Brownlie et a l, 1988).
(4) Although PT is widely considered to be a major virulence factor of B. pertussis, 
Bordetella species in which the pertussis toxin gene is not expressed i.e., B. parapertussis 
andB. bronchiseptica (Arico and Rappuoli, 1987) retain virulence and secrete an active, 
CaM-sensitive ACT ( Pearson et al., 1987).
(5) ACT production is a feature of virulent B. pertussis and the production is lost together 
with several other virulence factors, in phase variant, avirulent strains (Parton and Durham, 
1978).
(6 ) ACT and antibodies to AC appear to be protective in animal models (Brezin et al., 
1987; Guiso e ta l, 1989; Guiso e ta l, 1991).
(7) High tides of anti-AC antibodies are produced in man during pertussis infection (Farfel 
e ta l, 1990., Arciniega e ta l, 1991).
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Homology o f ACT with RTX toxins.
AC has been included in the family of pore forming toxins, designated as RTX 
(Repeat in Toxin ). The family comprises broadly disseminated cytolytic toxins including E. 
coli alpha-haemolysin (HlyA), haemolytica leukotoxin (Lkt A) m d Bordetella
pertussis adenylate cyclase toxin (CyaA). Other toxins related to this group are found in 
Actinobacillus actinomycetemcomitans (AktA), Proteus vulgaris, and Morganella morganii 
(Welch, 1991; Coote,1992). The common structural feature among these toxins is the 
presence of a tandem array of a nine amino acid repeats (L-X-G-G-X-G(N/D)-D-X) in each 
of the toxin proteins (Welch, 1991; Coote, 1992 a).The amino acid sequence of the 
C-terminal 1250 aa of AC exhibits 25% similarity with E. coli haemolysin and 22% 
similarity with haemolytica leukotoxin (Glaser et aU, 1988 b ).
Analysis of the sequence homology between these toxins shows that starting from aa 50 
(350 in cyaA ),all toxins reveal obvious similarity up to and including the glycine -rich 
repeats. These are followed by a C- terminal end of 134 residues in HlyA 128 in LktA, 77 
in CyaA, and 209 in AktA, Within the homologous region, all the proteins share two 
important domains; several hydrophobic, potentially membrane spanning regions in the 
N-terminal half and the glycine- rich repeats towards the C- terminal end. A comparison of 
the genetic organization of the RTX determinants is given in Fig. 4
PART I - 34 - INTRODUCTION
Fig. 4
Genetic organization of RTX toxins.
Comparison of the genetic organization of the RTX toxin determinants. A) The 
genes encoding the HlyA, LktA, AktA and associated proteins are identically 
organized, tolC is unlinked to the hly operon. The tolC equivalent on the cya 
operon, B), is cyaE .. cyaC is encoded in the opposite orientation on cya operon. 
The figure is based on the data from Glaser et ah (1988 a,b); Barry et al. (1991) 
and Welch (1991).
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Cloning and expression o f the cya locus in E .coli
Using the interaction between ACT and CaM as a probe, Glaser etal. (1988 a,b) 
determined its complete nucleotide sequence after cloning the corresponding cya gene from 
B. pertussis to a cya -defective E. coli harbouring a plasmid which expressed high levels 
of calmodulin. According to their findings, ACT is synthesized as a large precursor of 1706 
amino acid residues, endowed with catalytic and haemolytic activity. The protein has been 
given the name of cycolysin to indicate its activities (Glaser et ah, 1989). The secretion of 
the CyaA protein was found to require the products of three genes : cya B, D, and E 
coordinately expressed with the cyaA (the structural gene)
Brownlie et al. (1988), with the help of appropriate expression vectors, cloned the B. 
pertussis adenylate cyclase structural gene into E. coli and demonstrated AC activity in E. 
coli . Moreover, this enzyme activity was enhanced by calmodulin, although not to the 
levels found in pai'ent strain extracts of B. pertussis.. They cloned the AC genetic 
determinant on a broad- host -range plasmid pLAFRl. The recombinant plasmid, designated 
as pRMB 1 was identified by its ability to restore the AC enzymic and haemolytic activities 
of a transposon insertion mutant B. pertussis strain BP348, deficient in both these 
activities. A 10 kb Bam HI fragment contained in pRMBl was subcloned into the vector 
pIC20H to give the plasmid pRMB3. Expression of AC in E. coli was found to be 
dependent on the orientation of the insert, and was thus expressed from the lacZ promoter 
present in the vector. A 3kb Bam HI/ Eco R1 fragment was subcloned into pIC20H to give 
pRMB9. AC enzymic activity was reported from both the constructs which was shown to 
be increased 250- fold in the presence of exogenous CaM. However,these constructs were 
unable to show haemolysis on BG medium and extracts from them were found non-toxic in 
a S49 mouse lymphoma cell assay. The 10 kb Bam HI fragment was subcloned in another 
vector, pGLW ll, in two orientations to give plasmids pRMB6  and pRMB7 and the 
expression of AC was determined in these constructs . Production of AC was found in 
pRMB6  and not in pRMB7 indicating again that the insert in the former depended on the tac 
promoter in the vector and needed an exogenous promoter for expression . Comparison of 
the open reading frame (ORE) for B, pertussis AC (Glaser et al., 1988 b) with pRMB3 and 
pRMB9 showed that pRMB3 contained the entire ORE whereas pRMB9 contained only 5' 
end (2.6 kb) of the ORE and produced a 95 kDa protein. (Brownlie et a l, 1988) which 
includes the CaM-binding and catalytic domains of the polypeptide. The restriction maps of 
plasmids containing cloned B. pertussis DNA and which were used in the present work 
are given in Eig.5
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Figo5
Restriction Maps of Plasmids Containing B. pertussis cya
DNA.
Restriction sites are shown for Bam HI, B., Eco Rl, E. The position of promoters 
and direction of transcription are indicated as arrows over each plasmid . The 
genetic organization of the cya operon is also shown.The Fig. is based on the data 
from Brownlie et a i (1988); Glaser et a i (1988 a,b); and Barry et al. (1991).
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Rogel et al. (1989) reported the production of 200 kDa CyaA protein by expression 
of pRMB3 in a Lon- protease defective E. coli strain. This protein was recognized by 
anti-AC monoclonal antibody but had no haemolytic activity and was non - toxic in S49 
lymphoma cells..
The export of CyaA from E. coli using the transport system of E. coli alpha 
-haemolysin (hlyB, hlyD and tolC ) has been reported recently by Masure et al.. 
(1990). This group suggested that the gene products of the hly toperon may have 
recognized the signal sequence of CyaA and facilitated the secretion of 215 kDa AC. 
However, only 20% of the total AC activity was released into the culture medium ( cf > 
70% for B. pertussis Tohama). This form exhibited the enzymic activity but was found 
non-toxic in mouse neuroblastoma cells.
Expression of toxic AC from cloned E. coli has very recently been reported 
(Sebo et al., 1991) after the identification of the fifth gene, cyaC, of the cya operon 
responsible for the activation of cyaA product. Reconstruction of the cya locus by 
cloning different genes on appropriate vectors, and under the control of E. coli 
promoters and tran'slational signals enabled the production of a 200 kDa CyaA in E. 
coli with full invasive and partial haemolytic activity (Sebo et al., 1991).
POLYMORPHONUCLEAR (PMNs) LEUKOCYTES: ROLE IN
PHAGOCYTOSIS.
Phagocytes were the first eukaryotic cells to be used by Confer and Eaton (1982), 
as target cells to detect the toxic activity of ACT.In order to understand the effects that 
AC toxin may have on phagocytes, their activities and functions should be explained.
The role of PMNs in health and disease is well-established. Bacterial pathogenicity 
is heavily dependent on the capacities of the microbial cells to avoid or to resist the 
antimicrobial activities of poplymorphonuclear leukocytes, the first line of phagocytic 
defence against infection (Spitznagel, 1983).
Neutrophils are the most active and common (60-70%) leukocytes in the blood 
(Van Furth and Willemze, 1979) and exist in blood as circulating cells but in 
pathological conditions they adhere to the post- capillary venules, leave blood stream 
and migrate towards damaged tissue (Beesley et al., 1978).Neutrophils are attracted to 
the area of infection or damage by microbial or host-derived chemotactic factors, 
including complement components C5a and C3b, f-Met-tri peptides, collagen peptides, 
lymphokines, interleukin 1, leukotriene B4, and platelet activating factors. In immune 
complexes, neutrophils are attracted by formation of activated complement components
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following Ab-Ag reactions (Romeo, 1982).
Phagocytosis occurs with sequential receptor-ligand binding between the PMN 
and the microorganism. The motive force of phagocytosis resides in actin, myosin and 
actin-binding proteins. It has been proposed that the cytoplasm near the site of 
partiele-PMN contact undergoes gelation and cross linking of F actin. This causes 
puckering of the plasma membrane at the site of contact because of attachment of 
microfilaments to the membrane. Bulging of the membrane around the particle occurs, 
and new particle-membrane contacts results. The net result is the formation of 
pseudopodia and a phagocytic vacuole (Yin and Stossel, 1982). Observations suggest 
that the concentration of free cytoplasmic Ca++ is involved in either activation of 
NADPH oxidase (enzyme responsible for superoxide production) or degranulation of 
primary granules into the phagosome (Sawyer et al., 1989) or in both processes (Clark 
,1990). Calcium and magnesium ions are also required for optimal phagocytosis 
(Wilkins and Bangham 1964 ; Janah et al., 1990; Baggiolini and Wymann 1990).
In general, bacteria and other particles must be coated or opsonized for attachment 
and ingestion to occur. The major opsonins are IgG (the only class of immunoglobin 
that promotes phagocytosis in PMNs) and complement. IgG binds to bacteria with the 
Fab end, allowing interaction between the Fc portion and Fc receptors on the 
phagocytic cell. Interaction of IgG and Fc receptors opens calcium-dependent channels 
that may be important in regulation of phagocytosis and post-phagocytic events (Young 
et al., 1985). Cell wall components of Gram-positive bacteria (Wilkinson et a/., 1978) 
and outer-membrane components of Gram-negative bacteria (LPS) can combine with 
serum factors to form C3 esterase and to fix C3b to microbial surfaces (Morrison and 
Kine 1977). Capsules of bacteria may prevent exposure of these outer-wall or - 
membrane components to the serum, and in such cases specific antibody to the capsule 
is required before complement activation can occur (Horwitz and Silverstein, 1980).
Microbiocidal Activty
A consequence of phagocytosis is the fusion of the phagosomal vacuole with the 
lysosomal granules which are involved in killing and digestion of the engulfed bacteria. 
Neutrophils contain two types of granules 1) primary (azurophilic), containing 
myeloperoxidase, lysozyme, acid hydrolases, cationic proteins and proteases.
2) Secondary (specific granules) containing the lysozyme, cytochrome b, collagenase 
and the high affinity iron - binding protein lactoferrin which limits the availability 
of iron to bacteria ( Sawyer et al., 1989).
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There are two main arms of the microbiocidal activity of the PMNs; oxygen- 
dependent mechanisms and oxygen-independent mechanisms. Oxygen-dependent 
mechanisms rely on toxic molecules produced as a result of the oxidative burst. Resting 
PMNs consume little oxygen, since most of their energy comes from glycolysis. 
Oxygen-independent mechanisms are responsible for microbial killing in anaerobic 
environments such as the gastrointestinal tract, and vaginal mucosa. These mechanisms 
utilize lysozyme, lactoferrin, and cationic proteins called defensins with MW between 
3 kDa and 3.9 kDa , substances which are localized in the azurophilic granules and 
possess antimicrobial activity against bacteria, fungi, and certain enveloped viruses 
(Ganz et al., 1985). Another cationic protein with microbicidal activity in PMN 
azurophilic granules is the bactericidal/ permeability-increasing protein (BPI). BPI is 
membrane-associated, and the intracellular presence of bacteria is required for its 
bactericidal activity (Weiss et al., 1978),
Oxygen-dependent mechanisms of phagocytes involve the production of the 
respiratory burst which consists of a marked increase in oxygen consumption that 
occurs during and subsequent to ingestion of microbes by PMNs. This increased 
oxygen consumption results from activation of a NADPH oxidase, which accepts two 
electrons from NADPH and transfers them to an FAD-flavoprotein associated with 
cytchrome b245 and from there to oxygen (Sawyer et al, 1989).
NADPH"®— >FAD-Protein“®----> Cytochrome b245"®----- > O2  —> 0 2 “ (superoxide)
NADPH oxidase is not expressed in the resting PMNs. Part of the cytochrome 
b245 is translocated from the cytoplasm (perhaps from the secondary granules) to the 
plasma membrane following stimulation. In an acidic milieu, superoxide anion is 
converted to H2 O2  by superoxide dismutase. Hydrogen peroxide with myeloperoxidase 
(released from primary granules) and a chloride ion produces hypochlorous acid, a 
potent microbicidal agent. Other halides, such as iodide, can be used in the 
myeloperoxidase-hydrogen peroxide reaction. Bacterial halogénation is closely 
correlated with bacterial death.
The hexose monophosphate shunt is activated during the respiratory burst and 
provides reduced pyridine nucleotide and reduced glutathione, which protects the PMN 
from oxidative damage by removing excess H2 O2  (Babior, 1984 ),
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CHEMILUMINESCENCE AS AN ASSAY.
Generation of chemiluminescence (CL) by human neutrophils during phagocytosis was 
originally described by Allen et al. (1972) . PMNs in their resting stage consume little 
oxygen . Perturbation or stimulation via the plasma membrane initiates a burst of metabolic 
activity with an accompanying dramatic increase in oxygen consumption, superoxide 
generation, formation of hydrogen peroxide, singlet oxygen, and activation of the hexose 
monophosphate shunt (HMP-shunt ). All contribute to phagocytosis and the phenomenon 
is collectively referred to as the respiratory burst (Babior, 1978). The generated oxidative 
species postulated to be involved in chemiluminescent reactions and their decay result in 
light production but the reactions of these species with endogenous substrate yields ultra- 
weak chemiluminescence ( < 1 photon / cell /  sec) which needs to be amplified by addition 
of a synthetic substrate e.g., luminol or DNDH, (see Materials and Methods, page 59) .This 
increases the light emission 1 0   ^ - 1 0  4 - fold (Anthony, 1986) by acting as a bystander 
substrate for these oxidative species and the oxidation results in the production of an excited 
aminophthalate anion which when relaxed to the ground state, emits light. The mechanism 
of light emission is totally myeloperoxidase - hydrogen peroxide dependent (Dahlgren and 
Stendahl, 1983).
In addition to resulting from phagocytosis of particulate matter, the respiratory burst 
may be elicited by certain soluble stimuli e.g., fMLP, concanavaHn A and PMA (Dechatelet 
and Shirley, 1976; 1982 ) .  Any membrane - associated event may alter the ablity of PMNs 
to generate chemiluminescence when induced with stimulant, e.g., PMA in a luminol or 
DNDH amplified response, and this is the basis for assesment of toxin activity. Light 
emitted, with the return of high energy state to ground state levels , during the activities of 
phagocytosis can be quantitated as chemiluminescence (CL) as originally described by Allen 
et al, (1972). It can be regarded as a cumulative measure of more than one function of the 
cellular response to stimulants,
CL has also been used to evaluate the effect of serum opsonins ( Robinson et al„
1984). Lillius et al. (1985) showed that CL can be used to detect the presence of opsonins 
against S. pertussis ; higher levels of opsonins against 5. pertussis were found in pertussis 
patients than in vaccinated individuals .
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Mechanism of Oxidative Burst.
The oxidative burst begins with the binding of stimulant to cell surface receptors 
activating a guanine nucleotide -binding protein (G protein), which in turn activates plasma 
membrane phospholipase.The latter hydrolyses phosphatidyl biphosphate, generating two 
intracellular secondary messengers, 1) 1,4,5- inositol triphosphate (IP3) and 2) 
diacylglycerol (DAG).IP3 releases Ca++ from intracellular stores,including the endoplasmic 
reticulum and microsomal organelles, calciosomes (Sawyer et a l 1989), increases the 
affinity of DAG for cytosolic protein kinase C (PKC), which is activated and translocated to 
the cell membrane (Janah et. al., 1990).The PKC phosphorylates the cellular proteins 
(actins) which brings about the cellular function in response to 
chemotattactants,e.g.,formyl-methionine-leucine-phenylalanine(fMLP) (Berridge,1984). 
Another stimulant, phorbol myristate acetate (PMA), on the other hand, circumvents the 
initial steps by acting directly on PKC, after which the course of events is similar to that 
evoked by fMLP (Niedel, 1983). A schematic representation of the events involved in the 
process of phagocytic cell response to the fMLP and PMA is shown in Fig. 6
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Fig. 6
A Simplified View of the Events Involved After Stimulation of PMNs 
with fMLP and PMA,
Coupling of fMLP to its cell surface receptor leads to G~ protein activation of 
phospholipase C(PLC), PLC hydrolyse phosphatidylinisitol 1,4,5- biphosphate 
(IP2) to produce two secondary messenger molecules : Inositol 1,4,5-trihosphate 
(IP3) and 1,2-diacyl glycerol (DAG). IP3 mobilizes calcium from intracellular 
stores, thereby increasing the concentration of cytosolic calcium, which may also be 
elevated by influx of calcium from the extracellular space via calcium channels. 
DAG is a direct stimulus of protein kinase C (PKC). PMA directly effects PKC. 
These processes lead to activation of a variety of intracellular processes collectively 
referred to as the respiratory burst. The figure is based on the data from Sawyer et 
«/. (1989).
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OBJECT OF RESEARCH
Among the many biologically active factors produced by B. pertussis y adenylate 
cyclase (AC) is one which is presumed to contribute to the pathogenesis of whooping 
cough in a unique manner, by inhibiting the various activities of host phagocytes by 
elevating their cAMP levels .This AC has been reported to exist in various forms . The 
aim of the present investigation was to identify and characterize these different forms 
of AC in B. pertussis, B. parapertussis , B. bronchiseptica, and also in recombinant 
E. coli. A further aim was the development of more convenient, rapid and sensitive 
procedures for detection of AC and for the determination of its enzymic and toxic 
activities.
AC should be considered as a potential immunogen for inclusion in future acellular 
pertussis vaccines, but as yet, there is a little evidence that AC may act as protective 
antigen. This study also involved the screening of human sera from pertussis patients 
for the presence of anti-AC antibodies in order to determine whether AC is one of the 
major antigens of B. pertussis recognized during pertussis infection. Intranasal 
passive protection tests in a murine model were planned to determine the protective 
activity of B. pertussis AC.
Another important aspect of AC is its genetic homology with a family of pore 
forming toxins (RTX toxins). This study also aimed at revealing the immunological 
relatedness of AC to the other RTX toxins which may help in understanding the 
structure- function relationship of AC.
MATERIALS AND METHODS
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BACTERIAL CULTURES 
Bordetellae
The strains used in this study and their relevant characteristics are listed in Table 3. 
These strains were obtained from the culture collection of the Department of 
Microbiology, University of Glasgow. Plate cultures of 5. pertussis , B. parapertusis 
B. bronchiseptica and B. avium were grown on Bordet-Gengou (BG,Gibco-BRL) 
medium with 1% glycerol and 15% defibrinated sheep blood (Becton-Dickinson) 
incubated at 37 °C for 72 h in a humidified box. Broth cultures were grown in 
cyclodextrin liquid medium (CDL, Imaizumi et a/., 1983, App.I ) at 37®C for 48 h on 
an orbital shaker with 80 rpm for aeration.
E, coli .
The strains of E. coli used in this study are listed in Table 4 and the plasmids used in 
Table 5. Cultures were grown on nutrient agar (Oxoid) with their respective antibiotics 
(see Table 4). Liquid cultures were grown either in nutrient broth or brain heart 
infusion broth (Oxoid) at 37 ®C for 24 hr on an orbital shaker at 80 rpm.
EXTRACTION OF ADENYLATE CYCLASE (AC) FROM  B ,  
PERTUSSIS  AND E. COLI STRAINS WITH UREA.
Crude preparations of adenylate cyclase (AC) were made by an adaptation of the 
method of Brownlie et al. (1988) and Confer and Eaton (1982). B. pertussis cells 
were grown as lawns on BG plates with their respective antibiotics (Tabled ) for 72 h 
at 37 ®C in a moist atmosphere. The resulting growth was used as inoculum in a ratio 
of 1 plate /  1 litre of CDL medium. E. coli cultures containing pRMB3 were grown at 
37 ®C for 24 h on nutrient agar with their respective antibiotics, and inoculated, as 
above, into 1 litre volumes of BHI broth. Cultures were incubated on a orbital shaker 
at 80 rpm for 48 h in the case of B. pertussis and for 24 h in the case of E. coli or until 
the cultures reached ODg5o=2 , monitored on a Shimadzu recording spectrophotometer. 
The cells were harvested at 6000 g for 10 min at 4 (Sorvall RC5B). The pellet 
(approx. 1.3 g wet weight of the cells) was resuspended in 10 ml of distilled water 
containing 0.5mM of the protease inhibitor, phenyl methyl sulphonyl fluoride (PMSF, 
Sigma) and kept frozen overnight at - 20 ^C. On the following day, the suspensions
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were thawed at room temp and crystalline urea (BDH) was added to the final 
concentration of 4 M. Suspensions were stirred at 4 for 10 min . In order to 
solublize the intracellular AC from E. coli, cells were sonicated 3 times with a MSE 
sonifier at maximal output for 30 s on an ice bath. Low speed centrifugation of the B, 
pertussis and E. coli suspensions was carried out at 8000 g for 15 min at 4 ®C to 
remove the insoluble material. The supernate was ultracentrifuged at 160,000 g for Ih 
at 4 ^C in an OTD-Combi /  A 148561 machine. The resultant supernate was collected 
and stored at - 20 ^C as ’ urea extracts '. It is important to mention here that the 
samples prepared for toxicity assays did not receive PMSF to avoid the possiblility of 
interference of the protease inhibitor in the assays.
E. coli cells containing cloned AC under the control of the inducible tac promoter 
(Table 4 & 5 ) were grown in NB until OD 0.4 - 0.5, after which, IPTG (Sigma)
was added to 0.5mM final concentration and cells were harvested at 0 0 5 5 0 =1 . The rest 
of the steps were performed as above.
DIALYSIS
Urea extracts were dialyzed against dialysis buffer (100 mM NaCl, 10 mM Tiis-HCl 
pH 7.5, 1 mM CaCl2  ) before any toxicity assay to remove urea, according to the 
method of Brownlie et al. (1988). Conventional dialysis was carried out in dialysis 
membrane ( size 1 - 8  / 32 " ) against 2000 volumes of dialysis buffer at 4 for 48 h 
with continous stirring. The buffer was changed twice per day. After completion of 
dialysis, the samples were centrifuged at 6000g for 5 min to remove insoluble 
precipitates, and stored at - 2 0  ^c , usually for not more than one month if the 
samples were to be used for toxicity assays. An alternative method to the conventional 
dialysis, a microdialyzer (Pierce. USA ) was used according to the manufacturer’s 
instructions. The molecular mass- cut off of the membrane was 50,000. This method of 
dialysis was used with the small volumes of purified AC.
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Table 3 Strains of Bordetellae Used in this Study.
Strains Plasmid/mutation/ 
antibiotic marker
Phenotype
B. pertussis 348pRMBl« Recombinant, Tc^ 
pRMBl, vir +
AC++» HLY+
B. pertussis Tohama v/r + Wild type
B pertussis 165 Wild type
B. pertussis 18323 vi’r + Wild type
B. pertussis 77/18319 vir + Wild type
B. pertussis BP347* vir -l::Tn5 Km^ vir-
B, pertussis BP349* hly -2 :: Tn5 Km^ AC±, HLY -
B. pertussis BP348* hly ~l::Tn5 Km^ AC -, HLY -
B. pertussis BP353* j%a-lxTn5 Km^ FHA", AC+
B. pertussis BP357* ptr -2:: Tn5 Km^ PT -, AC+
B , parapertussis 5952 Wild type AC+
B. avium 4148 Wild type A C -
B. bronchiseptica 214 Wild type AC+
-  Tn5 insertion mutants ( Weiss et aL, 1983).
• = Recombinant strain ( BP348 [Tn5 mutant, HLY" AC“]harbouring plasmid pRMBl 
Brownlie et aî,, (1988).
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Table 4 E.colî Strains Used in This Study
Strain 
E, coli
Plasmid Genotype & antibiotic marker
H1469 /(?«-: :TnlO-Tc^
H1469 (pRMB3) pRMB3 cya Amp^^,Tc^
H1469 (pRMB9) pRMB9 cyaA, Ampl^jTcl^
H1469 (pRMB6 ) pRMB6 cya A,B,D, Amp^,Tcl^
H1469 (pRMB6,pANN202) pRMB6 , pANN202 cya A,B,D hly C {E. coli 
AmpE,Tcl^,CmE,
H1469 (pANN202) pANN202 hly C (E. coli ) 
TcR,CmR.
H1469 (pRMB6 ,pKIMl) pRMB6 , pKIMl cyaA,B,D.hlyC 
{P,vulgaris ) 
Ampl^,Tc^,Cm^
H1469 (pKIMl) pKIMl hlyC {P.vulgaris) 
Ampl^,Tc^
H1469 (pRMB6,pANGE3) pRMB6 , pANGE 3 cya A,B,D, C 
Ampf^,Tc^,Cmf^
H1469 (pANGE3) pANGE3 cyaC
E, coli 582 pSF4000 Crn^
E. coli G802 A cya
VBrvranBnBnBnanBBnsss?E9Bsni
pRMB3, pRMB9, pRMB6  (Brownlie et a/.,1988), pANN202, pKIMl obtained from Kim 
Hardie (University of Cambridge), pANGE3 (G.W estrop,Department of 
Microbiology,University of Glasgow).
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Table 5
Plasmids of Recombinant E.coli Strains Used in This Study
Plasmid Vector Promoter
pRMB3 pIC20H la c
pRMB9 pIC20H lac
pRMB6 pGLWll tac
pANN202 pACYC184 hlyC (E. coli )
pKEVH pACYC184 hlyC {P. vulgaris)
pANGE3 pACYC184 tet^
pRMB3, pRMB9, pRMB6 , Brownlie et a l (1988)
pANN202, pKIMl. Obtained from Kim Hardie ( University of Cambridge)
pANGE3 G.Westrop (Department of Microbiology, University of Glasgow)
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CHROMATOGRAPHY TECHNIQUES.
Phenyl-Sepharose Chromatography.
The method was essentially that of Hewlett et aL (1989). 4 M Urea extracts 
(2ml, 2 mg protein / ml ) of B. pertussis BP348 (pRMBl) were diluted 1:1 with buffer 
A1 (10 mM Tricine pH 8 , 0.5 mM ethylenediamine - tetraacetic acid, di sodium salt 
[EDTA, BDH], 0,5mM ethylene glycol bis N N-N'-N'tetraacetic acid [EGTA, Sigma ]) 
to reduce the urea concentration to 2 M. This material was loaded onto 3 ml 
phenyl-sepharose CL4 B (Sigma) previously equilibrated with buffer AL The column 
was washed with 3 bed volumes of buffer A1 containing 2 M urea. Bound protein was 
eluted with 8 M urea in buffer A l, and the eluates were collected in 0.5ml volumes . 
Protein concentration was determined, and fractions were stored at -20^C .
Calmodulin - Agarose Chromatography (Affinity chromatography)
Purification of AC from urea extracts of B. pertussis BP348 (pRMBl) was carried 
out as described by Bellalou et a l (1990 a). 4M urea extracts (2 ml) were diluted 1 in 4 
in buffer A2 (50 mM Tris-HCl pH 8 , 0.22 mM CaCl2  and 0.1% Nonidet-P40, [Sigma]) 
and left to adsorb onto 3 ml Calmodulin-agarose (Sigma) in polystyrene tubes on a 
rotating mixer with a speed of 15 rpm for 12 h at 4 ^C. The gel was loaded into a 
column and washed with 50 ml of buffer A2 containing 0.5 M NaCl. Bound proteins 
were eluted with 8  M urea in Buffer A2. The eluates were collected sequentially in 0.5 
ml aliquots by gravity flow. The purified AC was not dialysed as described in the 
original method but was stored frozen immediately at - 2 0  ^C.
PROTEIN ESTIMATION.
Protein estimation was carried out by the method of Bradford (1976), using bovine 
serum albumin (Sigma) as standard. The protein was measured at A5 9 5  using a 
Shimadzu recording spectrophotometer.
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SODIUM  DODECYL SU LPH A TE P O L Y A C R Y L A M ID E  GEL 
ELECTROPHORESIS (SDS-PAGE)
SDS-PAGE was performed acording to the method of Laemmli (1970) . 7,5% 
resolving gels were used throught this study unless otherwise stated. Stacking gels 
contained 4.5% acrylamide. Samples were solubilised in an equal vol of sample buffer 
(App.II) and boiled in a water bath at 100 ®C for 3 min . The same procedure was 
applied to the molecular weight standards (SDS-6 H), obtained from Sigma. Loading 
volume of samples was adjusted according to the capacity of the respective gel i.e.,50 
/O-l (Img protein/ml ) for 1.5 mm thick gels and 25-30yul (Img protein/ml) for 0.8 mm 
thick gels. Samples were electrophoresed into the stacking gel at 20 mA and at 25 mA 
in the separating gel for 0.8 mm thick gels. For 1,5 mm thick gel, the current for the 
stacking gel was increased to 30 mA and for the separating gel to 45 m A . Gels were run 
until the tracking dye reached the bottom of the gel, after which gels were stained either 
by Coomassie blue or by the silver staining method adapted from the procedure of 
Oakley etal .(1980).
IMMUNOBLOTTING / WESTERN BLOTTING
Immunoblotting was performed according to the method of Towbin et al. (1984) in 
a Bio-rad 'Transblot ' transfer apparatus. A sandwich of nitrocellulose membrane 
(Schleicher and Schuell) or Hybond-C (Amersham) and gel was prepared between two 
sheets of Whatman paper (3mm) , with one scotch bright pad on each side. This 
sandwich was loaded into a sandwich assembly and placed in a tank of transfer buffer 
(App.III) with the nitrocellulose facing the anode. Protein was transferred at 30V across 
the sandwich for 18 h followed by 50V for 1 h in order to transfer the higher molecular 
weight proteins . Then , the nitrocellulose membrane was stained with 0.5% Ponceau S 
in 0.1% acetic acid for 5 min and then destained with distilled water with three to four 
changes. Transferred protein bands were visualized and bands of MW standard were 
marked. A complete destaining was then performed with multiple rinses with PBS 
(pH7.3). Non-specific binding sites were blocked with Blotto/ Tween (3% skimmed 
milk + 0.2% Tween 20 in PBS,DulbeccoA, pH 7.3, Oxoid). by incubation at room 
temp for Ih on a shaker. Blots were probed with the appropriate antibody, diluted in 
blotto/ Tween, at room temperature for Ih under shaking condition. After probing, 
nitrocellulose membrane was washed two times for 15 min each, with PBS 
(DulbeccoA,pH 7.3,Oxoid) and then incubated with anti-immunoglobulin serum 
conjugated to horseradish peroxidase (Scottish Antibody Production Unit, SAPU),
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diluted in Blotto/ Tween . Subsequent washing was carried out two times for 15 min 
each in PBS (Dulbecco A, pH 7.3, Oxoid),Colour development was performed with 
diaminobenzidine (DAB,Aldrich) substrate solution (App.ni).The reaction was stopped 
after approximately 3 min with distilled water and the blots were stored in the dark.
ISO-ELECTRIC FOCUSING.
A method from the instruction manual 1-2117-EOl (LKB -Pharmacia) was applied 
for fractionation of urea extracts and purified AC in isoelectric focusing gels. Stock 
solutions of acrylamide (29.1%),N,N-bis-methylene acrylamide (bis)0.9% and 
ammonium persulphate (1 %) were prepared in deionized water and filtered through 
Whatman paper 1, stored at 4 in dark and used within two weeks of preparation. 
Ampholines of pH range 3.5-9.5 (product no 1804-101) were obtained from LKB 
Pharmacia .Electrodes solutions used were : cathode=lM NaOH, anode=lM H3PO4 .
A total volume of 60 ml was prepared by mixing 10 ml of bis acrylamide, 7 ml of 87% 
glycerol, and 3.5 ml of ampholines. The volume was adjusted to 58.5 ml with deionized 
water, 1.5 ml of ammonium persulphate was added and the contents were mixed by 
gentle swirling and immediately poured into the casting mould. Gels containing 6 M urea 
were also used , in which case , 20 ml of 6  M urea was prepared first and rest of 
solutions were added step by step to this solution . After polymerisation (20-30 min), 
the gel was removed from the thick glass plate and excess water from the surroundings 
was removed with filter paper by capillary action . The gel was then placed on the 
cooling plate of LKB model 2117 Multiphor system . Electrode wicks (LKB 1850-911) 
were dipped in electrode buffers, and laid along the cathode and anode sides of the 
plate. Samples (30 yul) were applied to the sample applicators provided in the kit 
(LKB 1850-901). Three different positions for the application of each sample were 
selected i.e., near the cathode , in the middle of the gel, and near the anode. The p/ 
standard marker (Pharmacia) was also applied near the cathode at position 1 .Gels were 
run at 8  , initially at 25 V /cm at a current of 30 mA. The voltage was increased in
steps after every 10 min to 100 V/cm after 70 min and sample applicators were removed. 
The run was terminated after 2.5 h or until the tracking dye of standard reached the 
anode .Gels were placed in fixing solution (App.III) for 30 min and in staining 
solution (App.in) for 10 min preheated at 60®C.Destaining was carried out with several 
changes of destaining solution (App.III).
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Table 6 Antibodies / antisera used in this study
Antibodies/antisera Description
R164 Polyclonal anti-AC antibody, raised in mice against punfied 50 and
kb'vAC
200[obtained from E.Hanski,Israel.Reacts with 50 kDa,95 kDa and 
210 and 200 kDa AC on immunoblots at 1:500 dilution.
McU
PcU
Monoclonal anti-AC antibody, obtained from A.Ullmann, Pasteur 
Institute, Paris. Reacts with 210, 200 kDa AC on imunoblots at 
1:4000 dilution
Polyclonal anti-AC antibody, raised in rabbit against 45 kDa AC, 
obtained from A. Ullmann, Pasteur Institute, Paris. Reacts with 
200 and 210 kDa and other forms of AC on immunoblots at 1:1000 
dilution.
Mc9D4 Monoclonal anti-AC antibody, ascites IgG2a, obtained from 
E,Hewlett, University of Virginia, USA., reacts with 200 and 210 
kDa AC on immunoblots at 1:1000 - 1:1500 dilution
MclH6 Monoclonal anti-AC antibody, ascitesIgGi, obtained from E.
Hewlett, University of Virginia, USA.Reacts with 200 and 210 kDa 
AC on immunoblots at 1:1000 dilution.
Msl Monospecific anti-AC serum, raised in rabbits against CaM - affinity 
purified AC (this study). Reacts with 200 and 210 kDa AC on 
imunoblots at 1 : 1 0 0 0  dilution.
McFHA5 Monoclonal anti-FHA antibody, obtained from Dr.A.E 
Ashworth, PHLS,CAMR,UK.Reacts on immunoblots at 
1 : 1 0 0 0  dilution.
HS Convalescent sera of culture-confirmed pertussis patients. 
Provided by Prof. A.C Wardlaw, Dept, of Micribiology, 
University of Glasgow.
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PREPARATION OF RTX TOXINS.
The range of RTX toxins used in the investigation included the leukotoxin of P. 
haemolytica strain S/C 82/1, the leukotoxin of A. actinomycetemcomitans strains JP
2 and 29523 , the a-haemolysin of E. coli strain 582, and the ACT of B. pertussis . 
Leukotoxin of P. haemolytica S/C 82/1 was kindly provided by Mr Qurban Ali, 
Department of Microbiology, University of Glasgow, as a lyophilized culture supemate, 
which was reconstituted in sterile distilled water to the final protein concentration of 2  
mg / ml. Exotoxin of A. actinomycetemcomitans was prepared from whole cells grown 
on blood agar for 24 h in the presence of 5% CO2  . The growth was directly solubilized 
in sample buffer (App.II) ,E. coli alpha -haemolysin was prepared by growing the cells 
in BHI broth with Cm (20 |ig/ml) for 24 h at 37 “ C on an orbital shaker at 80 rpm. The 
culture supernate was filtered through a 0.45 jam filter (Acrodisc, Gelman ) and 
concentrated by Aquacide (Sodium salt of carboxymethyl-cellulose, Calbiochem.). 10 
ml culture supernate was concentrated down to 1 ml ( protein = 0.4 mg/ml ). All these 
toxin preparations were solubilized (except A. actinomycetemcomitans which was 
already prepared in sample buffer) in sample buffer and boiled for 3 min prior to 
SDS-PAGE.
PRODUCTION OF ANTIBODIES (Msl) AGAINST NITROCELLULOSE 
-BOUND ACT.
The method was adapted and modified from the procedure of Diano et al. (1987). 
CaM-affinity purified AC obtained from the urea extracts of B. pertussis BP348 
pRMBl(AC'^'^) was resolved by SDS-PAGE using a 7.5% acrylamide gel and 
transferred to nitrocellulose membrane (Schlercher &Schuell) overnight at 30V and 15 
oc. The transferred protein was stained with Ponceau S (0.5% Ponceau S in 0.1% 
acetic acid) for five min. The membrane was rinsed in sterile deionized distilled water for 
3-4 times after which, the bands at 210-200 kDa were carefully cut o u t. Precautions 
were taken to handle the material carefully with gloved hands and alcohol - sterilized 
scalpel and forceps to avoid contamination. Bands were destained in sterile PBS 
(Dulbecco A , pH 7.3, Oxoid ) and stored frozen at - 20 °C.
When material from 20 bands was collected, (representing 50 - 60 jig protein) the 
frozen bands were further chopped into 2-3 mm^ pieces.The material was suspended in
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sterile PBS (500 jil /  band) and sonicated at maximal output, with 20 -seconds cooling 
intervals in an ice bath until the nitrocellulose was reduced to a fine suspension, and the 
paiticle size was small enough to pass through an 18-gauge hypodermic needle.
The suspension of AC-bearing nitrocellulose in PBS was emulsified in Freund's 
incomplete adjuvant (Sigma) in 1:1 ratio. A female New Zealand Albino rabbit was 
injected with 1.5 ml subcutaneously at two sites. Before injection, the rabbit was bled 
for pre-immune serum. The first injections were followed by two boosters at 15 day 
intervals.The rabbit was bled on day 40 and serum was collected.
CONCENTRATION OF M SI BY SALTING-OUT TECHNIQUE.
Ice-cold (10 ml) anti-AC antiserum raised against nitrocellulose bound AC, was 
stirred in a beaker. While stirring , 7 ml saturated ammonium sulphate was added. The 
mixture was stirrred for 1 h at room temperature and then centrifuged at 6000 g for 1 0  
min at 4 ®C. The pellet was collected and resuspended in saturated ammonium sulphate 
as before. The suspension was stirred for another 30 min and then centrifuged at 6000 
g for 10 min at 4 ^C. The pellet was resuspended in 5 ml of saline (0.15 M NaCl), and 
dialyzed against 2000 volumes of saline overnight at 4 “C to remove the salt. The 
concentrated immunoglobulin was stored at - 2 0  ®C for future use.
ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA)
The specificity and titre of the antiserum raised against nitrocellulose bound AC 
was determined by ELISA. CaM-affinity purified AC was diluted to give a protein cone 
of 4 |ig/nil in 50 mM carbonate /coating buffer (App. IE). 100 jil of this diluted antigen 
was dispensed in each well of the microplate (Nunc ImmunoplateF). The plate was 
incubated at 4 °C after which the wells were emptied and washed three times by 
carefully flooding with washing buffer (App. Ill) . Washing buffer containing 1% 
bovine serum albumin was dispensed into the wells as blocking agent. The plate was 
incubated for Ih at 37 °C. Wells were again washed three times with washing buffer. 
Antiserum was diluted 10-fold up to lin 20,000 in washing buffer and 100 jil/well was 
added . The plate was incubated for Ih at 37 °C , then was washed three times with 
washing buffer. HRP-anti rabbit IgG conjugate (lin 5000 in washing buffer ) was 
added (100 \i\! well ), incubated at 37 °C for Ih and washed 3 times with washing 
buffer. Finally, 100 jil /well chromogenic substrate O- phenylene diamine (OPD, Sigma 
, App.IE) was added to the wells and the plate was incubated at room temp for 30 min
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in dark for colour development. The reaction was stopped by the addition of 50 |Lll 12.5 
% H2 SO4  Absorbance (Ag2 0 ) each well was measured on an ELISA reader (Anthos 
reader, 2001). Net absorbance was determined by substracting the Ag2 0  controls from 
the values obtained from antiserum- containing wells.
INTRANASAL PASSIVE PROTECTION TESTS IN MURINE MODEL.
Test 1. B,pertussis 18323 was giown on Bordet-Gengou agar supplemented with 
15% defibrinated sheep blood, at 37 ®C for 48 h . The growth was suspended in 1% 
cas amino acids (CAA, in PBS Dulbecco A, pH 7.3, Oxoid) was made up to 10 opacity 
units (ou) (2 X 10  ^ cfu /  ml) by comparison with the 5^  ^ International Reference of 
Opacity (WHO, 1975). The suspension was diluted 1 in 5 ( ~4 x 10  ^cfu/ ml=Dilution
1) and 1 in 10 (- 2 X 10  ^cfu /m l = Dilution 2 ).
Monospecifc antiserum Msl (Table 6  ) , was raised against nitrocellulose bound, 
CaM-affinity purified AC, as described on page 53. The antiserum reacted with urea 
extracts at 1 : 1 0 0 0  dilution on immunoblots.
High dilution and low dilution challenge suspensions (0.5 ml each) were mixed 
with 0.5 ml 1% casamino acids (in PBS Dulbecco A, pH7.3, Oxiod). These served as 
positive conti'ols of the high challenge dose -  2 x 1 0  ^cfu / ml and low challenge dose 
= 1x1 0  ^cfu / ml respectively .
Msl (0.5 m l), heated at 56 °C for 20 minutes to inactivate the complement activity 
was incubated with 0.5 ml each of the original suspensions of the challenge at room 
temperature for 1 h.
Groups of 10, 3 - 4  week old, CD-I strain mice were anaesthetised with ether, and 
infected by intranasal administration of 25 pi bacterial suspension in casamino acids 
with or without antiserum . One group of mice was given CAA only and one group of 
mice was left uninoculated as control. Mice were weighed every two days and any 
fatalities noted over a period of 3 weeks.
Bacterial counts from the inocula were performed by sampling 10-fold serial 
dilutions on BG. Three weeks post infection, mice were individually weighed and 
sacrificed and leukocyte count (by Coulter counter) and lung pathology were recorded. 
Lungs were removed and weighed, and pieces of lungs were spread aseptically over 
BG plates. Plates were incubated at 37 ®C in a moist atmosphere for 72 h and 
examined.
Test 2 .The immunoglobulins in Msl antiserum were concentrated by salting out (see
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page 54), and dialyzed against saline. The experiment as described in test Iwas repeated 
with concenti’ated Msl and halothane as an anaesthetizing agent.
ASSAYS FOR ADENYLATE CYCLASE ENZYMIC ACTIVITY.
Salomon Assay
Adenylate cyclase activity was determined according to the method of Salomon et a l
(1974). The reaction involved the conversion of [alpha ^2p] ATP to [alpha cAMP, 
which was then separated from substrate [alpha ^^P] ATP by two sequential 
chromatography steps using Dowex 50 x4 (200-400 mesh) and Neutral alumina 
columns. The assay was performed in a final volume of 100 pi at 30 ®C containing 25 
mM Tris-HCl, pH 7.5, 10 mM MgCl2 , 1 pM CaM (bovine brain calmodulin. Sigma), 
ImM ATP, and 10-20 cpm /  pmol [alpha 32P] ATP. The reagents were incubated for 
10 min and the reaction was terminated by addition of 100 pi of 2% SDS (Sigma), and 
ATP (1.4 mM), after which 100 pi of cAMP recovery standard ([% ] cAMP ) was 
added. The samples were loaded onto the first column which bound cAMP (by a non­
specific interaction with the resin) allowing other labelled compounds to be washed 
away . The cAMP was then washed with distilled water directly onto the second column 
(alumina) to which it absorbed together with any remaining ATP. Bound cAMP was 
recovered by washing the column with imidazole buffer (0.3 mM, pH 7.4) and 
quantified by liquid scintillation counting.
Amersham Assay (Binding Protein Assay)
This involved using a cyclic AMP assay kit (Amersham TRK428) as per
manufacturer's instructions. The assay is based on the competition between unlabelled 
cAMP of the test sample and a fixed quantity of the tritium - labelled compound for 
binding to a protein. The detection limits for this assay are 0.2 -16 pmol. The standard 
amounts of 1,2,4,8, and 16 pmol cAMP were used and a blank count was also 
performed. Since the assay has a narrow range for detection of cAMP, the urea extracts 
of B. pertussis and cloned E .coli had to be tested at a range of dilutions i.e., neat and 
10 - fold diluted (10“l, 10'^, 10"  ^) in a total volume of 40 p i . The samples were mixed 
with 120 pi of 0.002 M ATP in 0.02M MgCl2  , 80 pi 0.18 M Tricine pH 8 , and an 
optional 250 units bovine brain calmodulin (Sigma). Controls with no ATP were also
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included. After incubation for 15 min at 30 , the reaction was terminated by boiling
for 20 min. Test samples at this stage could be stored at - 20 ^C. Subsequent steps 
involved the measurment of cAMP in these test samples by use of the cAMP assay kit 
(Amersham TRK428) according to the protocol provided by the manufacturers.
Microplate Assay
A simple qualitative assay for cAMP was developed for the detection of enzymatic 
activity of adenylate cyclase . E.coli G802 (A cya ) indicator strain (see Table 4) was 
streaked onto NA+ 0.025% IPTG+ 0.025% X-gal and incubated at 37 for 12 h. A 
single white colony was used to inoculate a 10 ml test suspension (BHIB4- 0.025% 
IPTG+ 0.025% X-gal ). For qualitative analysis, 25 pi of reaction mixture (App.III) 
was dispensed in the wells of a microtitre plate followed by 25 pi of dialysed urea 
extracts./ culture supemate / CaM-affinity purified AC. The contents were mixed and the 
plate was incubated at 37 °C for Ih , then 150 pi of test culture {E.coli G802, grown 
at 37 °C until OD ggg 0.4 in test suspension) was added. The contents were mixed and
the plate was incubated at 37®C for 12h . Adenylate cyclase transforms ATP into 
cAMP which permeates into the indicator strain where it stimulates the production of 
h-galactosidase from the lac operon. This enzyme utilizes the X-gal, a substrate 
analogue, and hydrolysis produces a blue colour.
For the semi-quantitative analysis of the AC enzymic activity in the cyclase 
preparations, the assay was further developed.A standard curve of exogenously added 
cAMP (Sigma) in known concentrations (micromol ) was obtained against OD5 2 0  using 
an ELISA reader (Anthos reader, 2001). cAMP was diluted in a range of 64 micromol to 
0.5 micro mol / 50 pi . The dilutions were added to the wells in triplicate. Samples of 
unknown were prepared. A 50 pi sample was incubated with equal volume of reaction 
mixture at 37°C for 15 min , after which the sample was boiled at 100 °C for 15 min to 
destroy any residual AC activity, A 2-fold dilution of the samples was made in distilled 
water. Test culture (150 pi ) was added to the wells containing cAMP and unknown, 
plus to two extra rows as a control. The volume was adjusted with reaction mixture. 
The contents were mixed and the plate was incubated for 12 h at 37®C. ODg2 0  was 
measured on ELISA reader (Anthos reader, 2001) after 12 h incubation .The standard 
curve of ODg2 0 .was plotted against the concentration of cAMP added.
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ASSAYS FOR ADENYLATE CYCLASE TOXIC ACTIVITY.
Neutrophil Preparation
Glycogen-induced rabbit peritoneal neutrophils were obtained from female New 
Zealand white rabbits according to the method of Lackie (1977). Normal sterile saline 
(500 ml) containing (0.1% ) oyster glycogen (Sigma) was injected intiapeiitoneally via a 
18 gauge needle. The peritoneal exudate was collected after 4 h stored at 4 ^C and used 
within 2 days of isolation . PMNs were recovered from the fluid by centrifugation at 500 
g for 10 min. Contaminating erythrocytes were removed from the resulting neutrophil 
pellet by hypotonic lysis (5 ml distilled water for 5 sec) and cells washed once in 
divalent -cation -free HEPES buffer (App. Ill) .Washed cells were resuspended in 
HEPES buffer and were used within 1 day of preparation. A monodisperse population 
of cells was obtained by passing the cells through a 10 p m Nitex filter (Plastok 
Associates, Birkenhead). This technique produced a PMN suspension of > 95% purity 
and viability as determined by the Trypan blue dye exclusion test. Cell numbers were 
standardized after counting in an improved Neubauer counting chamber (Weber 
Scientific International Ltd.England.).
Nitroblue Tétrazolium Reduction (NBTR) Assay.
An assay based on the method reported for pertussis toxin by Craig and Parton 
(1988) and Craig et al. (1990) was used for the detection of toxic activity of AC using 
nitroblue tétrazolium reduction (NBTR) activity of rabbit peritoneal neutrophils as a 
probe. Rabbit neutrophils from peritoneal exudate were purified as described above. 
Rabbit neutrophils (50 pi of 10  ^cells/ml ) were dispensed into the wells of a microtitre 
plate. Test sample (50 pi of dialysed urea extracts) and its 2-fold dilutions was added to 
the neutrophils, the contents were mixed and the plate was incubated at for Ih in a 
humidified box.After incubation, 50 pi of NBT (2.3 mM in HEPES) and 20 pi of a 
soluble stimulant, phorbol myiistate acetate ( PMA, O.lpg/ml in HEPES ) was added to 
the wells. The contents were mixed and the plate was incubated at 37 ®C in a humidified 
box. The results were recorded between 30 min to Ih after incubation. The toxin 
activity of ACT was judged by failure of neutrophils to reduce nitroblue tétrazolium to 
blue formazan. Unaffected neutrophils showed a purplish blue colour, an indication of 
actively metabolizing neutrophils.
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Chemiluminesence Assay (CL Assay)
The CL assay was performed using an automated luminometer (Wallac LKB 1251 
luminometer) connected to an Acom BBC B microcomputer . Chemiluminesence 
emission was measured in millivolts (mV) at 37 ^C. The number of neutrophils per 
assay tube was 1 0 *^ and the final volume of sample per tube was 1 0 0 0  pi. 
Dimethylamino-naphthalene-1,2-dicarbonic acid hydrazide (DNDH,Boehringer 
Mannheim GmbH , W. Germany ) was used instead of luminol because of its 2 -3 
times larger quantum yield than luminol in CL emitting oxidation - reduction reactions 
(Allen, 1982). DNDH was first prepared as a 10"  ^M stock solution in dimethyl 
sulphoxide, diluted 100-fold in HEPES buffer (App II), then stored at -20 °C until 
used. After adding neutrophils plus buffer, DNDH was added to a final concentration of 
10"  ^M. The stimulus for CL was either the soluble chemotactic factor,PMA (Sigma) or 
as otherwise stated. PMA was first prepared as a 1 mg/ml stock solution in dimethyl 
sulphoxide and diluted to the working dilution of 1 pg/ml. The final concentration of 
PMA per assay tube was O.lpg/ml. Neutrophils were always pre-warmed at 37 ^C for 
5 min before use. Samples were usually assayed in duplicate and the CL results shown 
are the mean values. The CL curves shown in the results are derived from a number of 
replicate observations. The peak values and the total CL is also presented in tabulated 
form for the ease of comparison of the data. The percentage inhibition was calculated 
according to the method of Al-Tuwaijri et al. (1990).
Opsonisation of B. pertussis Cells for CL Assay
The method followed an adaptation of the procedures of Chang et al. (1986) and 
Friedman etal. (1987 b). B. pertussis strains : BP348 (pRMBl) (AC"^+) and BP348 
(AC") were grown on BG medium for 72 h at 37 ^C in a humidified box. Bacterial 
growth was collected and washed with HEPES buffer (App.II) at 6,000 g for 6  min at 4 
°C. The pellet was resuspended in HEPES buffer and the opacity was adjusted to 10 ou. 
by comparison with the 5^  ^ International Reference Preparation of Opacity, WHO
(1975). This suspension (= ~2xl0^ cells / ml ) was diluted 200 times in HEPES buffer 
to 10  ^cells / ml. To one volume of bacterial suspension, 0.5 volume of fresh normal 
rabbit serum (heated at 56“C for 30 min for inactivation of complement), and 0.5 volume 
HEPES buffer was added. The suspension was tumbled end to end in polystyrene tubes 
for 30 min at 37^C. After incubation with serum, the suspension was centrifuged at 
2000 g for 3min and then washed 2 times with ice cold HEPES buffer .The pellet was
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resuspended to the original volume of the bacterial suspension . 500 p-1 of this 
suspension was added per assay tube. The final density of rabbit neutrophils was 
adjusted in HEPES buffer to 5x10^ / ml and 250 [il of this cell suspension was added 
per assay tube. After adding 200 |al DNDH and 100 |il HEPES, the ratio of bacterial 
cells to PMNs was ~ 40:1.
Effect of Calcium on AC Toxic Activity in CL.
Rabbit peritoneal neutrophils were obtained as described above. The neutrophils 
were washed in Ca++ - and Mg++- free HEPES containing 0.8 mM EDTA and 0.8 mM 
EGTA and resuspended in the same buffer. A stock solution of CaCl2  (50 mM) was
prepared in distilled water .The calcium requirements of rabbit neutrophils for CL 
response were measured on 1 0  ^cells / assay tube by adding the calcium from the stock 
to the vials giving the final concentrations of O.lmM, 0.3 mM , Im M , 3 m M , and 10 
mM. The effect of ACT (dialyzed urea extracts) for each calcium concentration was 
investigated.The neutrophils were incubated with 20 p,g protein / assay tube in the 
presence of different concentration of calcium as described above. After 15 min 
incubation at 37 °C, the stimulus (PMA) was added.The sum of CL measured in mV 
and the % inhibition of CL compared with the controls was calculated for each 
concentration of calcium.
Haemolytic Assay for AC.
Haemolytic activity of CaM-affinity purified AC from the urea extracts of B, 
pertussis BP348 (pRMBl) was determined by the method of Bellalou et al. (1990 b) 
except that 2% RBCs were used instead of 1%. RBCs from rabbit and sheep were 
compared for their sensitivity and were prepared as follows:
The blood was centrifuged at 5000 rpm at room temp for 3 min . The pellet was washed 
three times in haemolysis buffer (buffer H, 10 mM Tris-HCl pH 7.5, 100 mM NaCl, 
ImM CaCl2 ) and resuspended in buffer H to give final concentration of 2%. Neat and 2
fold dilutions of CaM-affinity purified ACT (representing 100 nmol cAMP / min /  ml 
enzymic activity in a total volume of 50 jxl of H buffer and its 2-fold dilutions) were 
used. Dilutions were prepared in duplicate in a round bottom microplate. Equal volumes 
of 2% sheep or rabbit RBCs were added to the wells. The plate was incubated at 37 
°C for 12-15 h in a humidified box.The haemolytic activity after incubation was
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measured by fransferring with great care, 30 |J,1 of the supemates into another empty 
microtitre plate. This plate was read on ELISA reader (Anthos 2001) at A5 4 0 . The 
assay was performed in duplicate and the mean was calculated.
In order to observe any blocking effect of anti- AC antisera on the haemolytic 
activity, the same assay was performed in the presence of monospecific anti-AC 
antiserum (Msl, Table 6 ). Neat and 2-fold dilutions of purified ACT (representing 60 
nmol cAMP/ min/ml AC enzymic activity in total volume of 50 \xl of buffer H before 
dilution ) were prepared in a round - bottom microtitre plate. A duplicate set of the same 
samples was prepared initially with 60 nmol cAMP / min / ml enzymic activity and its 2- 
fold dilution in a total volume of 25 \il of haemolysis buffer and incubated with 25 pi of 
anti-AC monospecific antiserum Msl for Ih at room temp. Controls of buffer and 
Msl+ buffer were also included in this assay. After incubation, equal volumes of 2% 
sheep RBCs were added to all the wells .The plate was incubated at 37 ^C for 12-15 h 
in a humidified box.The haemolytic activity after incubation was measured by 
transferring with a great care , 30 pi of the supemates into another empty microtitre 
plate. The plate was read on an ELISA reader at A5 4 0 . The assay was performed in 
duplicate and the mean was calculated.
Chinese Hamster Ovary (CHO) Cell Assay for AC Toxic Activity.
The CHO cell assay was performed as described by Hewlett et al. (1983).Cultures of 
CHO cells showing confluent growth were trypsinized for 5 min and diluted in 10 % 
foetal calf serum (GIBCO) to a concentration of approximately 2x10^ cells / ml. 250 pi 
of this cell suspension was dispensed into each of the wells of a sterile flat bottom 
microtitre plate and incubated at 37 “C in the presence of 5 % CO2  . After 16 h of 
incubation , the viability and adherence was checked by microscopy. When the cells 
showed a monolayer growth, the filter sterilized, CaM- affinity purified AC (200 nmol 
cAMP/ min / ml enzymic activity and its 2-fold dilutions in 100 mM phosphate buffer 
containing 0.5 M NaCl) was added under sterile conditions under the laminar flow 
cabinet. The plate was incubated in the same conditions and the morphological changes 
were recorded after 16-24 h growth. Medium was aspirated carefully from the wells and 
cells were air dried and fixed in 4 % formalin in PBS (Dulbecco A, pH 7.3 Oxoid, 200 
pi /  well ) for 15-20 min at room temp. After fixing, the formalin solution was poured 
off and cells were stained for 15 min with 50 pi / well of Coomassie blue staining 
solution (App. II). The weHs were rinsed with distilled water and the plate was air dried.
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results were recorded by observing AC - treated cells for elongation in comparison with 
control cells under the microscope.The assay was performed in duplicate and the 
controls of buffer without toxin were also included.
BHK Cell Assay
Baby hamster kidney (BHK) cells were trypsinized with trypsin -versene solution 
(TV= 0.5 ml of 2.5% trypsin in 20 ml of versene [1 mM EDTA in PBS pH 7.4]) and the 
cell sheet was rinsed 2 times with 5 ml HEPES buffer (App IH). The cells were treated 
again with TV , swirled and TV was drained. After five min the cells were checked 
under microscope and found to be detached and round. 5 ml HEPES containing 10% 
calf serum (GIBCO) was added to the cells and with a pasteur pipette, cells were mixed 
by aspirating and expelling the cell suspension 20 times. Cells were centrifuged at 1000 
rpm and the pellet was resuspended in HEPES. The cell density was estimated in a 
counting chamber. For assaying each sample, 5 ml of cell suspension containing 10  ^
BHK cells was needed.
Preparation o f cover slips Detergent -washed and dried cover slips (Imm^) were 
immersed in 2 ml of coating solution (20 |ig fibronectin /ml in HEPES) in a petri dish 
and left for 15 min and then coating solution was drained and replaced by 2 ml HEPES 
containing 0.5 mg/ml haemoglobin for another 15 min, after which this solution was 
drained and replaced with HEPES.
The samples to be tested and positive control (0.1 mM dibutyryl cAMP) were 
prepared in a final volume of 5 ml of the cell suspension containing 1 0  ^cells( 2x 2 ml 
for each duplicate sample). HEPES was removed from the cover slips and carefully the 
samples (2ml /cover slip) were added.The dishes were incubated at 37 °C for 45 min to 
1 h and then the cells were fixed with fixing solution ( 0.4% formalin in HEPES) for 15 
min. The fixing solution was removed and the cells were stained with Coomassie blue 
(App II) for 15 min, and then rinsed with distilled water 2-3 times. The cover slips were 
air-dried, and mounted with clear mount on slides . The result were scored on Leitz 
ortholux microscope connected to a BEEB vidio digitizer interphase and BBC 
microcomputer. Data collected for 50 cells included the area dispersion and % 
scattering measured as described by Edwards et al. (1988).
RESULTS
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IDENTIFICATION AND CHARACTERIZATION OF ADENYLATE 
CYCLASE (AC)
Extraction of Adenylate Cyclase by Urea.
Extracts of whole organism and concentrated culture supemates have been used as 
starting material by different groups for the isolation and purification of B. pertussis 
AC.In the present study, extraction of AC from intact cells of the B. pertussis and 
cloned E. coli sU’ains listed in Table 3&4 was carried out, High enzymic AC activity 
from the AC structural gene (cyaA ) has been expressed in E. coli from cloned DNA 
(Brownlie et a l, 1988). A 10 kb Bam HI fragment containing the open reading frames 
for cyaA , B, and D was cloned into the E. coli plasmid vector pIC20H to give a 
plasmid, pRMB3. Another 2.6 kb Bam HI fragment containing the 5'end of the cyaA 
open reading frame was also cloned into pIC20H to give pRMB9. Both were 
expressed under the control of lac promoter (Brownlie et a l, 1988). Each plasmid was 
then transfered into Lon " (protease negative) E, coli H I469 (Rogel e ta l, 1989).The 
10 kb Bam HI fragment was subcloned in another vector, pGLW ll, in two 
orientations to give plasmids pRMB6  and pRMB7 . The insert in the former depended 
on the tac promoter in the vector. Production of AC was determined in these 
constructs.
AC was extracted by a 'urea extraction technique'. The method applied was an 
adaptation and modification of the procedures of Brownlie et a l  (1988) and Confer 
and Eaton (1982) as described in Materials and Methods (see page 44). The cells after 
harvest were suspended in distilled water containing 0.5 mM PMSF (phenyl methyl 
sulphonyl flouride, a protease inhibitor) rather than in urea solution as described in the 
original protocols, and stored overnight at -20 “C. The cell suspension was thawed and 
urea was added to a final concentration of 4 M , which gave optimal results for 
extraction of AC from both B. pertussis and cloned E. coli strains. Moreover, this 
concentration of urea was easier to remove from the extracts in subsequent dialysis 
steps.
It is noteworthy to point out here that an extreme viscosity was observed when B. 
pertussis cells were harvested and ti'eated with 4M urea in their early log phase (22 - 24 
h), presumably due to the large amount of nucleic acid present in actively growing 
cells. The cell debris proved difficult to sediment in subsequent centrifugation steps. 
Therefore, cells were harvested after growth for 48 h (ODggg = 2) when the culture was 
in early stationary phase. This time of harvest solved the problem of viscosity and
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improved the yield in terms of total protein obtained per batch in which the AC ratio 
was 2- times higher than the AC obtained from the cells harvested at 24 h . The E. coli 
cells were harvested after 24 h. This agrees with the findings of Glaser et a l . (1989) 
who reported the maximum AC activity in recombinant E. coli cell extracts when the 
cells reached eaiiy stationary phase. Overall, these alterations of the methods led to an 
optimized production of crude AC by the urea extraction technique.
Isolation and Identification of AC in Urea Extracts by SDS-PAGE.
In order to detect the presence of AC in urea extracts of B, pertussis ( wild type 
and recombinant ) and E. coli ( harbouring plasmids containing different fragments of 
the B. pertussis cya operon ), the extracts were subjected to SDS-PAGE as described 
under Materials and Methods (see page 50). Coomassie blue staining of the gels 
showed a complex pattern of bands of various MWs ranging from 210-20 kDa (Fig7A) 
The differences in gel profiles of B . pertussis BP348 (pRMBl) (lane 1) andB. 
pertussis BP348 ( lane 2) were examined. Diffuse bands at 210, 110 and 95 kDa 
positions in urea extracts of the AC+ strain of B. pertussis BP348 (pRMBl) were 
more prominent than in B. pertussis BP348 (AC"). Bands visualized in the profile of 
B. pertussis BP348 (pRMBl) at 37 kDa and a few other low MW bands were missing 
from the gel profile of B. pertussis BP348.
The high MW bands were exclusively absent from the gel profile of a urea extract 
of a vir " transposon mutmt B . pertussis BP347 (lane 3) which fits with the inability of 
this strain to produce vir regulated proteins, including AC . Urea exh acts of another 
transposon insertion mutant B. pertussis BP349 Hly “ AC + showed a gel profile 
(lane 4 ) not very much different from that of B. pertussis BP348 (pRMBl) AC+ 
(lane 1) except that the 210 kDa band was less prominent in the gel profile of B. 
pertussis BP349.The profile of urea extract of the wild typeB. pertussis Tohama (lane 
5) showed a comparatively faint band at 210 kDa. Other bands in the range of 180 - 
95 kDa, and a prominant band at 69 kDa, were observed.
Urea extracts of other Bordetellae i.e., B. bronchiseptica , B. parapertussis and 
B. avium were also investigated for the presence and absence of bands which could be 
related to AC.Lane 6 , showing the gel profile of B. bronchiseptica, revealed a band at 
220 kDa which did not corresponded to the bands in the gel profiles of urea extracts of 
B. pertussis strains (lanes 1- 5). The bands common to the gel profiles of urea extracts 
of the B. pertussis were 210 and 50 kDa. Another band at 110 kDa was 
comparable to that in the gel profile of wild type B. pertussis Tohama ( lane 5 ) .  The 
profile of the urea extracts of B. parapertussis (lane 7) showed a comparatively
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reduced number of bands. In lane 8 , representing the profile forB. avium (AC '), a 
band at 110 kDa comparable to the bands visualized in the gel profiles of B. 
bronchiseptica diVidB. pertussis Tohama was observed. The possibility that this 
band was AC in B. bronchiseptica and in B . pertussis Tohama was therefore 
unlikely.
Urea extracts of E. coli harbouring various plasmids i.e., E, coli H I469 
(pANN202), E. coli H1469 (pANN202, pRMB3), E. coli H1469, E. coli H1469 
(pRMB9),and E.coli H I469 (pRMB3), were investigated. The relevant characteristics 
of these strains are listed in Tables 4 & 5 (see pages 47 &48) and pANN202 is 
described fully on page 75. Fig.7 B shows that none of the AC*** E. coli urea extracts 
showed high MW 210 or 200 kDa band in the profile of Coomassie blue- stained gels. 
Comparison of gel profiles of urea extracts of AC*** E. coli strains with AC " strains 
revealed a common band of 95 kDa in all the AC+ preparations ( lane 3= E. coli 
H1469 (pANN202, pRMB3), lane 5 =E. coli H1469 (pRMB9) and lane 6 = E. coli 
H1469 (pRMB3).
In order to investigate whether the absence of high MW bands of AC from 
Coomassie blue - stained gel profiles of urea extracts of E. coli was due to less AC 
protein being expressed in these strains, a more sensitive method, silver staining 
(detection limit for protein = 2 ng) was carried out. Fig. 8  shows the gel profile after 
silver staining , revealing a single band of 210 kDa, along with several other bands in 
the lane representing the urea extracts of E. coli H I469 (pRMB3) AC+ (lane 4).This 
single band was correspondingly absent from the E. coli H I469 AC " (lane 5). The 
extract of the strains with two plasmids i.e., E. coli H I469 (pRMB3, pANN202) did 
not show any band at high MW position . However, the bands at 50, and 95 kDa were 
observed (lane 2) which were missing fi’om the profile of the control preparation E. 
coli H I469 (pANN202) (lane 3).It was therefore assumed that the bands observed at 
high MW position in AC*** B. pertussis and E. coli urea extracts represented 
adenylate cyclase. The overall view was that the stained profiles of SDS-PAGE - 
separated urea extracts , either of B. pertussis or E. coli , displayed some differences 
among the profiles of AC*** and AC " strains, but it seemed difficult to identify these 
bands as AC at this stage.
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Fig. 7
SDS-PAGE Analysis of Crude P reparations (Urea E xtracts) of 
Adenylate Cyclase (AC) from B. pertussis and E. c o li .
Samples were separated by SDS - PAGE using 7.5 % acrylamide resolving gels. 
The gels were stained with Coomassie blue .Airows indicate major band difference 
between profiles.
Panel A) Urea extracts of B. pertussis and other Bordetellae
l=B. pertussis BP 348 (pRMBl) (AC++)
2 - B. pertussis BP348 (AC")
3~ B . pertussis BP 347 (AC")
4=B. pertussis BP349 (AC+, HLY ")
5~ B, pertussis Tohama (AC"**)
6 =B, bronchiseptica 214 
1~B. parapertussis 5952 
8 =B. avium 4148
Panel B) E. coU urea extracts harbouring B. pertussis cya gene and hly C 
gene from E. coli.
1 = SDS-6 H (MW standard )
2 =E. coli H1469 (pANN202) (AC ")
3= E. coli H1469 (pANN202 , pRMB3) (AC+)
4= E. coli H1469 (AC ")
5= E.coli H1469 (pRMB9) (AC***)
6= E.coli H1469 (pRMB3) (AC+)
B■ fe jË É
1
MW KD  
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4 5
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180
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Fig. 8
SDS-PAGE Analysis of Crude Preparations (urea extracts) of AC 
from B. pertussis and E. coli by Silver Staining Technique.
Samples were separated by SDS - PAGE using 7.5 % acrylamide resolving gels. 
The gels were stained by silver staining. Arrows indicate major band difference 
between profiles.
1= SDS-6 H ( MW standard)
2= E. coli H1469 (pANN202, pRMB3 ) (AC+) 
3= E. coli H1469 (pANN202) (AC")
E.coli H1469 (pRMB3) (AC+)
5^ E.coli H1469 (AC")
6= B. pertussis BP348 (pRMBl) (AC++)
1~ B. pertussis BP348 (AC")
MW KD 
205
116
97
66
45
29
KD
210
95
50
45
1 2 3 4 5 6 7
PART III - 6 8 - RESULTS
Detection of AC by the Immunoblotting Technique.
A number of anti- AC antibodies, ranging from polyclonal to monoclonal were 
used to detect AC unequivocally using the immunoblotting technique.The antibodies 
applied in these studies comprised anti - AC polyclonal PcU raised in the rabbit against 
a 45 kDa fragment of AC, mono-specific antibodies R164 raised in mice against a 
purified 50 kDa fragment of AC, anti-AC monospecific antibodies Msl and 
monoclonals 9D4, 1H6 and McU. The relevant characteristics of these antibodies are 
listed in Table. 6 , Urea extracts (20 |Lig protein/ lane) of B, pertussis and E. colt were 
resolved by SDS-PAGE and transferred to nitrocellulose as described under Materials 
and Methods (see page 50 ). Fig. 9A shows the immunoblot profile of urea extracts 
of different Bordetellae including recombinants and mutants, probed with anti-AC 
monoclonal 9D4. Generally, a profile with 2 major bands at MW 210 and 200 kDa 
was observed with B. pertussis, rather than a single band of 216 kDa (Hewlett et al 
1989), or 200 kDa (Rogel et al, 1989) as previously reported. Lane 1, illustrating the 
immunoblot profile obtained from urea extracts of B. parapertussis showed a single 
band at 210 kDa , Lane 2, representing B. avium (AC ") did not reveal any band in the 
whole profile, nor did a urea extract of B. pertussis BP348 (lane 3) a transposon 
insertion mutant, deficient in AC and HLY. This indicated the absence of AC from 
these strains and agreed with previous reports (Weiss et a l, 1983; Brownlie et a l, 
1988). Another mutant, B, pertussis BP349 (AC'*', HLY") showed a very faint band 
at 210 kDa (lane 4) suggesting the production of AC at a very low level, which agreed 
with finding of Weiss et a l . (1983) who reported that B. pertussis BP349 produced a 
reduced level of AC.Comparison of the immunoblot profiles of wild type B. pertussis 
77/18319,165, 18323, and Tohama (lanes 5, 8 , 9, and 10 respectively) showed 
different intensities of the reaction, indicating variable amounts of AC in these strains. 
B. pertussis 165 and 18323 showed a similar level of reaction. A weakly reactive 
profile was observed in the lane representing B. pertussis Tohama, as compared to 
other wild type B. pertussis , showing a faint band at 210 kDa and less prominent 
band at 200 kDa . B. pertussis 77/18319 revealed a moderate reaction and both 
bands i.e., 210 and 200 kDa were obseiTed. When other transposon insertion mutants 
were compared with B. pertussis (wild type and recombinant) for the presence of AC, 
the immunoblot profile of urea extracts of BP357 (PT ") showed an equal level of 
intensity of reaction (lane 7) to that of the recombinant B. pertussis BP348 (pRMBl) 
(AC'*"*',HLY"*') (lanell).This recombinant has been reported to produce 5 - fold higher 
AC toxin and 3- fold higher AC enzyme compared to the wild-type B. pertussis 
Tohama (Brownlie et a l 1988 ).
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On the other hand, another transposon mutant, B. pertussis BP353 (lane 6 ) ,  
deficient in FHA displayed a low level of reaction,comparable to B. pertussis Tohama.
These data suggest that despite prepaiing all the urea extracts under the same set of 
conditions, the levels of production / expression of AC varied from strain to strain in 
B. pertussis and that AC produced by these strains, by order of magnitude, was as 
follows :
B. pertussis BP348 (pRMBl) = BP357 > 165=18323 >77/18319 >B. parapertussis 
>BP353 > Tohama.
Polyclonal antiserum raised against a 45 kDa fragment of AC (PcU, Table 6 ) was 
used to recognize AC in the urea extracts of B . pertussis and E. coli on immunoblots.
The antiserum recognized a complex pattern of bands on immunoblots (Fig.9B). 
When the profile of urea extracts of AC+ strains : E. coli H I469 (pRMB3), E, coli 
H I469 (pRMB3, pANN202) and B. pertussis BP348 (pRMBl) (lanes 2, 4, and 6  
respectively ) were compared with those of AC “ strains , only high MW AC was 
differentiable and was distinguished in E.coli H1469 (pRMB3) as a single band of 
210 kDa, and in pertussis BP348 (pRMBl) as two major bands at 210 and 200 
kDa and a minor band of 195 kDa with a few other faint bands presumably due to some 
degradation of high MW AC. Other faint bands at low MW positions were also 
observed in the profiles of urea extracts of E.coli H I469 (pRMB3) and E.coli H1469 
(pRMB3, pANN202) at 47 - 50 kDa. These bands were missing from the profile of 
AC- strains used as controls i.e., E.coli H I469 (lane 3) and E.coli H I469 
(pANN202) (lane5). Common cross- reacting bands visualized in AC+ and AC " 
preparations may be due to the use of polyclonal antibodies which may contain 
antibodies against group- specific antigens.
Urea extracts of E, coli H I469 (pRMB 3), andE. coli H1469 ( pRMB 9 ), were 
tested for the presence of AC by using monospecific antiserum R164, raised in mice 
against purified fragment of 50 kDa AC. Fig. 10 A shows that urea extracts of E. 
coli H1469 (pRMB3) (lanel) showed a single sharp band of 210 kDa which was not 
present in AC " E. coli H I469 ( lane 3). E. coli H1469 (pRMB 9 ) carrying a 2,6 kb 
fragment of 5' end of the open reading frame of cyaA (Brownlie et al, 1988), revealed 
a 95 kDa band (lane 2) not present in lanes 1 and 3. The band at 50 kDa was also 
visualized in AC " E. coli H1469 (lane 3) and could not therefore be associated with 
pertussis AC. In addition, other faint bands at lower MW positions were found in all 
the three profiles, and may be due to other non - specific reactions.
In order to confirm that the high MW 210 - 200 kDa band visualized by probing 
with monospecific antiserum were AC, anti - AC monoclonal McU (Table 6 ) was 
used to detect the AC on immunoblots. Fig. 10 B shows thatB. pertussis
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BP348 (pRMBl) (lane 1) revealed the 2 band profile at 210 and 200 kDa (plus a 
couple of bands, possibly degradation products) which was consistent with the 
previously visualised bands observed after probing the extracts with monospecific and 
polyclonal antisera.Immunoblot profile of wild type B. pertussis strain 18323 showed 
two bands (lane 2).The immunoblot profile of B. pertussis BP348 (AC ") revealed a 
band reacting at 67 kDa MW position (lane 3) which was not seen with monoclonal 
4 D4 (Fig. 9A). The profile of E. coli H I469 (pRMB3) revealed a single band of 
210 kDa (lane 4) and no other band was observed. The urea extract of E. coli H1469 
was used as a control and the immunoblot profile showed no band in the whole lane 
(lane 5), confirming that the bands observed in the profiles of AC+ and missing from 
the profiles of AC ~B. pertussis and E. coli after probing with anti - AC polyclonals 
and monospecific antisera were in fact AC.
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Fig. 9
Identification of Bordetella  AC by the Immunoblotting Technique 
with Anti-AC Monoclonal and Polyclonal Antibody.
Urea exti'acts of Bordetella were separated by SDS-PAGE using 7.5% acrylamide. 
The resolved proteins were then electrophoretically transferred from gels to 
niti'ocelluiose. The nitrocellulose blots were probed with anti-AC monoclonal 
(1:1000) or anti-45 kDa AC polyclonal PcU (1:500).
Panel A) Immunoblot of Bordetella AC, probed with monoclonal 9D4.
l~ B. parapertussis (AC+)
1~B. avium (AC")
3= B. pertussis BP348 (AC")
4= B. pertussis BP349 (AC +, HLY")
5= B. pertussis 77/18319 (AC+)
6 = B. pertussis BP353 (AC+. FHA " )
7= B. pertussis BP357 (AC+, PT " )
8 = B. pertussis 165 (AC+)
9 = 5 . pertussis 18323 (AC'*')
10 = B. pertussis Tohama (AC+) 
n=B. pertussis BP348 (pRMBl) (AC++)
Panel B) Immunoblot of B. pertussis and E. coli probed with polyclonal PcU.
1= MW standard SDS-6 H
2= E. coli H1469 (pRMB3) (AC+)
3=5. coli H1469 (AC")
4= E. coli H1469 (pANN202, pRMB3) (AC+)
5= E. coli H1469 (pANN202) (AC")
6^ B. pertussis BP348 (pRMBl) (AC*"*-)
1= B. pertussis BP348 (AC")
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210
200
1 2 3 4 5 6  7 8 9  10 11
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Fig.lO
Id en tif ica tio n  of C loned B. pertussis AC in E. coli by the 
Immunoblotting Technique,
4M urea extracts of E. coli containing the cloned AC gene were subjected to 
SDS-PAGE in 12.5% (panel A) and 7.5% (panel B) acrylamide resolving gels and 
electrophoretically transferred to nitrocellulose. The blots were probed with 
mono-specific anti-AC antibodies R164 raised against 50 kDa AC., and 
monoclonal anti-AC antibodies McU. The dilutions of antibody were 1: 500, and 
1: 4000 respectively.
Panel A) Immunoblot of E. coli urea extracts, probed with anti-AC 
monospecific antibodies R164
1=5. coli H1469 (pRMB3) (AC+)
2=5. coli H1469 (pRMB9) (AC+)
3=5. coli H1469 (AC")
Panel B) Immunoblot of 5. coli urea extracts, probed with anti-AC 
monoclonal antibodies McU
l=B. pertussis BP348 (pRMBl) (AC++)
2= B . pertussis 18323 
3=5. pertussis BP348 (AC " )
E.coli H1469 (pRMB3) (AC+)
5=5. coli H1469 (AC")
6 =MW standard
210
93
50
MW KD
B
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Calmodulin - Affinity Probing of AC
Taking advantage of the affinity of AC for calmodulin (CaM), an alternative 
method was sought for the detection of AC on Western blots. The binding site for CaM 
is a part of the N-terminal portion of the toxin , adjacent to the catalytic site (Glaser et 
al., 1988).
Urea txtrsLCts of B. pertussis BP348 (pRMBl), and 5. co// H1469 (pRMB3) 
containing the high MW AC (as confirmed by its positive reaction with ant- AC 
monoclonal antibody), and the AC" BP348 and E. coli H1469 (controls) were 
separated by SDS-PAGE and electrophoretically transferred onto nitrocellulose. 
Tranferred proteins were probed with bovine brain calmodulin (50 units/lane) for Ih. 
Bound calmodulin was detected by probing the complex with goat anti- calmodulin, 
and finally with HRP-anti goat IgG. Substrate detection was carried out using DAB 
(diaminobenzidine substrate solution) as described in Materials and Methods under the 
procedure for immunoblotting (see page 50).
Fig. 11 shows the profile obtained after using calmodulin as a probe. Two major 
bands at 210 and 200 kDa and a minor band at 195 kDa were observed in the profiles 
representing two different urea extracts of B. pertussis BP348 (pRMBl) (lanes 4 and 
5), and a single faint band at 210 kDa in the profile of E. coli H1469 (pRMB3) (lane
2). This was consistent with the previous profiles obtained by probing the B. pertussis 
BP348 (pRMBl) and E. coli H I469 (pRMB3) with monoclonal and polyclonal 
antibodies (see Fig.9 & 10). These bands were missing from the profile of B. 
pertussis BP 348 (lane 3) and E. coli H1469 (lanel), which were used as AC " 
controls. Vaiious other common bands between AC"*" and AC " B. pertussis and E. 
coli were observed possibly due to the presence of calcium-binding proteins in the 
crude AC preparations. Since non - fat dried milk was used as a blocking agent, 
calmodulin may have coupled with these proteins via calcium present in milk and 
subsequently recognized by anti - calmodulin antibodies. However, the presence of 
high MW 210 and 200 kDa bands, similar to those observed by probing with 
monoclonal, polyclonal, and monospecific anti-AC antibodies in the urea extracts of 
AC"*" strains, and their parallel absence from the urea extracts of AC " strains of both 
B. pertussis and E. coli confirmed that the bands observed in the profiles were 
AC.Therefore, this novel method could be proposed as an alternative, although less 
sensitive technique for the detection of AC where anti- AC antibodies for the detection 
of AC are not available.
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Fig. 11
Detection of ACT in Urea Extracts by a Calmodulin - Affinity 
Probing Technique.
Urea extracts of B. pertussis and E. coli were resolved on SDS-PAGE with 7.5% 
acrylamide gel and transferred electrophoretically to nitrocellulose. The blots were 
probed with bovine brain calmodulin, followed by anti - calmodulin , and finally 
with anti- IgG conjugate.
1=5. coli H1469 (AC")
2 =5. coli H1469 (pRMB 3) (AC+)
3= B. pertussis BP348 (AC")
4= B. pertussis BP348 (pRMBl) (AC++) 
5= B. pertussis BP348 (pRMBl) (AC++) 
6 = SDS-6 H (MW standard )
MW KD 
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EXPRESSION OF B. PERTUSSIS AC IN E, COLI
Analysis of adenylate cyclase production from the E.coli strains, H1469 (pRMB3), 
and H I469 (pRMB9) showed a loss of AC production when repeatedly subcultured, 
as determined by immunoblotting (data not shown) although the antibiotic selection 
was maintained. This problem was not observed when freshly transfoimed cells were 
used. This finding suggested that, since pIC20H is a high copy number plasmid, the 
lac repressor protein (chromosomally encoded in E. coli strain H I469) might be 
limiting and expression of AC would therefore be constitutive. Overproduction of AC 
might have caused a metabolic burden or toxicity for the plasmid-bearing strain 
resulting in a slow and steady loss of the insert expressing AC by internal 
rearrangements of the plasmid. The E. coli strain harbouring double plasmids (5. coli 
H I469 pRMB3, pANN202) failed to produce full length AC. However, bands at 45, 
47 , and 50 kDa were detected by anti- AC polyclonal antibodies PCU (see Fig. 10) 
and AC enzymic activity was detected when these samples were tested by the 
microplate assay (Table 8 , see page 82 ).
In order to overcome these problems, a new construct H I469 (pRMB6 ) was 
prepared by Dr. Gareth Westrop . Here the same Bam HI fragment was cloned into 
vector pGLW ll cai*rying a lac I gene, encoding the lac repressor (Brownlie et ah, 
1988). Expression of AC in this sti'ain is under the tac promoter and is inducible, 
requiring ImM IPTG. Restoration of the plasmid stability was thus achieved by 
placing cyaA expression under the control of the inducible promoter. The new construct 
was characterized for the production of AC (Fig. 12A). Expression of cyaA in the 
presence of IPTG showed a stablized production of AC (lane 5, panel A) when 
compared with the AC production in the absence of inducer (lane 4, panel A ) which 
did not reveal any band. However, the AC produced by the strain E. coli H1469 
(pRMB6 ) was found non-toxic in the CL assay (toxicity assay) as shown in Table 17.
It has been recently reported that cyaC , which is located upstream of cyaA, is 
required for activation of the cyaA to its cell invasive form and the cyaC is 
homologous to hlyC of E. coli (Barry et ah, 1991). In order to activate the cyaA gene 
product in cloned E. coli , plasmids carrying either hlyC of P. vulgaris (pKIMl) or 
hlyC of E. coli (pANN202), or cy<3 C of B. pertussis (pANGE3) were cloned in a 
E. coli H I469 (pRMB6 ) background by transformation. These strains were donated 
by Dr. G. Westrop, Dep arment of Microbiology, University of Glasgow .The relevant 
characteristics of these strains are outlined in Tables 4 & 5 (Materials and Methods, see 
pages 47 &48).Stabilized production of AC by these strain namely : E. coli H1469 
(pRMB6 , pKIMl) , E. coli H1469 (pRMB6 , pANN202), and E. coli H I469
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(pRMB6 , pANGE 3) was observed , Fig. 12 B shows the immunoblot profile of urea 
extracts of these strains probed with anti-AC monoclonal 9D4. The high MW AC (210 
kDa) and a few minor bands were observed in the profile of all these strains (lanes
3-5) which was comparable to the positive control, B. pertussis 18323 (lane 2 ). B. 
pertussis BP348 (pRMBl) showed a family of bands ranging from 180- 45 kDa 
because the protein content was normalized in order to apply equal protein per well for 
B. pertussis and E. coli. The strong reaction of the bands reflects a 3 - 4 fold more 
production of AC by this strain which supports the previous reports for the 
overproduction of AC by this strain. Urea extracts of E. coli H1469 (pANGE 3) 
(lane 6 ) and E. coli H I469 (pKIMl) (lane 7) were included in this study as controls 
which did not show any band reacting to the anti-AC monoclonal 9D4 .Lane 8  shows 
the production of AC in 5. coli in the presence of pRMB6  alone.These data indicate 
that high MW AC (210 kDa) was expressed by these strain in the presence of two 
compatible plasmids. Further characterization of the activation of CyaA by HlyC was 
determined by toxicity assays as described on page 128.
PART III - 7 7 -  RESULTS
F ig .12
Expression and Induction of Cloned B, pertussis AC in E. coli : 
Immunoblot Assessment .
Urea extracts of B. pertussis strains and E, coli H1469 (pRMB6 ) (AC 
production under tac promoter and induced with IPTG) were separated by 
SDS-PAGE using 7.5% acrylamide resolving gels, and transferred to 
nitrocellulose.The immunoblot was probed with anti-AC monoclonal 9D4 (1:1000 
dilution).
Panel A)
1=B.pertussis BP348 (pRMB 1)
2= B. pertussis BP348 
3~ B. pertussis BP349
4= E. coli H1469 (pRMB6 ) not induced with IPTG 
S~ E.coli H I469 (pRMB6 ) induced with IPTG
Panel B) Immunoblot assessment of production of AC by B. pertussis strains 
and by E.coli strains haibouring single or double plasmids. All strains containing 
pRMB6  were induced with IPTG.
Urea exti*acts were resolved by SDS-PAGE and transferred to immunoblots. 
Probing was carried out with anti-AC monoclonal 9D4 (1:1000)
1 - B . pertussis BP348 (pRMBl)
2= B . pertussis 18323
3= E. coli H1469 (pRMB6 , pKIMl)
4= E. coli H1469 (pRMB6 , pANN202)
5= E. coli H1469 (pRMB6 , pANGE3)
6=5. coli H1469 (pANGE3)
7= 5. coli H1469 (pKIMl)
8=5, coli H1469 (pRMB6 )
29  —
B
KD
210
200
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DETERMINATION OF ADENYLATE CYCLASE ENZYMIC ACTIVITY
Estim ation of AC Enzymic Activity by Binding P ro tein  Assay 
(Amersham Assay).
Adenylate cyclase enzyme assay was performed with urea extracts of B.pertussis 
and E. coli strains using a cyclic AMP assay kit as described under Materials and 
Methods (see page 56).The assay was based on the competition between unlabelled 
cAMP of the test sample and a fixed quantity of tritium-labelled compound for binding 
to a protein which has affinity for cAMP. The detection limit for this assay was 0.2-16 
pmol and due to the narrow range for detection, the urea extracts of B. pertussis and 
E .coli were used as neat and 10 - fold diluted (10"l, lO" ,^ 10"4 ) samples. The urea 
cxtrsLCts from B . pertussis {pRMBX), B. pertussis BP348, H1469
(pRMB3), and E. coli H1469 were assayed. The samples were mixed with reaction 
mixture and incubated for 15 min at 30 ®C , and the reaction was terminated by boiling. 
Test samples were stored at - 20 ^C at this stage. The cAMP assay was performed as 
per manufacturer's instructions and, finally, the samples were added to scintillation 
fluid. Tritiated cAMP was counted in a scintillation counter.
The results showed that the amount of cAMP produced by AC from urea extracts 
of B. pertussis BP348 (pRMBl) was off the scale in neat and 10 " ^ dilution and it 
was measurable only in 10 dilution , in which the AC enzyme activity was scored as 
20 |imol cAMP/min/mg of protein. Measurable AC enzymic activity was observed in 
urea extracts of E.coli H I469 (pRMB3) in 10 dilution equilvalent to 6 . 8  pmol 
cAMP/min/mg of protein. E.coli H I469 and BP348 showed < 0.002 pmol 
cAMP/min/mg activity. The diffculty encountered in this assay was due to its narrow 
detection limits, since it required a range of dilutions of the samples which increased 
the number of tubes 4 -5  -fold for each sample. The assay itself was uneconomical 
due to the short half life of the cAMP binding protein used in this assay. Therefore, 
another assay, based on the method of Salomon et a l . (1974) was performed for the 
detection of AC enzyme activity.
Determ ination of Adenylate Cyclase Enzymic Activity by Salomon 
A ssay.
Adenylate cyclase enzymic activity was measured by conversion of [alpha -^^P] 
ATP to [^^P] cAMP in a cell- free assay as described under Materials and Methods 
(see page 56) . The AC enzyme activity of urea extracts from various strains of
PART III - 7 9 -  RESULTS
B.pertussis and 5 .co/i is given in Table 7. As is evident from the Table, the 
enzymic activity obtained varied from strain to strain. The recombinant strain B. 
pertussis BP348 (pRMBl) showed the highest level of enzyme activity. This agrees 
with the findings of Brownlie et a l, (1988 ) who reported a 3-fold increased enzymic 
activity over the wild type B. pertussis in this strain , The level of enzymic activity 
in the extract of a transposon insertion mutant B, pertussis BP357 (PT “) was 
comparable to that of B, pertussis BP348 (pRMBl) which corresponds to the data 
from the immunoblot study (see Fig 9A ).
On the other hand, the extracts of wild type B. pertussis : Tohama, 165, 18323, 
and 77/18319 displayed variable enzymic activities ranging from as low as 36.7 nmol 
cAMP/min/mg protein activity in the case of B . pertussis Tohama to 413 nmol cAMP 
/min/mg protein enzymic activity in case of B. pertussis 165. Comparable to the 
activity of extract of B. pertussis 165 was the activity detected in the extract of B. 
pertussis 18323 . The level of enzymic activity obtained by B. parapertussis was 
comparable to B. pertussis Tohama which agrees with the data from the immunoblot 
study.
Enzymic activity obtained from extracts of other transposon insertion mutants of B. 
pertussis also differed from strain to strain . B. pertussis BP353 (FHA") did not 
show high levels of AC activity like BP357 and a 94 nmol cAMP /min/mg protein 
enzymic activity was found in this strain. Enzymic activities obtained from B. pertussis 
BP348 (AC ", HLY") and B. pertussis BP349 (AC+, Flly "), which is reported to have 
a low level of enzymic acdvitiy (Weiss et al., 1983), were not different from each other 
and in both cases < 0.02 nmol cAMP/min/mg protein enzymic activity was observed.
When urea extracts of E. coli strains with single and double plasmids were tested 
for their AC enzymic activity, E. coli H I469 (pRMB6 , p A N N s h o w e d  the highest 
level of enzymic activity (1652 nmol cAMP/min/mg protein) as compared to E. coli 
H1469 (pRMB6,pAN'qa3), E. coli H1469 (pRMB6 ,pKIMl) and E. coli H1469 
(pRMB6 ). The data presented here indicate that the AC enzymic activity of cell extracts, 
despite preparation under the same set of conditions, seems to vary from strain to 
strain.
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Table 7
Determination of AC Enzymic 
Assay.
Activity of Urea Extracts by Salomon
Strain Protein content (mg/ml)
of urea extracts
Enzymic activity 
(nmol cAMP/min/mg protein)
Bordetellae *
B. pertussis BP 348 (pRMBl) 2 1450.68
B. pertussis Tohama 2 36.70
B. pertussis 18323 2 315.68
B. pertussis 165 2 413.65
B. pertussis BP357 2 1267.27
B. pertussis BP353 2 94.65
B. pertussis 77/18319 2 40.96
B. pertussis BP349 2 < 0 . 0 2
B. pertussis BP348 2 < 0 . 0 2
B. parapertussis 5952 2 40.13
B.bronchiseptica 214 2 541.37
E.coli ••
H1469 (pRMB6 ) 2.59 416.88
H1469 (pRMB6 , pANN202 ) 1.36 1652.73
H1469 (pRMB6 , pKIMl) 2.29 713.49
H1469 (pRMB6 , pANGE3) 1.62 1136.11
H1469 1.62 < 0 . 0 2
= Average of three determinations 
= Average of two determinations
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Determination of AC Enzymic Activity by Microtitre Plate Assay,
A plate assay was developed for the detection of enzymatic activity of AC. The 
principle of the assay involves cross feeding of an AC " strain of E. coli (indicator 
strain) with cAMP to activate its lac operon for B- galactosidase production in the 
presence of X-gal. Utilization of this chromogenic substrate by the indicator strain 
results in a blue colour. This assay was performed successfully with urea extracts and 
culture supernates of both B. pertussis and E.coli (with cloned AC gene). The 
results indicate that the AC enzymic activity is detectable from both species . Examples 
of the assay used qualitatively are shown in Fig. 13 A and Table 8 . In order to 
quantify the levels of cAMP required to produce a clear blue colour, the detection 
limits of the assay were worked out. Controls with exogenous cAMP at different 
concentrations were set up in tiiplicate . A standard curve of cAMP concentration 
plotted against A5 2 0  suggests that AC enzymic activity could be conveniently detected 
between the range of 4-32 micromol cAMP (Fig. 13 B, Table 9). It was observed , 
however, that the Ag2 0  plateaued below 4 jimol and above 32 jamole cAMP 
suggesting rather narrow detection limits of the assay. When calmodulin 
affinity-purified AC was investigated for its specific enzymic activity in the microplate 
assay, and with the same assay conditions (i.e., 15 min incubation of the sample at 37 
° C with reaction mixture and subsequent boiling for 15 min to stop the reaction) as 
were used with the Salomon assay, 33 (Xmol cAMP / min / mg protein specific 
activity was detected. This level of AC activity was comparable with the activity 
obtained by Salomon assay for purified AC (Table 11, see page 90 ).
These findings suggest the possibility of the use of this assay as a tool for the rapid 
and safe investigation of AC activity in any sample, including urea extracts.
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Table 8
Determination of Enzymic Activity of AC by Microplate Assay
Sample
1 2 3 4
Strain 
5 6 7 8 9
Urea extracts ++ ++ + ++ +
Culture + + 
supernates
+ ND ND ND ND
Dialyzed urea extracts (25 |i,l) and culture supernates (25 |al) of B, pertussis and E. 
coli were incubated in duplicate with reaction mixture (25 |al) for Ih at 37 . Test
culture (150 \xl) i.e., test suspension previously inoculated with the indicator strain E. 
coli G802 and grown at 37°C to an of 0.4, was added and the plates were
incubated at 37 for 12 h.
1=B. pertussis BP348 (pRMBl)
2= B. pertussis 18323 
3= B, pertussis BP348 
A -B . pertussis Tohama 
5=5. coli H1469(pRMB3)
6= E.coli H1469 (pRMB3,pANN202)
1 ^ E.coli H1469 (pRMB9)
%= E.coli H1469
9=Conti'ol (reaction mixture and test suspension only)
ND= Not determined 
++ = Strongly positive 
+ = Positive 
- = Negative
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Table 9 cAMP Standard Curve for AC Enzymic Activity
Sample ^620
cAMP (micromol/50p,l)
64 1.96
32 1.80
16 1.27
8 1 . 1 0
4 1 . 0 0
2 1.99
1 0.94
0.5 0.92
Unknown
Neat 1.469
1 /2 1.290
1/4 1.068
1 /8 0.981
1/16 0.964
1/32 0.931
1/64 0.930
Different concentrations of cAMP ranging from 64 micromol to 0.5 micromol in a 
final volume of 50 \x\ were dispensed in a microplate in triplicate. For the sample with 
unknown activity, 50 jitl of the sample was incubated with 50 jil of the reaction 
mixture for 15 min at 37 °C and then boiled for 15 min. This sample was diluted 
2-fold in distilled water in the same plate and to all the wells, 150 [il of test culture 
i.e., test suspension previously inoculated with the indicator strain E. coli G802 and 
grown at 37 “C to an OD5 5 0  of 0.4, was added. Contents were mixed and the plate 
was incubated at 37 °C for 12 h, Ag2o was measured on an automated ELISA reader 
and the standard curve was plotted. The data are a mean of four determinations.
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Fig. 13 Determination of AC Enzymic Activity by Microplate
Assay.
Pane] A) AC enzymic activity in urea extracts.
Dialyzed urea extracts (25 pd) of B. pertussis and E. coli were incubated in 
quadruplicate with 25 pd of reaction mixture for Ih at 37 . Test culture (150
pd) was added and the plates were incubated at 37 for 12 h .
1 -B. pertussis BP348 (pRMB 1 )
2~B. pertussis 18323 
3=B. pMrtussis BP348 
4~B. pertussis Tohama 
5=5. co/f H1469(pRMB3)
6=E.coli H1469(pRMB3,pANN202)
7=E.coli H1469(pRMB9)
8= 5. coli HI469
9= Control (Reaction mixture and test suspension only)
Panel B) cAMP standard curve for estimation of AC enzymic activity by 
microplate assay.
Different concentrations of cAMP ranging from 64 micromol to 0.5 micromol in 
a final volume of 50 pd were dispensed in a microplate in triplicate. 150 p\ of 
test culture was added to the wells. Contents were mixed and the plate was 
incubated at 37 ^C for 12h, A5 2 0  was measured on an automated ELISA reader 
and the standard curve was plotted.
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EFFECT OF DIALYSIS ON AC
The effect of extensive dialysis on AC in urea extracts of B. pertussis BP348 
(pRMBl) was investigated as described in Materials and Methods (see page 45). 
SDS-PAGE analysis of dialyzed and undialyzed urea extracts showed a decrease in 
intensity of some protein bands , including AC, by about 25% in dialyzed urea 
extracts (Fig.l4A). Protein estimation of urea extracts before and after dialysis 
(extensive) yielded 1 0 -2 0 % less protein (mg/ml) in dialyzed urea extracts, possibly 
due to the sticking of protein onto the inner wall of the dialysis membrane or possibly 
due to dilution of the sample since the volume sometimes increased slightly during 
dialysis.
Stablity of enzymic activity of dialyzed and undialyzed urea extracts was then 
compared; a 40-50% loss of activity was observed within 2 months in dialyzed urea 
extracts as determined by adenylate cyclase enzymic assay (binding protein assay). 
The results obtained are outlined in Table lO.These results suggest that extracts could 
be stored in 4-8M urea at -20 ®C for up to 2 months with only 15-20% loss when 
stored with urea. A substantial loss was observed when urea was dialyzed out 
(Fig. 14 B) These findings correspond with those of Gentile et a l  (1990) who 
reported the similar loss of activity in dialyzed urea extracts.
EFFECT OF PROTEASE INHIBITOR ON AC
The heterogeneity of AC revealed by SDS-PAGE and immunoblotting signified 
that it might be susceptible to degradation by endogenous proteases and suggested that 
at least some low MW polypeptides present in urea extracts are degraded forms of 
AC. In order to protect AC from degradation, a protease inhibitor, phenyl methyl 
sulphonyl flouride (PMSF), effective against serine proteases, was used at 0.5 mM 
concentration . Addition of PMSF immediately after harvest of the cells (Materials and 
Methods, see page 44) appeared to reduce degradation as determined by SDS-PAGE 
and immunoblotting with polyclonal antibodies.Fig. 15 A&B shows the SDS-PAGE 
and immunoblot profiles of PMSF- treated and untreated urea extracts of B. pertussis 
BP348 (pRMBl)(AC+), It is evident from
the profiles that PMSF-treated urea extiacts of B. pertussis BP348 (pRMBl) showed 
less degradation bands then PMSF-untTQSLtcd B. pertussis BP348 (pRMBl). The 
PMSF was used routinely after these observations, However, the samples prepared 
for the toxicity assays did not recieve PMSF in order to avoid the possiblity of 
interference of this product with the assays.
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Table 10 Effect of Dialysis on AC in Urea Extracts
Urea exti'act 
BP348 (pRM Bi)
Time
(months)
Protein 
(mg/ml )
Activity
(nmolcAMP/min/mgprotein)
Undialyzed 0 2.71 4378.3
Dialyzed 0 2.53 3816.2
Undialyzed 2 2.58 3483.5
Dialyzed 2 2.47 2146.5
The values are mean of two determinations
PART III - 87-  RESULTS
Fig. 14
Effect of dialysis on AC
Urea extracts (dialyzed and undialyzed) were resolved by SDS-PAGE and stained 
with Coomassie blue . Panel A represents the effect of dialysis on fresh urea 
extracts.
Panel B represents the effect of dialysis on AC after storage.
Panel A) Effect of dialysis on urea extracts of B. pertussis 
1= SDS-6 H ( MW standard )
2”  Undialyzed urea oxtrsLCtofB. pertussis BP348 (pRMBl)
3= Dialyzed Urea extract of B, pertussis BP348 (pRMBl) 
4 =■ D i oly zed Lfrta. extract* of &. 6 P 34-% .
Panel B) Effect of dialysis on AC after storage.
1” Undialyzed B. pertussis BP348 (pRMB 1) urea extract.
2= Undialyzed urea extracts oi B , pertussis BP348 (pRMB)l after 2 months 
storage at - 2 0  °C
3= Dialyzed urea extract of B. pertussis BP348 (pRMB 1) after 2 months storage 
at - 2 0  OC
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Fig.15
Effect of Protease Inhibitor (PMSF) on AC
Q'ude preparations of adenylate cyclase (urea extracts ) were used to investigate 
the effect of protease inhibitors on AC. A urea extract containing 0.5 mM PMSF 
was kept at 4 ^C for 48 h. A control of untreated sample was also included in this 
study.
Panel A) Coomassie blue - stained gel of PMSF-treated and untreated urea 
extracts.
1=5. pertussis BP348 (pRMB 1) without PMSF 
2= B . pertussis BP348 (pRMB 1) with PMSF 
3= MW standai'd
Panel B) Immunoblot of PMSF- treated and untreated urea extracts.
The blots were probed with anti-AC monoclonal 1H6 at a 1:1000 dilution
1= B. pertussis BP348 (pRMBl) without PMSF 
2 - B. pertussis BP348 (pRMBl) with PMSF
Ba
i
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PURIFICATION OF ADENYLATE CYCLASE BY CAM-AFFINITY 
CHROMATOGRAPHY.
Enzymatically and biologically active AC had been shown previously to be 
recoverable by one-step chromatography (Friedman, 1987 a ; Bellalou et al .,1990 a), 
a convenient and reproducible method of purification , Adenylate cyclase from B. 
pertussis BP348 (pRMBl) and E.coli with cloned AC was purified by calmoduhn- 
affinity chromatography as described by Bellalou et a l (1990 a).
Urea extracts of B . pertussis BP348 (pRMBl), BP348, and E. coli strains listed 
in Tables. 3&4 (see pages 46 &47) were diluted 1 in 4 and adsorbed onto CaM- 
agarose. The gel was washed and eluted with 8  M urea as detailed under Materials and 
Methods (see page 49). The purified enzyme was stored at - 20 ^C in the undialyzed 
state . Adenylate cyclase activity was measured using the procedure of Salomon et a l 
(1974) and the purification factor was calculated. The purification of AC is 
demonstrated in Fig. 16 and Tàbloll.ThQB. pertussis BP348 (pRMB 1) preparation 
(lanes 2 -5 )  but not the control 5. pertussis BP348 (lane 1) displayed two bands of 
210 and 200 kD that were recognized by the anti-AC monoclonal antibodies. The 
intensity and thickness of the AC bands (in mm) was considerably greater than in the 
crude preparations (not shown) and only trace amounts of lower MW bands were seen 
The two bands observed on immunoblots possibly indicate the existence of AC in 
two forms as has been reported by Rogel et a/. (1991) who found that the purification 
of AC resulted in two forms after separation by SDS-PAGE. These were isolated from 
B. pertussis BP348 (pRMBl) , were both of 200 kDa yet one form was toxic, 
capable of generating cAMP in the target cells, whereas the other was not.
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T a b le .l l
Purification of AC from 
Chrom atography.
Urea Extracts by Calm odulin - Affinity
Sample Activity*
(crude)
Activity*
(Purified)
Purification
factor
E.coli
H1469 (pRMB6 ) 0.37 2.39
H1469 (pRMB6 , 
PÀNN202)
0 . 2 2 5.02 22.82
H1469 (pRMB6 , 
pKIMl)
0.27 3.84 14.22
H1469 (pRMB6 , 
pANGE3)
0.40 6.36 15.90
B. pertussis
BP348 pRMBl 5.03 30.57 6.08
18323 1.43 2 0 . 6 14.03
BP 348 <0 . 0 0 1 - -
* specific activity , jitmol cAMP / min / mg protein, mean of 4 determinations.
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F ig . l6
Immunoblotting of Calmodulin - Affinity Purified ACT
ACT purified from urea extracts of B. pertussis BP348 (pRMBl) by 
calmodulin - affinity chromatography ; bound AC was eluted and sequential 0.5 
ml factions were collected. Each fraction was subjected to SDS-PAGE and the 
resolved protein was electrophoretically transferred to nitrocellulose 
membrane.Immunoblot was probed with anti-AC monoclonal antibody McU 
( 1:1000)
1= BP348 (Third fraction )
2= First fraction of B. pertussis BP348 (pRMBl)
3= Second fr action of B , pertussis BP348 (pRMBl)
4= Thii'd fraction of B . pertussis BP348 (pRMBl)
5= Fourth fraction of B. pertussis BP348 (pRMBl)
KD
210
200
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ISO - ELECTRIC FOCUSING OF ACT
Analytical iso-electric focusing of calmodulin-affinity purified ACT in 
polyacrylamide was carried out in the presence of 6  M urea in an attempt to isolate 
and characterize the two high MW forms seen by SDS-PAGE and immunoblotting . 
Ampholines were used with a wide pH range (3.5-10) as described under Materials 
and Methods( see page 51). The sample was applied at three different sites to detect 
the iso-electric point of the ACT. Fig. 17 shows the focusing pattern of ACT when the 
sample was applied at the cathode (lane 1 ), in the middle (lane 2 ) and at the anode side 
(lane 3) . Lane 4 shows the migration profile of a CaM-treated urea extract of B. 
pertussis BP348 (pRMBl). p/ standards were also applied at the anode and the 
cathode sides (lane 5 and 6  respectively). The migration profile from the cathode 
exhibited a single diffused band at p/ of approximately 7 (lane 1) after staining with 
coomassie blue.This coincides with the previously reported p/ for AC (Leusch et al., 
1990). Application of ACT at the other sites did not reveal any focussed band and 
only a precipitation of the sample at the site of application was observed.
Attempts were made to transfer and detect the iso-electric focused AC on 
nitrocellulose, by Western blotting but this did not prove successful. This may be 
because the non-denaturing conditions used in iso-electric focusing were not 
favourable for transfer of the high MW, aggregated form of AC. In order to provide 
the denaturing conditions to the focused AC, 0.0375 % SDS was added to the transfer 
buffer for the Western blotting but the same problem was faced; that is poor transfer 
and negative reaction after probing with monoclonal anti-AC antibodies. This indicated 
that the SDS in the transfer buffer did not denature the ACT well enough for it to be 
transferred to the membrane . Another possibility could be that the ampholines 
interfered with the transfer.
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Fig.l7
Iso-Electric Focusing (lEF) of ACT
Calmodulin-piuified ACT (10 pg) from urea extract of B. pertrussis BP348 
(pRMBl) was subjected to lEF in a polyacrylamide gel in the presence of pH 
range 3.5 -10 ampholines, and 6 M urea . The samples were applied at the 
cathode, middle and anode sites. The gel was stained with Commassie blue and 
destained until the background was clear.
1= CaM - purified ACT applied at cathode 
2= CaM - purified ACT applied in middle 
3= CaM - purified ACT applied at anode 
4= CaM- treated extract of B. pertussis BP348 
5= p/ standard applied at cathode 
6 =p/ standard at anode
tpH
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DETECTION OF HOMOLOGY BETWEEN ACT AND OTHER RTX -
RTX (Repeat in toxin) is a designation given to a family of 102-177 kDa 
cytotoxins produced by a number of Gram-negative pathogenic bacteria. The important 
and common feature of these toxins is the presence of a series of glycine -rich repeat 
units at the C-terminal end of each protein. The members of this family include : 
Escherichia coli haemolysin (HlyA), Pasteurella haemolytica leukotoxin (LktA), 
Actinobacillus actinomycetemcomitans leukotoxin (Akta) and Bordetella pertussis 
adenylate cyclase toxin (ACT or CyaA) (Welch, 1991; Coote, 1992).
In order to search for any antigenic homology between these toxins, an 
immunoblotting investigation was performed. Toxins preparation is given in the 
Materials and Methods (see page 53). The toxins were separated by SDS-PAGE and 
transferred to nitrocellulose. Probing was carried out with anti-AC monoclonal 
antibodies and polyclonal antibodies.
Fig. 18 A shows the monoclonal 9D4 reacted positively with all the four toxins 
tested at their respective positions on the blots. Leukotoxin of P. haemolytica (S/C 
82/ 1) was recognized at the MW 106 kDa, alpha-haemolysin of Exoli (582) was 
recognized at 110 kDa, and A.actinomycetemcomitans (JP2 and 29523) exotoxin at 
116 kDa. It was observed, however, that the exotoxin of A. actinomycetemcomitans 
was extremly unstable when extracts from whole cells were used. Cross- reactive 
high MW bands at 116 kDa were observed only in fresh preparations and low MW 
bands (presumably the breakdown products of the toxin) were observed when the 
samples were used after freezing and thawing. LktA failed to be recognized by 
polyclonal anti-AC antibodies as is evident in Fig. 18 B,a, although it was recognized 
by its homologous hyperimmune serum (Fig 18 B, b) and by anti-AC monoclonal 
9D4. B. pertussis ACT however, was not recognized by the anti-LktA hyperimmune 
serum. Failure of the recognition of epitopes by polyclonal antisera but not with the 
monoclonal antibody has also been observed by Dr.R. Welch, (personal 
communication). Other cross-reactive bands revealed in the urea extracts of B. 
pertussis BP348 (pRMBl) after probing with anti-AC polyclonal antibodies (PcU) 
mdm ü-P, haemolytica hyperimmune serum (Fig. 18 panels B,a and B,b ) could be 
due to the presence of preexisting cross-reacting antibodies against B. pertussis 
components.
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Fig.18
Inves t iga t i on  of Homology Between RTX Toxins  by 
Im m unoblotting,
Urea extracts of B. pertussis , A. actinomycetemcomitans, and culture supemates 
of P, haemolytica and E. coli were separated by SDS-PAGE , transferred to 
niti*ocellulose and probed with various sera.
Panel A ) Immunoblotting of RTX toxins , probed with anti- AC monoclonal 
9D4 (1; 1000).
1= MW standard
2 - B, pertussis BP348 (pRMBl)
3= A. actinomycetemcomitans JP2 
4= A. actinomycetemcomitans 59524 
5=Lkt (P. haemolytica )
6~ alpha -haemolysin {E.coli 582 )
Panel B) Cross reaction of Lkt and ACT
Samples were run in triplicate and probed with a) Anti-AC polyclonal PcU (1: 
500), b) anti-Lkt hyperimmune serum (1: 500), and c) anti-AC monoclonal 9D4,
1==B. pertussis BP348 (pRMB 1) (AC++)
2= B. pertussis BP348 (AC")
3= B. pertussis BP349 (AC+ HLY")
4= B. pertussis 18323 (AC“^ )
5= LktA {P. haemolytica )
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DETERMINATION OF AC TOXIC ACTIVITY.
The aim of this study was to establish a simple, reliable, sensitive and convenient 
assay for the detection of toxicity of the AC . Toxic AC is capable of penetrating into 
target cells where it is activated by a host cell protein, calmodulin, and catalyzes the 
generation of uncontrolled cAMP by using host cell ATP (Confer and Eaton., 1982). 
Previous studies described the toxic effect of AC on various cell types, including 
human PMNs and macrophages (Confer and Eaton., 1982), lymphocytes, (Hanski 
and Farfel., 1985), monocytes, CHO cells , mouse S49 lymphoma cells, isolated rat 
pituitary cells (Hewlett et al., 1985 ; Gentile et al., 1988), and red blood cells (Rogel 
et al., 1991) . The bases of evaluation of toxicity in these assays involved the 
demonstration of high levels of cAMP in the target cells, which, although reliable, is 
not simple and convenient. Therefore, a more direct approach was sought to detect the 
toxic activity of AC by using a variety of alternative assays.
Nitroblue Tétrazolium Reduction Assay (NBTR Assay) for detection of 
AC toxic activity.
Nitroblue tétrazolium (NET) is a useful marker of normal redox capabilities of 
polymorphonuclear neutrophils (PMNs) in which it is reduced to a blue formazan 
derivative. Nitroblue tétrazolium reduction is an indicator of neutrophil superoxide 
production for which NET serves as an artificial electron acceptor (Baehnerer 
a/., 1976). NET in its oxidized state is colourless and soluble, but when reduced, is 
precipitated into insoluble blue formazan.The reduction occurs due to oxygen- 
dependent oxidase activity in the form of excitable 0 % products i.e., superoxide anion, 
hydrogen peroxide , and singlet oxygen.
The overall reaction is:
NADH (NADPH) + O2 .............> NAD(NADP) + O2  + 2H +
O2  + NET + 2H+............................> O2  + NBTH2  (Formazan)
This property of NET was used to detect the toxic effects of AC on PMNs.
Rabbit neutrophils were pre-incubated in a microtitre tray with the dialyzed urea 
extracts of B. pertussis and E. coli (20 pg protein / well and its 2-fold dilutions as 
described under Materials and Methods (see page 58 ) and induced with PMA (phorbol 
myristate acetate). Controls included PMA-induced and uninduced neutrophils without 
the extracts . The reaction in the microplate was examined visually. Control cells
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induced with PMA showed the purple- blue colouration as a sign of their metabolic 
activity and NBT reduction while uninduced cells remained colourless suggesting 
their resting state. Extracts from B. pertussis Tohama and 5. pertussis BP348 
(pRMBl) were able to inhibit the NBT reduction when used neat and 1 in 2 dilution 
respectively. B. pertussis BP348, E. coli H I469 (pRMB3), E, coli H I 469 
(pRMB9) and E, coli H I469 failed to inhibit the NBT reduction even when used 
neat (Fig. 19). These data support the previous reports of the absence of toxicity of the 
E. coli AC extracts (Brownlie etal., 1988 ; Rogel et al., 1989), but indicate that 5. 
pertussis ACT can inhibit the NBT reduction of phagocytes, in the present case, rabbit 
neutrophils.
Determination of Haemolytic Activities of ACT on Sheep and Rabbit 
RBCs.
Haemolytic activity of calmodulin - affinity purified ACT was determined 
according to the method of Bellalou et al. (1990 b), except that 2% RBCs were used 
in this assay. Sensitivity of two species of RBCs towards ACT was investigated. 
Purified ACT (100 nmol cAMP / min / ml AC enzyme activity ) and 2-fold dilutions of 
this activity were incubated with 2% SRBCs as detailed under Materials and Methods, 
(see page 60 ).
The results (Fig. 20 A ) showed a clear linear relationship between % haemolysis 
and the toxin dilutions . The rabbit RBCs were found fragile and some autolysis was 
observed in control cells. Sheep RBCs , on the other hand were found to be sensitive 
enough to detect haemolytic activity of ACT down to the less than 6.25 nmol cAMP 
/min /ml AC enzymic activity. The haemolytic activity of ACT was found to be dose 
-dependent.
In order to determine the blocking effect of anti - AC antibodies on the haemolytic 
activity of ACT, calmodulin affinity-purified ACT (60 nmol cAMP /  min / ml AC 
enzyme activity and its 2-fold dilutions) were incubated with neat anti-AC 
monospecific antibodies (Msl). A 60% reduction of haemolysis was observed in the 
cells which were incubated with Msl-treated ACT as compared to the cells, incubated 
with ACT alone (Fig.20 B ) . This coincides with the findings of Rogel et al. (1991) 
who reported the neutralization of haemolytic activity of ACT by anti-AC polyclonal 
antibodies when incubated with ACT for Ih prior to the addition to sheep RBCs.
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F ig .19
Nitroblue Tétrazolium Reduction Assay (NBTR assay) of ACT
Rabbit peritoneal neutrophils (5x10  ^/  well ) were incubated with neat ( 20|Lig 
protein / w ell, row A) and 2- fold dilutions ( rows B —  F ) of dialyzed urea 
extracts of 5. m d E.coli and induced with PMA,
Column 1 = 5 .  pertussis BP348 (AC ")
Column 2 =B.pertussis Tohama (AC^)
Column 3 = 5 . pertussis BP349 (AC ")
Column 4 = 5 . pertussis BP348 (pRMBl) (AC '^ **')
Column 5 = 5 . coli H1469 (pRMB3) (AC +)
Column 6  = 5. coli H1469 (AC ")
Column 7 = Control (Cells + PMA )
Column 8  = Control (Cells - PMA )
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Fig. 20
Determination of Haemolytic Activity of ACT on Sheep RBCs and 
its Neutralization by Mono specific anti-AC antibodies (Msl)
Panel A) Comparison of sheep and rabbit RBCs for their sensitivity towards 
ACT
(2%) rabbit (1) and sheep (2 ) RBCs were incubated for 12h at 37 ^C with AC 
of 5. pertussis BP348 (pRMBl) (lOOnmol cAMP/min/ml AC enzymic activity 
and its 2-fold dilutions. The haemolysis was measured on an automated ELISA 
reader at Ag^o
Panel B) Neutralizing effect of Msl
Calmodulin - affinity purified AC (60 nmol/min /  ml AC enzymic activity), neat 
and 2 - fold dilutions were incubated with 2% sheep RBCs (1). The same amount 
of the AC was incubated with anti-AC mono-specific antibodies (1:1) at room 
temp for Ih and 2% sheep RBCs were added (2). The haemolysis was measured 
on an automated ELISA reader at A^ ^Q
%
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Chinese Hamster Ovary Cell Assay (CHO Cell Assay)
Morphological changes of Chinese hamster ovary cells induced by ACT were 
investigated. CHO cells have been used extensively as a bio-assay system for 
studying a number of toxins, especially the heat - labile enterotoxins (Guerrant et a l, 
1974) and pertussis toxin (Hewlett etal., 1983). The assay involves the elongation 
of CHO cells due to increased intracellular cAMP levels (Sandefur and 
Peterson, 1977).
Approximately 5 x 1 0  ^cells were incubated with different concentrations of 
CaM-affinity purified ACT as detailed under Materials and Methods (see page 61).The 
effect was evaluated after observing the cells by microscopy and assessed by counting 
the number of elongated cells /lOO cells / dilution. The assay was found to be 
sensitive enough to detect 12.5 nmol / min / ml AC enzymic activity applied at which 
25% cells were found elongated. Below this level an elongation was difficult to detect 
was considered nill since some of the control cells also showed some elongation-like 
effect, probably due to squeezing of the cells. The effect at 50 nmol /min/ml AC 
enzymic activity applied is shown in Fig.21. Higher concentrations of toxin (>200 
nmol/min/ml AC enzymic activity) were found either ineffective or deleterious for the 
CHO cells and apparently disturbed their growth. The morphological effects were 
prevented when AC was incubated with anti-AC monospecific antibodies (not shown). 
This results support the data showing that the morphological changes were caused by 
an increase in intracellular cAMP. However, the use of this assay to determine the AC 
toxin activity depended on a rather subjective approach in which the possibility of error 
seemed to be high.
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Fig.21 Effect of ACT on CHO Cells.
CHO cells (5x1Q 4  cells/well) were incubated with CaM-affinity purified ACT. 
2-fold dilution of 200 nmol /min/ml AC enzymic activity was applied. The cells 
were incubated in 5% CO2  at 37®C for 15 -20 h in a humidified chamber.
Panel A) The photograph shows CHO cells affected with 50 nmol /min /  ml AC 
enzymic activity
Panel B) Control CHO cells
B
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Baby Hamster Kidney Cell Assay (BHK Cell Assay )
The effect of crude ACT from B.pertussis and E.coli was investigated on baby 
hamster kidney cells (BHK cells) with the collaboration of Dr. John Edwards, 
Department of Cell Biology, University of Glasgow. BHK cells in presence of high 
cAMP, tend to change their shape from regular to a complex , dendritic form. The 
effect of crude ACT (dialyzed urea extracts) on BHK cells was recorded by measuring 
the mean area and % scattering of 50 randomly - picked affected cells with the help 
of Leitz ortholux microscope connected to a computer.Fig.22 shows the effect of 
dialyzed urea extracts B. pertussis BP348 (pRMBl) (AC++) and B. pertussis 
BP348 (AC") on the BHK cells. B. pertussis BP348 (pRMBl) showed a positive 
effect on the cells resulting in the deshaping of the cells, and the effect was 
approximately comparable to that of the positive control (exogenous dibutyryl cAMP). 
On the other hand, B. pertussis BP348 failed to produce any effect on the cells 
indicating the specificity of the assay for ACT.
The effects of dialyzed urea extracts from various B. pertussis strains and from E. 
coli H1469 (pRMB6 ,pKIMl) are given in Table 12 .It was observed that the toxicity 
IqyoIs of B . pertussis BP348 (pRMBl) (AC++) m&B. pertussis BP357 
(PT ") were comparable to each other, which agrees with their enzymic activity 
(Table 7, see page 80). B. pertussis BP349 (AC, HLY “ ) failed to produce any toxic 
effect. AC expressed in E. coli H I469 (pRMB6 ,pKIMl), a strain harbouring 
separate plasmids expressing AC and HlyC {P. vulgaris ) showed an effect 
comparable to that of B. bronchiseptica when three times more protein than that used 
for 5. bronchiseptica was applied in the assay.
These data suggest another possible assay for the detection of AC toxic / invasive 
activity.
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Table 12 Effect of ACT on BHK Cells
Sample Protein
)Xg protein /  5xl04 cells
Enzymic activity
nmol cAMP/min/mg protein
Mean area % Scattering
HEPES^ - - 2286 740
cAMP • - - 950 300
Urea extracts 
B. pertussis
BP348 (pRMBl) 75 1450 1240 430
BP348 1 0 0 < 0 . 0  2 1861 603
BP357 1 0 0 1267 1330 426
BP349 1 0 0 < 0 . 0  2 2288 746
B, bronchiseptica 1 0 0 40 1720 556
E. coli H1469 
(pRMB6 ,pKIMl)
730 270 1700 550
- Negative control
• Dibutyryl cAMP(O.lmM) = positive control.
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Fig.22
Effect of ACT on BHK cells.
BHK cells (5x1 Cri ) were treated with dialyzed urea extracts of B. pertussis 
BP348 (pRMBl) (AC"*” )^ and 5. pertussis BP348 (AC"). Results were 
recorded by measuring the mean dispersion and % scattering of the cells in 
the presence and absence of the toxin. Positive controls (dibutyryl cAMP) 
and negative controls (HEPES buffer ) were also included in the assay.
Rows 1&2= Negative Control ( Buffer )
Rows 3&4= 1/20 Dilution of Dialyzed urea extract of B. pertussis BP348 
(pRMBl)
Rows 5&6= Positive Control
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Chemiluminescence Assay
In this study, the chemiluminescence properties of PMNs were exploited with 
ACT.The rabbit peritoneal neutrophils were selected as target cells as they have been 
previously used for chemiluminescence assays for pertussis toxin (Craig et al., 1988). 
Moreover, the rabbit is susceptible to B, pertussis aerosol infection and therefore 
constitutes a relevant model for the disease in humans (Ashworth et a l, 1982), To 
exclude the possible influence of pertussis toxin on the assay of crude ACT, PMA was 
used as a stimulant (unless otherwise stated) since pertussis toxin does not have an 
effect on PMA-induced events of the respiratory burst (Becker et aL, 1985) . PMA 
affects the reactions of the respiratory burst initiated via the activation of protein kinase 
C and increases the cytoskeletal actins in phagocytosis. Pertussis toxin does not have 
any effect on this sequences of events (Schefcyk et aL, 1985; Becker et a l, 1985).
Determination of the PMA-Induced CL Response of Rabbit Peritoneal 
Neutrophils.
The dose response curve to find the optimal concentraion of PMA needed to 
stimulate 10^ PMNs was determined.Various concentrations of PMA ranging from 
0.01 to 2.0 pig /ml were used to induce the metabolic burst in the rabbit PMNs. The 
PMA-induced response was noted to be dose dependent .The increase in CL was very 
rapid and the peak response occurred at less then 3 min with the higher doses of PMA. 
At 0.01 pig of PMA/ml, the response was sluggish and the peak CL occurred later, at 
30-40 min. An optimal response was observed at a concentration of 0.1 pg/ml 
(Fig.23) in which the peak CL occurred in 10-15 min. It is noteworthy that no CL 
response was observed in the absence of DNDH, showing that a detectable PMA 
response is dependent upon the presence of a suitable substrate. This agrees with the 
finding of Westrick et al. (1980).
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Fig. 23
CL Response of Rabbit Neutrophils to PMA.
Rabbit peritoneal neutrophils (1 0  ^cells /  ml of HEPES) were prewarmed at 
37 'C for 5 min and then stimulated with 0.1 jig PMA. The figure shown is 
a mean of four observations and representative of six separate experiments. 
Each point is a mean and SEM of four observations.
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Influence of Pre-Incubation Time on AC Toxic Activity
For evaluation of AC toxic activity on rabbit PMNs at different time exposures 
prior to PMA-stimulation, the effect of crude (20 |ig protein) and calmodulin -affinity 
purified ACT (50 nmol/min/ml enzymic activity applied) was investigated. Fig. 24 
shows the CL response of PMA-induced rabbit peritoneal neutrophils, after different 
pre-incubation times at 37 °C. A 2-fold increase of CL response was observed when 
cells were treated with crude ACT for Imin, indicating a possible role for other 
components of B. pertussis, like FHA and endotoxins, which are reported to enhance 
the CL response of rabbit peritoneal neutrophils to fMLP (Craig et a l, 1988).With 
CaM-affinity purified ACT, however, the CL response was inhibited by up to 50% 
within 1 min. Hewlett et al, (1989) also reported a rapid AC toxin activity when CHO 
cells were treated with ACT at 30 °C; an accumulation of cAMP was observed without 
any lag period. A reduction in CL response was observed by up to 99% with pure 
toxin and up to 96% with crude toxin when pre-incubated with neutrophils for 15 
min,before the addition of PMA (stimulant) ( Fig. 24).
Effect of Purified PT and ACT on CL Response of Rabbit PMNs to 
PMA or Zymosan.
In order to determine the influence of PT on the CL inhibition response of ACT, 
purified PT (2 0 pg/ 1 0 6  cells) was used to inhibit CL response induced by two different 
stimuli (PMA, and zymosan). Fig.25 A shows that the PMA - induced response of 
PMNs was not inhibited by PT (kindly provided by Miss. F Mirza, Department of 
Microbiology, University of Glasgow ) and there was a massive stimulation after 15 
min incubation of PT and PMNs. Increasing the pre-incubation time of PT with PMNs 
to Ih did not show any sign of inhibition but a reduction in stimulation was observed. 
This result agrees with the findings of Becker et al. (1985). On repetition of the same 
experiment with a particulate stimulus, zymosan, about 98% inhibition of the response 
was recorded with PT after 15 min pre-incubation, and complete inhibition was 
observed with Ih incubation with PMNs. PT appeared to be inhibitory with 15 min 
pre-inubation time (Fig. 25B). When the effect of ACT was compared in the presence 
of each stimulus, the PMA- induced CL response was markedly inhibited whereas 
zymosan induced CL response was inhibited by 40-50 % after 15 min pre-incubation.
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Fig.24
Influence of Pre-incubation Time on the Effect of Purified 
and Crude ACT on Neutrophil Chemiluminescence Response to 
PMA.
Rabbit peritoneal neutrophils were pre-incubated with dialyzed urea extracts 
or purified AC for Imin and 15 min before the addition of PMA. The figure 
shown is a mean of four observations and representative of six separate 
experiments.
Panel A) Effect of crude ACT after Imin and 15 min 
1 = 1 min
2= Control ( No ACT )
3= 15 min
Panel B) Effect of purified ACT 
1= Imin
2= Control (No ACT)
3= 15 min
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Fig.25
The Effect of PT and ACT on CL Response of PMNs to PMA 
and Zymosan.
Rabbit peritoneal neutrophils were pre-incubated at 37 °C with purified PT 
(20 pg/ assay tube) or ACT (50 nmol/min/ml enzymic activity ) for 15 min or 
Ih before the addition of stimuli. Pre-incubation time is given in brackets. 
The figure shown is a mean of four observations and representative of six 
separate experiments.
Panel A) Effect of PT and ACT on PMA- induced CL response.
1= Control (No ACT or PT) 
2= ACT (15 min) 
3=PT(15min)
4= PT (Ih)
Panel B) Effect of PT and ACT on zymosan -induced CL response
1= ACT (15 min)
2= Control 
3=PT (15 min)
4= PT (1 h)
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Effect of Crude ACT from Different Bordetellae on CL Response
The aim of this study was to determine the effects of ACT produced by different 
Bordetellae under the same set of growth and extraction conditions . Dialyzed urea 
extracts (20 p-g of protein / assay tube) of the strains of wild type 5. pertussis 18323, 
B. pertussis Tohama, recombinant B, pertussis BP348 (pRMBl) (AC‘**+) and 
transposon insertion mutants B. pertussis BP348 (AC “), B. pertussis BP349 
(HLY"), 5 . pertussis BP353 (FHA"), pertussis BP357 (PT "), B. pertussis 
BP347 (Vir-)and other Bordetellae including m d B . parapertussis
were tested for their ablity to inhibit the CL response. The results aie summarized in 
Table 13. An extract from the AC " strain B. pertussis BP348 showed a 26% 
stimulation of CL response compared to the control cells. This possibly indicates the 
interfering effect of FHA and LPS in the crude preparations. Extracts of B. pertussis 
BP349 (AC+, HLY ") showed a 29% stimulation of the CL response. This mutant is 
reported to have low (7.1 nmol cAMP/min/mg protein) AC enzymic activity (Weiss et 
aly 1983) although this was not confirmed in this study (Table 7, see page 80 ). No 
toxicity was observed even with high doses (60 pg protein / assay tube) of extracts of 
B. pertussis BP349 . Extracts of B. pertussis BP353, a Tn5 mutant for FHA, 
exhibited inhibition of CL similar to that of B. pertussis Tohama (wild type). Another 
Tn5 mutant, BP357 (PT "), showed inhibition of CL similar to BP348 (pRMBl) 
(AC'*"*") which is reported to have five-fold higher toxic activity than wild type B. 
pertussis (Brownlie et al., 1988). B. parapertussis showed a very low level of 
toxin activity (15% inhibition). This toxicity was however increased when high doses 
of protein were used. B bronchiseptica was found equally as inhibitory as B. 
pertussis 18323.
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Table.l3
CL Inhibition Effect of Urea Extracts from Different Bordetellae on CL 
Response of Rabbit PMNs to PMA.
Source of 
urea extracts
CL (mV) ±. SEM ^
Total CL Peak % %
Inhibition Stimulation
Control 1084+ 32.4 120 + 3.58 0 100
B. pertussis
BP348 (pRMBI) 4 + 0 .1 1 1 + 0.02 99.6 + 2.97
Tohama 259 +7.74 38+ 2.13 76+ 2.34
BP349
BP348
1408 + 33.11 172+ 5,14
1372 + 36.32 150 + 4.48
129
126
18323 10 + 0.29 1 + 0.03 99 + 2.9
BP357 12+ 0.35 1 + 0.04 98 + 2.9
BP353 236 + 6.65 32+ 1.21 78+ 3.3
B, bronchiseptica 14 + 0.41 1 + 0.03 98 + 2.9
B , parapertussis 920 + 25.35 89+ 2.44 15+ 0.51
* Individual CL counts were summed over the total assay time and the mean value was 
obtained for each sample (n=4). Each point is a mean and + SEM of four observations.The 
assay was done for 30 min with each vial being counted approximately every 60 sec.The % 
inhibition or stimulation data relate to the total CL values.
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Determination of AC Toxic activity of Live Opsonized B. pertussis
The effect of ACT from live, phase I, intact cells of B. pertussis was determined. 
Approximately 5x10^ cells of B. pertussis BP348 (pRMBl) and B.pertussis BP348 
were opsonized with normal fresh rabbit serum as described in Materials and Methods 
(see page 59). The ratio of bacteria to PMN was approx 40 : 1. Fig.26 shows a 
time-dependent reduction in CL response of neutrophils treated with B. pertussis 
BP348 (pRMBl) (AC++). An initial burst was observed due to interaction of 
opsonized bacteria and PMNs, but it was reduced by up to 60% -70% within 30-40 
min compared to B. pertussis BP348 (AC “). This result indicates the effect of ACT, 
which may be exposed at the bacterial surface or the ingestion of the virulent, AC+ B. 
pertussis by PMNs.
Determination of IDgQ Dose of Crude ACT and Dose Response Curve 
for Purified ACT.
Crude and CaM-affinity purified ACT were used to determine the dose 
responsible for 50% inhibition of PMA-induced CL response of rabbit neutrophils 
(ID5 0 ), and to create a dose response cuiwe. Dialyzed urea extract (20 pg protein) and 
its dilutions and purified ACT (50 nmol cAMP/min/ml AC enzymic activity) and its 
10-fold dilutions were pre-incubated with 1 0  ^PMNs for 15 min at 37 ^C. Fig.27 and 
Table 14 shows a 49% inhibition of PMA-induced CL response of PMNs at the 
dose of 3.3 pg protein of crude ACT from B. pertussis BP348 (pRMBl).When 
CaM-affinity purified ACT of the same strain was used, an interesting response was 
observed as demonstrated in Fig.27 &Table 15. The results indicate a three stage toxic 
effect on PMNs . At a concentration of 50 nmol cAMP /min/ml enzymic activity dose, 
the ACT showed 99% inhibition of CL response .A 64% inhibition was observed at a 
dilution of 10 and a small inhibitory effect (5%) was seen with 10 "^.The dilutions 
1 0  -1 0 “^  showed a slight stimulation and when the dilution shifted from 1 0 "^  - 1 0
a massive stimulation rather than an inhibition of the CL response was observed. This 
stimulation of the oxidative burst could be attributed to the action of ACT at sub-toxic 
doses.It is been reported that human neutrophils treated with sub-lytic doses 
(picograms) of E, coll alpha-haemolysin created a 14-fold increase in superoxide 
generation (Keane et a/., 1987). Bhakdi and Martin (1991) have very recently reported 
the stimulatory effect of alpha-haemolysin of E. coli . Since ACT exhibits 25% 
homology with E. coli alpha-haemolysin, (Glaser et a/., 1988b) and is a member of 
the RTX family (Welch, 1991),the stimulatory effect at low doses might be 
anticipitaed.
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Fig.26
Determination of Neutrophil Chemiluminescence Response to
Live B. pertussis
Rabbit peritoneal neutrophils were treated with opsonized , live , B. pertussis 
BP348 (pRMBl) or BP348. The approximate ratio of bacteria to neutrophils was 
40:1. The figure shown is a mean of four observations .
l~  B . pertussis BP348 (pRMBl) (AC++)
2 -B . pertussis BP348 (AC ")
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Table 14
Determination of 50% Inhibition Dose for Crude ACT
Dilution Total CL Peak
CL(mV)±. SEM*
% inhibition Protein(yLig )
Conti'ol 2305 ± 46.44 210 ±4.22 0 -
1 : 1 0 0 231 ±4.65 34 ± 0.68 89 ± 1.81 2 0
1 : 2 0 0 528 ± 10.63 6 6  ± 1.32 77 ± 1.55 1 0
1:300 687 ± 13.84 82 ± 1.65 70 ±1.41 6 . 6
1:400 755 ±15.12 8 8  ± 1.77 67 ±1.34 5
1:500 975 ±23.65 102 ± 2.05 57 ± 1.15 4
1:600 1174 ±23.64 120 ±2.14 49 ±  0.99 3.3
* Derived as in Table 13 ; n = 4
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Table 15
Dose Response Curve for Purified ACT Activity.
Dilution Total CL
CL (mV) ±. SEM * 
Peak % %
inhibition stimulation Dose*
Control 2221 ± 69.37 256 ±7.98 0 1 0 0 0
Neat 15 ± 2.34 8  ± 0.24 99.62 - 50
1 0 - 1 790 ± 24.64 114 ±3.41 64.32 - 5
1 0 -2 2106 ± 65.68 248 ± 7.44 5.1 - 0,5
10-3 2265 ± 70.64 264 ± 7.92 0 101.98 0.05
10-4 2315 + 72.20 256 ± 7.62 0 104.23 0.005
10-5 2449 ± 76.37 262 ± 7.86 0 110.26 0.0005
1 0 - 6 4612 ± 143.82 589 ±17.67 0 207.65 0 .0 0 0 0 :
* Derived as in Table 13 ; n = 4.
• nmol cAMP/min/ml AC enzymic activity/ vial.
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Fig.27
Panel A) Determination of ID5 0  for Crude ACT.
Rabbit peritoneal neutrophils were pre-incubated with neat (20 pg protein /  assay 
tube) and different dilutions of dialyzed urea extract of B. pertussis BP348 
(pRMBl) at 37 °C for 15 min before the addition of PMA.
The individual counts of CL over 30 min were summed and % inhibition of the 
control by each dilution was plotted.
The figure shown is a mean of four observations and representative of six 
experiments.
Panel B) Dose response curve
Rabbit peritoneal neutrophils were pre-incubated with neat (50 nmol cAMP 
/min/ml enzymic activity) and 10-fold dilution of CaM-affinity purified ACT of B. 
pertussis BP348 (pRMBl) at 37®C for 15 min before the addition of PMA.
The individual counts of CL over 30 min were summed and % inhibition of the 
control by each dilution was plotted.
The figure shown is a mean of four observations and representative of six 
experiments.
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Effect of Exogenous Calcium on the CL Inhibition Effect of ACT
The influence of exogenous calcium on CL inhibition due to ACT was 
investigated by CL assay on rabbit peritoneal neutrophils. The calcium concentration 
required for maximum ACT activity was evaluated by tieating the calcium- deprived 
PMNs with known amounts of exogenous calcium (mM) as detailed under Materials 
and Methods (see page 60). Chelation of calcium in the presence of 0.8 mM EDTA 
and EOT A caused 95% reduction in CL inhibition effect of ACT toxicity . An 
interesting response of AC towards calcium was that the effect on ACT was not linear 
with increasing concentrations of calcium but was bi -modal i.e; the exposure of cells 
to 20 qg of AC in presence of 0.1 and 0.3 mM calcium did not show a significanct 
effect on CL response but as soon as the concentration of calcium was shifted from 
0.3 to 1 mM, a rapid shift in toxicity was observed (Table 16). On the other hand, the 
CL produced in PMNs in response to PMA rose with an increase in the calcium 
concentration . This result agrees with the findings of Janah et aL (1990) who reported 
a higher CL response in 1-2 mM calcium as compared to 0.1-0.5 mM calcium . Fig 
.28 and Table 17 summarizes the influence of calcium on the toxicity of AC. These 
findings correlate with the reports of Hewlett et al. (1990, 1991), who observed a 
conformational change in ACT at low levels of calcium (1-10 |iM ) and half maximal 
toxicity was observed at 500 pM. According to the data presented here, extracellular 
calcium is absolutely required for toxic activity of ACT and toxicity is blocked in the 
presence of calcium chelators in the medium. The minimal concentration of calcium to 
achieve 90% inhibition of PMA- induced CL response of 1 0 6  rabbit peritoneal 
neuti'ophils by crude ACT is 3 mM.
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Table 16
Influence of Calcium on Chemiluminesence Inhibition Effect 
of ACT
CL(mV)± SEM*
Sample Ca+ + (mM) Peak value Total
Buffer
ACT
0.1
0.1
78 ± 3.22 
72 + 3.10
565 ±  15.56 
528 + 12.88
Buffer
ACT
0.3
0.3
76 + 3.16 
60 + 2.91
560 ±18.61 
485 + 16.25
Buffer
ACT
1.0
1.0
8 8  ±21.34 
18 +2.23
6 8 6  ±19.11 
148 + 7.42
Buffer
ACT
3.0
3.0
120 ±3.12 
4 +2.14
734 ±18.23 
58 +4.83
Buffer
ACT
10.0
10.0
284 ± 9.32 
4 +1.4
2030 ±41.67 
36 + 5.72
* Derived as in Table 13 ; n = 4. .
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Fig.28
Influence of Calcium on the CL Inhibition Effect of ACT.
Rabbit peritoneal neutrophils were pre-incubated with dialyzed urea extracts of B. 
pertussis BP348 (pRMBl) (20 pg protein /  1 0 ^ cells) in presence of different 
concentrations of calcium for 15 min at 37 ®C before the addition of PMA.The 
figure shown is the mean of 4 observations .
1=0.1 mM calcium
2= 0.1 mM calcium + ACT
3= 3 mM calcium
4= 3 mM calcium + ACT
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Influence of Calmodulin on the CL Inhibition Effect of ACT.
The effect of exogenous calmodulin (CaM) on the toxicity of ACT was determined 
by CL assay. Exogenous CaM at |iM concentrations has been reported to inhibit the 
cAMP response of cells to ACT (Rogel et al., 1988). Crude ACT (dialyzed urea 
extract ( 6  fig protein/ assay tube) of B. pertussis BP348 (pRMBl) was pre-incubated 
with 3 fiM bovine brain CaM at room temp for Ih. The controls of CaM with buffer 
and ACT with buffer were also incubated at room temp for Ih.As shown in Fig.29, a 
50% reduction in CL inhibition activity of ACT was observed, suggesting a role for 
calmodulin in conformational changes of ACT which consequently change its toxic 
activity. These data agree with the results of Shattuck and Storm (1985) who 
demonstrated the inhibition of c AMP accumulation in target cells when ACT (partially 
purified) was treated with CaM.
Neutralization of AC Toxic Activity by Human Convalescent Pertussis 
Antiserum and Anti-AC Monospecific Antibodies.
Neutralization of biological activity of ACT in the presence of human covalescent 
pertussis antiserum HS2 and anti-AC monospecific antiserum Ms 1 was investigated. 
Cude ACT (dialyzed urea extract ofB.  pertussis BP348 (pRMBl)) was preincubated 
with each anti serum at room temp for Ih in 1:1 ratio. Controls of ACT and buffer and 
antisera and buffer+ ACT were also included for incubation . The results (Fig .30) 
show a 50-60 % reduction in the CL inhibition effect of ACT in PMA-induced rabbit 
neutrophils. This result contradicts the report of Farfel and Han ski (1990) who 
reported the inability of post- infection antisera to neutralize the enzymic or toxic 
activities of AC. However the findings coincide with with those of Brezin et at. (1987) 
and Guiso et al. (1989) who reported the neutralization effect of anti-AC antibodies 
against the toxic and enzymic activity of ACT.
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Fig.29
The Effect of Extracellular Calmodulin on CL Inhibition Effect of
ACT
Bovine brain calmodulin (3 mM) was incubated with crude ACT (dialyzed urea 
extract of B. pertussis BP348 (pRMBl), 6  jig protein) for Ih at room temp . 
Rabbit peritoneal neutrophils were pre-incubated with CaM-treated and untreated 
ACT for 15 min at 37 ^C before the addition of PMA.The figure shown is the 
mean of fom* observations .
1= Control (no ACT or CaM) 
2= UnU'eated ACT 
3= CaM - treated ACT 
4= CaM only
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F ig .30
Neutralization of Toxin Activities of ACT in Presence of Human 
Convalescent Pertussis A ntiserum  and Anti-AC Monospecific 
Antibodies (M sl)
Dialyzed urea extract of B, pertussis BP348 (pRMBl) (4 protein ) was 
incubated with human convalescent pertussis antiserum HS2 or anti-AC 
monospecific antibodies Msl (1:1) at room temp for Ih . Rabbit peritoneal 
neutrophils were then added and incubated for 15 min at 37^C. Controls 
consisted of antisera alone and ACT. The neutrophils were stimulated with PMA.
Panel A) Neutralizing activity of human convalescent pertussis antiserum HS2
1= Control (PMA only)
2= ACT + human convalescent pertussis antiserum 
3= Human convalescent pertussis antiserum only 
4= ACT
Panel B) Neutralizing activity of anti-AC monospecific antiserum Msl
1= Anti-AC monospecific antiserum only 
2= ACT + anti-AC monospecific antiserum 
3= Control 
4= ACT
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Effect of Cloned B, pertussis AC on PMA- Induced CL Response of 
Rabbit Peritoneal Neutrophils.
Strains of E, coll harbouring single plasmids which expressed the cyaA gene 
under the control of the tac promoter and compatible plasmids which expressed the 
cyaA gene and the hlyC gene of either P, vulgaris or E. coll or the cyaC gene of 
B. pertussis were constructed by Dr. G. Westrop. The relevant characteristics of 
these constructs are summarized in Table 4 (see page 47 ).
Urea extracts of these strains were prepared as described in Materials and Methods 
(see page 44 ) and examined for the presence of AC by immunoblotting (see page 77 ). 
The activation of cyaA in E. coli was determined by CL assay as described in 
Materials and Methods (see page 59). Rabbit neutrophils were incubated with dialyzed 
urea extracts and stimulated with PMA. Fig. 31 indicates a 98% inhibition of CL 
response by B. pertussis BP348 (pRMBl) and a stimulation rather than inhibition of 
CL response with all the E. coli extracts. The result shows that the stimulation was 
independent of cyaA gene expression since one of the controls {E. coli H1469 
pRMB7) showed the same level of stimulation. This suggests that the stimulation may 
be caused by a contaminating product of E. coli, possibly, LPS , It has been reported 
that LPS enhances the CL response of PMNs (Guthrie et aL, 1984; Aida and Pabst 
,1991). Before other E, coli extracts were tested, it was decided to try to remove the 
stimulatory component.
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Fig. 31
Effect of Cloned AC on CL Response
Rabbit peritoneal neutrophils were pre-incubated with dialysed urea extracts of E. 
coli and B. pertussis strains for 15 min before the addition of PMA. The Fig. 
shown is the mean of four observations and is representative of six experiments.
1= Conti'ol
2= E. coli H1469 (pRMB6 )
3= E. coli H1469 (pRMB6 , pKIMl)
4= E. coli H1469 (pRMB7)
5" B. pertussis BP348 (pRMBl)
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Removal of LPS by Detoxi-Gel Chromatography .
In order to investigate whether LPS enhances the PMA induced CL response of 
rabbit peritoneal neutrophils, the effect of commercially available LPS from E. coli 
was determined. The control PMNs were induced with PMA. When the CL response 
of PMA- induced PMNs in presence of LPS was compared with that of CL response 
of PMNs induced with PMA only, a 5- fold stimulation was observed in the response 
of cells treated with LPS (Fig. 32 A). These data indicate that the enhancement of 
PMA induced response of PMNs observed in the previous experiments may well have 
been due to LPS in the urea extracts of the E. coli strains.
Attempts were made to remove the LPS using a commercially available Detoxi-Gel 
chromatography system (Pierce,USA). A sample containing 20 jigLPS/ml was 
subjected to the gel as per manufacturer's instructions. The eluate was used to 
determine the removal of LPS from the sample. CL assay was performed with Detoxi 
Gel-treated and untreated LPS. Fig. 32 B shows the comparison of the effects and 
indicates that this method removed 98% stimulatory activity. The same method was 
applied on the urea extracts of E. coli strains. Dialyzed urea exti'acts from E. coli 
were passed through Detoxi-Gel and the effect was measured by CL assay. The 
comparative CL effect of Detoxi- Gel treated and untreated extracts is shown in 
Fig.33 A. The data indicate that no inhibition of PMA - induced CL response was 
observed with the extract, although the stimulatory effect was reduced by 98 %. This 
suggested that either the hlyC gene product from P. vulgaris was incapable of 
activation of ACT or the activity may have been lost during the purification steps. The 
second possibility was explored. Dialysed urea extract of B. pertussis 18323 was 
subjected to Detoxi-Gel and the eluate was collected. The effect of this eluate was 
determined by CL assay . Fig. 33 B shows the Detoxi-Gel -treated and untreated urea 
extracts of B. pertussis 18323. The result indicates that a 50% loss of AC toxic 
activity occured during purification with Detoxi-Gel treatment so presumably the ACT 
becomes bound to the column.
PART III -1 26 - RESULTS
Fig.32
Determination of Stimulatory Effect of LPS on PMA - Induced 
CL Response of Neutrophils.
A) Effect of LPS on CL response of rabbit peritoneal neutrophils, 
Commercally available LPS (20 |ig) from E. coli (Sigma ) was incubated with 
rabbit peritoneal neutrophils for 15 min at 37 “C before the addition of PMA. LPS 
was not added to the control.The figure shown is a mean of four observations .
1= Control
2= LPS
B) Removal of LPS effect by Detoxi-Gel.
A sample containing 20 |ig of commercially available LPS from E. coli (Sigma ) 
was passed through the Detoxi-Gel system. The eluate was incubated with rabbit 
peritoneal neutrophils for 15 min at 37 "C before the addition of PMA. LPS was 
not added to the control. Untreated LPS was also included to compare the effect 
of Detoxi-Gel treatment. The figure is a mean of four observations .
1 = Contr'ol
2= Detoxi-Gel treated LPS.
3= LPS only
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Fig .33
A) Removal of Stimulatory Activity from E. coli Urea Extract by Detoxi-Gel 
Chromatogi’aphy.
Dialyzed urea extract (20 |ag protein ) of E. coli H I469 (pRMB6 , pKDVH) was 
passed through the Detoxi-Gel and the eluate was collected. Rabbit peritoneal 
neuti’ophils were incubated with this eluate at 37 “C for 15 min prior to the addition 
of PMA. The figure shown is a mean of four observations .
1= Control
2= E, coli H I469 (pRMB6 , pKIMl) , Detoxi-Gel -treated 
3= E. coli H I469 (pRMB6 , pKIMl), Detoxi-Gel -untreated
B) Effect of Detoxi-Gel tr eatment on the extract of B. pertussis 18323
Dialyzed urea extracts of B. pertussis 18323 (20 jig protein) was passed through 
the Detoxi- Gel and the eluate was collected. Rabbit peritoneal neutrophils were 
incubated with this eluate at 37 °C for 15 min prior the addition of PMA. The 
figure is a mean of four observations.
1= Control
2= B . pertussis 18323, Detoxi-Gel-treated 
3= B . pertussis 18323, Detoxi-Gel -untreated.
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Effect of Cloned AC from E. coli Urea Extracts Purified by 
Phenyl-Sepharose Chromatographty
After encountering the problems of Detoxi-Gel chromatography , attempts were 
made to separate the stimulatory effect of urea extracts from E, coli by hydrophobic 
interaction chromatography using phenyl- sepharose 4 B ( hydrophobic matrix ) .  This 
method of separation depends on the hydrophobic interactions of surface hydrophobic 
groups with the gel.
Dialysed urea extracts were subjected to commercially available phenyl- sepharose 
4 B according to the method of Hewlett et al. (1989) as detailed in Materials and 
Methods (see page 49).The resultant eluate was dialyzed and used for CL assay of 
PMA-induced CL réponse of rabbit neutrophils .However, passage through 
phenyl-sepharose columns was not successful in removing the stimulatory effect from 
the E. coli urea extracts.
Effect of CaM-Affinity Purified AC from E. coli on CL Response of 
Rabbit Neutrophils.
One-step purification of E.coli urea extracts was carried out by CaM-affinity 
chromatography as described under Materials and Methods (see page 49) .Urea extract 
of B. pertussis BP348 (pRMB 1) was included as a positive control. The eluates were 
dialyzed and their enzymic activity was measured by the assay of Salomon et al., 
(1974). The purification profile of these extracts is given in Tablell. The effect of 
purified AC (50 nmol cAMP/min /ml AC enzymic activity ) from extracts of E. coli 
H1469 (pRMB6 ), E. coli H1469 (pRMB6 , pKIMl), E. coli H1469 (pRMB6 , 
pANN202), E. coli H I469 (pRMB6 , pANGE3) and their controls : E. coli H1469 
(pKIMl), E. coli H1469 (pANGE3) andE. coli H1469 (pRMB6 ) was determined 
by CL assay on PMA- induced rabbit neutrophils. It is evident from Table. 17 and 
Fig, 34 that AC purified from extracts of E. coli H I469 (pRMB6 , pKIMl), 
containing hlyC from P. vulgaris, showed 51% inhibition of CL response whereas 
its controls i.e., E. coli H1469 (pKIMl) containing hlyC alone and E. coli H1469 
(pRMB6 ), containing cyaA alone were unable to inhibit or reduce the CL réponse. 
This supplements the result of the effect of E. coli H1469 (pRMB6 ,pKIMl) extract 
on BHK cells (Table 12).AC purified from other constructs also showed a similar 
level of toxicity . AC from E. coli H I469 (pRMB6 , pANN202) containing hlyC 
from E. coli inhibited the PMA-induced CL response by 41% and E. coli H I469
PART III -1 29 - RESULTS
(pRMB6 , pANGE3) having cyaC from B. pertussis reduced the CL response by 
45% . The controls for each preparation showed stimulation of CL response rather 
than inhibition suggesting that the stimulating component from the extracts of E, coli 
strains may not be removed by one -step chromatography.
These data suggest that CyaA produced alone in E. coli has no CL inhibition 
activity (toxic activity) and that the C gene, either from P. vulgaris , E. coli ox B. 
pertussis activates CyaA to its toxic form which is responsible for inhibition of CL 
response of PMA-induced rabbit neuti’ophils.
It is important to point out here that despite normalizing the enzymic activity per 
vial for CaM-affinity purified AC from E. coli and from B. pertussis extracts, the CL 
inhibition effect was not comparable, i.e., cyaA in E. coli in the presence of C genes 
was found 50-60% less toxic than in B. pertussis . However, despite the fact that the 
E. coli extracts contained stimulatoiy, interfering activities, the active ACT, with CL 
inhibitory activity, could still be detected.
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Table.17
Effect of Cloned AC on CL Response of Rabbit Neutrophils.
Source
CL (mV) ±  
Total
SEM*
Peak % In* % St^
Control 1029 ±38.1 183 ± 15.4 - 100
E. coli H1469 (pRMB6 ), 1368 ± 42.5 262 ±  28.2 - 132
E. coli H1469 (pKIMl) 1351 ±39.1 238 ±23.1 - 131
E. coli H1469 (pRMB6 , pKIMl) 495 ± 11.6 95 ± 8.2 51 -
E, coli H1469 (pRMB6 , pANN202) 607 ± 10.3 153 ± 14.7 41 -
E.coli H1469 (pANGE3) 1138 ±31.5 219 ±18.3 - 110
E. coli H1469 (pRMB6 , pANGE3) 563 ±  22.0 140 ± 13.8 45 -
50 nmol cAMP/min/ml AC enzymic activity was applied per v ial. Controls were normalized 
by adding volume equal to their coresponding AC positive samples.
* = Derived as in Table 13 ; n = 4 
% In* = % inhibition of total CL 
% St“ = % stimulation of total CL
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Fig.34
Determination of Activation of CyaA in E. coli by CL Assay
Rabbit peritoneal neutrophils were pre-incubated with Calmodulin - affinity 
purified AC (50 nmol cAMP/min/ml AC enzymic activity / vial ) from E. coli 
H1469 (pRMB6 ,pKIM 1), E. coli H1469 (pRMB6,pANN202), and E. coli 
H1469 (pRMB6 , pANGE3) and the controls : E, coli H I469 (pRMB6 ), E. coli 
H I469 (pKIMl), E. coli H1469 (pANGE3) for 20 min at 37 “C before the 
addition of PMA. The figure shown is a mean and SEM of 4 observationsjuSi vi g
1= Conti'ol ( Buffer only)
2= E. coli H1469 ( pRMB6  )
3= E. coli H1469 ( pKIMl )
4= E. coli H1469 ( pRMB6 , pKIMl)
5= E. coli H1469 ( pRMB6 , pANN202)
6 = E. coli H1469 ( pANGE3)
7= E. coli H1469 ( pRMB6 , pANGE3)
2000 -1
^  1000 - 
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D E T EC T IO N  OF AN TI-AC A N TIBO D IES IN PERTU SSIS 
CONVALESCENT HUMAN SERUM.
Pertussis convalescent sera from 4 patients (adults) were tested for the presence 
of anti-AC antibodies by the immunoblotting technique. Fig,35 A demonstrates the 
reaction profiles of B. pertussis BP348 (pRMBl) after probing with the sera HSl, 
HS2, HS3, HS4 (lanes 2-5) and monospecific anti-AC antiserum R164, (lane 1) 
which was included in this study as a positive control. All were found positive for 
ACT. The titre ( the highest dilution of the antisera which could specifically recognize 
AC on immunoblots ) for each antiserum was determined by probing the extracts with 
1:100, 1: 300, 1: 500 , and 1:1000 dilutions of the antisera . HS2 showed the highest 
titre i.e., 1:1000 where HS3 and HS4 gave equal titres of 1:500. HSl was the lowest 
and reacted at 1 : 1 0 0  dilution only.
Further confirmation of the presence of anti-AC antibodies in these sera was done 
by probing the cloned B. pertussis AC expressed in E. coli . Urea extracts of AC + 
B. pertussis BP348 (pRMBl) and E. coli H1469 (pRMB3) and their AC " controls 
B. pertussis BP348 and E. coli H I469 were probed with HS2. Fig. 35 B shows that 
the antisera reacted positively at high MW position with AC+5. pertussis and E. 
coli strains and not with AC '  B. pertussis BP348 and E. coli H I469. ACT of B, 
pertussis was recognized as 2 major bands of 210 and 200 kDa and a minor band of 
195 kDa . Cloned AC from E.coli showed a single band of 210 kDa . The reaction 
profile with pertussis convalescent sera was consistent with the previous profiles 
recognized by anti-AC polyclonal, monoclonal, monospecific and calmodulin-affinity 
probed profiles of ACT. The reactions seen with other bands are presumably due to 
other immunogenic components of B. pertussis which are also present in these crude 
AC preparations .The reactions with E. coli are due to cross reacting antibodies and / 
or to pre- existing antibodies to the ubiquitous commensal.
These results clearly demonstrated the presence and production of anti-AC 
antibodies in high amounts during the course of the disease and they confirm the 
findings of Farfel etal. (1990).
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Fig.35
Im m unoblot Assessment of pertussis Antibodies in Human 
Convalescent Pertussis Sera.
The urea extracts of B. pertussis and E. coli were resolved by SDS-PAGE 
using 7.5% acrylamide resolving gel, electrophoretic ally transferred to 
nitrocellulose membrane and probed with different dilutions of human 
convalescent pertussis antiserum.
Panel A) Immunoblot of B, pertussis BP348 (pRMBl) AC (urea extracts ), 
probed with human convalescent pertussis antisera (HSl, HS2, HS3, HS4 )
1= Monospecific antiserum R164 (1:500) 
2= HS2 (1:1000)
3= HS3 (1:500)
4= HSl (1:100)
5= HS4 (1:500)
Panel B) Immunoblot of B. pertussis and E. coli urea extracts probed with 
HS2 (1:1000)
1 = E. coli H1469 (AC ~ )
2=  E. coli H1469 (pRMB3) ( AC + )
3 -  B. pertussis BP348 (AC " )
4=  E. pertussis BP348 (pRMBl) (AC + )
5= E. pertussis BP348 (pRMBl) (AC + )
6  -  SDS-6 H (MW standard)
KD
M  210200
Ml/yi KD 
205
116
97
66
45
29
1 2 3 4 5 6
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PRODU CTION OF ANTI-AC M O N O SPECIFIC  ANTIBODIES 
AGAINST NITROCELLULOSE. BOUND ACT.
ACT from urea extracts of B. pertrussis BP348 (pRMBl) was purified by the 
calmodulin -affinity purification method as described under Materials and Methods 
(see page 49). Purified protein was resolved by SDS-PAGE and transferred to 
nitrocellulose. The 210 and 200 kDa bands were excised, solubilized by sonication in 
PBS and used as immunogen in rabbits with Freunds incomplete adjuvant. The 
procedure is detailed in Materials and Methods (see page 53). Antiserum collected 
after two booster doses was designated as mono-specific 1 (Msl) and characterized by 
immunoblotting. Fig.36 clearly demonstrates the production of highly homologous 
antibodies against ACT. The Msl was used in 1:1000 dilution.The titre of the 
antiserum was evaluated by ELISA, with CaM-affinity purified AC (4 |ag protein / 
well) and was determined by reference to the monoclonal anti-AC antibody 1H6 (Table 
6 ). The unitage was calculated with a parallel-line bio-assay described by Manclark 
and Meade (1986).
To ensure that the serum recognizes only the proteins injected, B. pertussis BP348 
(AC ") was included as a conti’ol in this study. A cross reacting, 50 kD band was 
found in preimmune serum, which was successfully adsorbed out by using the urea 
extracts of AC " B. pertussis BP348. The specificity of Msl was compared with the 
anti-AC monoclonal antibody (McU) which showed a similar reaction profile. Crude 
preparations of AC from B. pertussis and E, coli were used to analyse the Msl in 
order to ensure the specificity of the antiserum and the purity standard of the affinity 
-purified ACT used for immunization. FHA, a 220 kDa protein of B.pertussis 
resolves closely on gels with ACT. Leusch et al. (1990) reported co-purification of 
ACT with FHA in one-step calmodulin-affinity purification. However, in the present 
study, the presence of FHA in purified ACT preparations was not detected when 
probed with anti-FHA monoclonal antibody (not shown). Moreover, if FHA had 
been copurified with ACT, antibodies should have been generated against i t , which in 
turn could have recognized the FHA in the urea extracts in BP348 (AC ", FHA ).
Taken together, these findings suggest that highly specific, homologous 
antibodies could be raised by this novel and simple method. Although monoclonal 
antibodies against ACT offer higher specificity, they are more difficult and 
time-consuming to produce.
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Fig.36
Immunoblot Assessment of Monospecific Antibodies Raised Against 
Nitrocellulose - bound ACT
Urea extracts were separated by SDS-PAGE using 7.5% acrylamide resolving 
gel, and transferred to nitrocellulose. Probing was carried out with anti-AC 
monospecific antibodies Msl (1:1000) and anti-AC monoclonal antibody McU 
(1:4000).
Panel A) Urea extracts probed with pre-immune serum.
l=B, pertussis BP348 (pRMBl)
2=B. pertussis B348 
3~ B, pertussis Tohama
Panel B) Urea extracts probed with monospecific antiserum (unabsorbed)
\=E.coli H1469 (pRMB6 )
2=SDS6H (MW standard)
3= B. pertussis BP348 (pRMBl)
4= B. pertussis BP348 
5= B. pertussis Tohama
Panel C) Urea extracts probed with monospecific antiserum (absorbed with 
extracts of BP348) )
E.coli H1469(pRMB6)
1~B. pertussis Tohama
3- B. pertussis BP348
4= B. pertussis BP348 (pRMBl)
Panel D) Urea extracts probed with monoclonal antibody.
B. pertussis BP348 (pRMBl)
2= B. pertussis BP348
B1 2 3 1 2 3 4 5 1 2 3 4 1 2
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INTRA- NASAL MOUSE PROTECTION TEST
The protective activity of monospecific anti-AC serum (Msl) was tested in mice 
against intranasal B.pertussis challenge. Msl was raised in rabbits against 
nitrocellulose- bound ACT as described in Materials and Methods, (see page 53) and 
was tested on immunoblots for its specificity for AC (see page 135). This antiserum 
was used for a mouse passive protection test. Msl was heated at 56 “C for 20 min to 
eliminate the possibility of complement mediated killing of the challenge . B. pertussis 
18323 were mixed in 1:1 ratio with the heat inactivated Ms land incubated at room 
temp for Ih. Controls included cells suspended in 1% casamino acid solution in PBS 
for each dilution (positive control) and 1% casamino acid solution in PBS (negative 
control). At this stage, before instillation, the viable count was performed for each 
preparation by plating the 10-fold serially diluted challenge doses on BG and the plates 
were incubated at 37 “ C for 72h in a humidified box.
The sublethal intranasal challenge of B. pertussis 18323 was given to 3- 4 week 
old, ether-anaesthetized mice in groups of 10. The protective effect of Msl was 
monitored against two challenge doses i.e., high challenge dose (5 x 1 0  ^cfu / mouse) 
and low challenge dose (2.5x 10  ^cfu/ mouse). The mice were inspected and weighed 
every alternate day for 14 days and the deaths were recorded. On day 14, the 
remaining mice were killed, weighed individually and the lungs were inspected for the 
signs of consolidation i.e., grayish discoloured areas. Healthy lungs were scored as 0 
and infected lungs from 1+ signifying few small areas of consolidation to 4+ for 
extensive consolidation in all lobes of lungs. Oedema was recorded and the weight of 
the lungs as % body weight was calculated. Lung culture was perfoimed by spreading 
aseptically a small peice of infected lung onto a BG plate. The total leukocyte count 
(TLC) was also performed.The data shown in Table 18 represents the mean of two 
identical experiments . As is evident from the data, a low level of protection was 
achieved when the protective effect of Msl was monitored by observing loss in weight 
gain (Fig.37 A), although lung pathology, lung culture and total leukocyte counts were 
very similar.
Examination of the lungs revealed a moderate pathology of lungs infected with 
both, high and low challenge doses with mean of 3 and 2.3 scores respectively. In 
mice challenged with Msl-mixed high and low challenge doses, the lung scores 
were lower at 2.2 and 1.4. Similarly, the mice challenged with Msl-treated bacteria, 
showed a reduction in loss of weight gain though this was not very significant. Lungs 
as % body weight, again, showed a difference of a narrow margin (Fig 38A) The total
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did not differ significantly between those of control mice challenged with CAA only 
or those which recieved high and low challenge doses. The reason for this could be the 
lack of consistent and reproducible infection in all mice since ether as an 
anaesthetizing agent was not found satisfactory in the present studies and challenge 
instillation was found difficult. In a further experiment, halothane was used as 
anaesthetizing agent in an attempt to improve the infection rate. In order to more clearly 
demonstrate a passive protection effect, Msl antiserum which had been concentrated 
2-fold by salting-out technique (see Materials and Methods, page 54) was used.
As is evident from Table 19, concentrated Msl(CMsl) partially protected the 
mice against infection. Deaths occured in mice, treated with high the challenge dose, 
between 1 2 th and 13th day but not in the mice treated with the low challenge dose or 
with either doses mixed with CMsl. The weight gain in CMsl-tieated mice was 
almost at control levels whereas that in challenge-alone groups was reduced (Fig.37
B). Similarly, there were clear differences in the lung weights of the challenge-alone 
groups compared with the CMsl- tieated groups (Fig. 38B). Total leukocyte counts 
did reveal differences although again these were not very significant. Viable counts of 
Msl- treated and un-treated challenge were approximately equal confirming the viablity 
of the challenge suspensions showing that the CMsl itself was not bactericidal. 
Recovery from lung culture (Fig. 39) was positive in high challenge dose and low 
challenge dose+ CMsl. These data indicate that ACT could possibly act as one of the 
major virulence factors and protective antigens during infection with B. pertussis 
since its neutralization by specific antibodies (CMsl) caused a reduction in the seventy 
and rate of infection and passively protected the mice.
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TablelS
The Protective 
Test
Effect of M sl in Mouse Intranasal Passive Protection
Challenge Deaths Mouse wt (g) 
/20 Mean ± SEM
Lungs as% 
body wt (g) 
Mean (SEM)
Score
LP«
TLC
log-
Lung
culture
CAA 0 23.5 ± 22.6 1 .2  + 0.06 0 3.3
HC 0 2 2 . 8  ± 18.8 2.4 + 0.44 3 3.4 +
HC+Msl 0 23.2 + 21.5 2 ±0.38 2 . 2 3.3 +
LC 0 23.0 ± 20.7 1.6 ±0.17 2.3 3.3 +
LC + Msl 0 23.7 ± 23.2 1.3 ±0.18 1.4 3.3 +
- and •• are the mean values of two replicate experiments (2 x1 0  mice per group). 
CAA = Casamino acids (1% v/w in PBS)
HC= High challenge dose of B. pertussis 18323 (5 x1 0  ^cfu / mouse)
LC= Low challenge dose of B. pertussis 18323 (2.5 xlO^ cfu /  mouse)
LP= Lung pathology
TLC=Total leukocyte count of WBCs / mm^ blood
Msl= Anti-AC monospecific antiserum raised in rabbits (see page 53)
+= Positive
PART III -139-  RESULTS
T able.l9  
The Protective Effect of Concentrated Anti-AC Monospecific Antibodies 
in Mouse Intranasal Challenge Test.
Challenge Deaths Mouse wt (g) Lungs as % Score - TLC Lung
10 mice (/lOmice) Mean ± SEM body wt (g) LP (log) culture
Mean (SEM)
Control
CAA
0 22.5 + 13.6 0.74 + 0.01 0 4,0 0
HC 2 17.4 ± 9.4 3.11 + 0.52 3.3 4.5 +
HC+CMsl 0 2 2 . 0  ± 1 0 . 6 2.18 ±0.19 3.2 4.3 +
LC 0 21.6+11.3 2.3 ±  0.17 3.3 4.6 +
LC+CMsl 0 22.3 ± 12.4 1 . 2  ±0.26 2.4 4.3 +
Mean and + SEM values are from 10 mice 
- and •• are the mean values of 1 0  mice 
CAA = Casamino acids (1% v/w in PBS)
HC= High challenge dose of B. pertussis 18323 (5x10^ cfu / mouse) 
LC= Low challenge dose of B. pertussis 18323 (2.5 xlO& cfu / mouse) 
LP= Lung pathology
TLC=Total leukocyte count of WBCs / mm^ blood
CMsl= Anti-AC monospecific antiserum raised in rabbits (see page 53 )
and concentrated by salting-out technique (see page 54).
+= Positive
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Fig. 37
The Effect of M sl on Loss of Weight Gain
The sublethal intranasal challenge of B. pertussis 18323 was given to 3- 4 weeks 
old, ether-anaesthetized (A) and halothane-anaesthtized (B) mice in groups of 10.
The protective effect of Msl (A) and Concentrated Msl (B) was monitored against 
two challenge doses i.e., high challenge dose (5 x 1 0  ^cfu / mouse) and low 
challenge dose (2.5x 10  ^cfu/ mouse) . The mice were inspected and weighed 
every alternate day for 14 days and the deaths were recorded.
Panel A) Effect of Msl
1= Casamino acid only
2= High challenge dose (5x10^ cfu)
3= High challenge dose+ anti-AC monospecific antiserum 
4=Low challenge dose (2.5xl0^cfu)
5= Low challenge dose+ anti-AC monospecific antiserum
Panel B) Effect of concentrated Msl
1= Casamino acid only 
2=High challenge dose (5x10^ cfu)
3=Msl= High challenge dose+ anti-AC monospecific antiserum 
4=Low challenge dose (2.5xl06cfu)
5= Low challenge dose+ anti-AC monospecific antiserum
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Fig .38
Mouse - Protective Effect of Monospecific anti - AC Antibodies.
Lungs as % body weight.
Groups of mice were challenged with B. pertussis 18323 at high challenge 
(HC~5xlO^ cfu) and low challenge (LC=2.5xl0^cfu) doses, treated and 
untreated with anti-AC monospecific antibodies Msl (Panel A) and concentrated 
Msl (Panel B), On the day 14, the mice were sacrificed, weighed individually, 
lungs were removed and related to body weight of mice.
Bars indicate SEM of the data of 10 mice.
CAA= Casamino acid only
HC=High challenge dose (5 x1 0  ^cfu)
HC+Msl= High challenge dose+ anti-AC monospecific antiserum 
LC=Low challenge dose (2.5xlQ6cfu)
LC+Msl= Low challenge dose+ anti-AC monospecific antiserum
3-,
;
f
J
CAA HC HC+Ms1 LC LC+MsI 
Challenge
B
?
!
e§
I
CAA HC HC+Ms1 LC LC + M s l  
Challenge
PART III -1 4 2  - R E S U L T S
Fig.39
Recovery of B. pertussis 18323 (Challenge Strain) from the 
Infected Lung.
Lung culture was performed by spreading aseptically a small peice of infected lung 
onto a BG plate and the plate was incubated at 37 “C for 72 h in a humidified box.

DISCUSSION
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ISOLATION OF ACT
Utsumi et aL (1978) showed that AC could be solubilized from B. pertussis cells 
by urea extraction and that AC activity was relatively stable under these conditions. In 
this way, Confer & Eaton (1982) were able to extract AC which had both enzymic 
and toxic activities and they reported that this activity was heat-stable.
The majority of AC enzyme has been shown to be cell-associated and 90% of the 
activity resides on the outer surface of the bacterial cell (Hewlett and Wolff, 1976; 
Masure & Storm, 1989).
Since the time of the discovery of AC in the mid-70s, urea extracts of B. pertussis 
organisms and concentrated culture supemates have been used for preparation of AC 
and ACT. In the present study, cell-associated AC from various strains of B. pertussis 
(including wild-type, recombinant and mutant) and E> coli strains harbouring the B. 
pertussis cyaA,B,D genes and the related C genes from other bacteria was extracted 
by modification of the techniques used by Confer & Baton (1982) and Brownlie et aL 
(1988). The modifications introduced were as follows:
The cells after harvest were stored at -20 ®C prior to addition of 4M urea . The 
crystalline urea was added after thawing the cell suspension. A low speed 
centrifugation before dialysis was found to be beneficial since removal of cell debris 
before dialysis facilitated the efficiency of dialysis. Brownlie et al. (1988) reported that 
more vigorous conditions were needed to obtain AC from E. coli strains, and used 
8 M urea. In the present work, this was found to be unnessesary because the cell 
storage overnight at - 2 0  ®C made it possible to extract AC from E. coli strains even in 
the presence of 4 M urea and no obvious difference was observed between 8  M or 4 M 
urea for recovery of AC.The reduction of the urea concentration was convenient for 
removal of urea in subsequent dialysis steps which was a requirement for the 
biological assays. These data indicate that osmotic pressure exerted on the cell walls 
of the organisms or rupture of the cells by ice crystals formed at -20 “C presumably 
facilitated the recovery of AC from these compartments.
CHARACTERIZATION OF AC BY IMMUNOBLOTTING.
The immimoblotting technique has been used previously by Hewlett et a/.,(1989) 
and Belial ou et aL, (1990 a) to analyse the composition of crude and purified AC, and 
a detailed study was done during the work presented here. Urea extracts of wild-type
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B. pertussis, recombinant B. pertussis strain BP348 (pRMBl), Tn5 mutant strains 
deficient in different individual virulence factors (Weiss et at., 1983) and the other 
Bordetella species, 5. parapertussis, B. bronchiseptica and S. avium., were 
examined. In addition, urea extracts from E. coli strains containing either the cya 
genes of B. pertussis or harbouring both the cya genes and one of the C genes either 
from E. coli {hlyC ), P. vulgaris (hlyC ) orB. pertussis (cyaC ) were examined . 
Immunoblotting with two polyclonal sera raised against AC in rabbits and guinea pigs 
against 45 kDa AC gave a number of bands which were also present in B, pertussis 
strain BP348 (AC “). However, these sera recognized the high MW holotoxin 
molecule of ACT in both B. pertussis and E. coli.. The other bands may have been 
due to cross- reacting antibodies present in these antisera since they were raised against 
crude AC.These sera could have been absorbed with extracts of AC "B. pertussis 
strains if sufficient quantity of these sera had been available.
Despite preparation of the urea extracts of all B. pertussis strains under the same 
set of conditions, they showed differences in immunoblot profiles.An important 
observation was the production of comparable levels of ACT by a Tn5 mutant lacking 
a functional PT gene, B. pertussis BP357 (Weiss et aL, 1983), and recombinant B. 
pertussis strain BP348 (pRMBl) which was reported to produce 5-fold higher toxin 
activity and 3-fold higher enzyme activity than wild type B. pertussis Tohama 
(Brownlie et aL, 1988). This property of strain BP348 (pRMBl) was attributed to a 
gene dosage effect by the authors. The high level of ACT shown on immunoblot s 
by BP357 may reflect a possibility of metabolic competition between PT and ACT 
molecules for synthesis and transport, in which case absence of one may facilitate the 
production and transport of the other. However, another Tn5 mutant BP353, 
deficient in FHA, produced a lower level of ACT than the wild type B. pertussis in 
urea extracts as revealed by immunoblotting . This is consistent with the reports of 
Weiss et at. (1983) who observed a lower production of cell-associated AC in this 
strain than in the parent strain BP338. However, they found higher AC activities in 
culture supemates of the FHA '  mutant and ascribed this to differences in 
compartmentalisation of AC and not as a reduction in total AC activity. Another 
possibility may be that since AC and FHA are both surface- associated proteins, they 
could compete for transport machinery. Consequently, in the mutant BP353, more 
sites would be available to ACT, which would result in high levels of ACT in the 
culture supernate rather than the intact cell. Since both FHA and AC are 
extracytoplasmic proteins, the loss of one may result in more efficient release of the 
other by either active or passive transport process. Bassford and Beckwith (1979)
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reported that the levels of secretion of extracellular proteins are interrelated. When 
synthesis of a 5 -galactosidase fusion protein of E. coli was induced, secretion of other 
proteins was impaired. A similar phenomenon could be suggested for BP353.Leusch et 
aL (1990) found the majority of AC enzymic activity in culture supernate fractions. 
This may explain the less cell-associated AC enzymic and toxic activity obtained in the 
present study.
The different behaviour of the two mutants (BP357 and BP353) regarding 
production of ACT may reflect differences in the regulatory mechanism involved in 
transcriptional activation of individual virulence determinants.Roy et aL (1989) showed 
that the fha promoter was active in E, coli in the presence of the bvg operon but the 
ptx promoter was not active under the same conditions , providing strong evidence for 
two different mechanisms of transcriptional control. Goyard & Ullmann (1991) have 
also suggested an indirect regulation by bvg of cya and ptx , and reported that the 
bvg locus was not sufficient for their activation in E, coli.. Additional 
promoter-specific factors seem to be required for transcriptional activation of these 
opérons. This common requirement of the cya and ptx opérons may account for the 
competition observed: lack of expression of one would allow the formation of more 
efficient promoter complexes and better expression of the other. Further work is 
required to confirm these suggestions.
The immunoblot study of crude ACT of all B. pertussis species showed not a 
single band of 216 kDa as reported by Hewlett et al. (1989), or of 200 kDa as reported 
by Rogel et al. (1989), Hanski, (1989) and Bellalou et al. (1990 a ) , but two bands 
at MW 210 kDa and 200 kDa reacting with monoclonal antibodies. The family of 
lower MW bands reacting with the monoclonals (9D4, McU) appeared only in the case 
of ageing of ACT and after repeated freeze-thaw procedures. A protease inhibitor, 
PMSF, was used to investigate whether the degradation was due to the proteases 
present in these preparations. Use of PMSF showed a reduction in proteolytic cleavage 
but the degradation was not completely prevented. The partial prevention suggests that 
other protease inhibitors may be necessary and perhaps used as a cocktail to prevent 
the proteolytic cleavage of ACT during storage. A similar study on degradation of FHA 
has been reported by Irons et at. (1983) in which they found that the degradation was 
totally abolished by the presence of ImM PMSF in the solution. These data support 
the view that the other bands observed in the crude and purified ACT preparations by 
previous investigators and in the present study were mainly the degradation products 
of the high MW form of ACT. This suggests that the major cell-associated ACT is the 
MW 210 and /or 200 kDa form. The two band pattern obtained by immunoblotting
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could be explained by the partial degradation of the 210 kDa form, but the CyaA 
protein expressed in E. coli did not reveal the 200 kDa component. Thus the presence 
of two bands of similar MWs, with more or less similar intensities may not not be a 
mere problem of degradation.
Further investigation was performed on purified ACT. The recombinant B. 
pertussis strain BP348 (pRMBl) was selected as a source for purification of ACT due 
to its high production of both enzymic and toxic activities (Brownlie et al., 1988).The 
high expression of B. pertussis ACT by this recombinant strain facilitated the 
purification of the AC by CaM-affinity chromatography of urea extracts. The AC was 
detected by immunoblotting with anti-AC monoclonal antibodies, which revealed that 
AC was again composed of two bands of 210 and 200 kDa. The 200 kDa form was 
found less stable on storage and this was consistent with the immunoblot study 
performed with crude AC. Rogel et al. (1989) reported the presence of toxic and 
non-toxic 200 kDa AC which resolved as two peaks by gel filtration. However, 
SDS-PAGE studies performed by these investigators showed only a single band of 200 
kDa. In an attempt to investigate further this observation, isoelectric focusing of CaM 
- affinity purified ACT from B. pertussis BP348 (pRMBl) was performed. The 
results showed a single diffuse band at p/ approx. 7 rather than two bands suggesting 
that the two forms observed by immunoblotting belong to the same polypeptide. These 
two different electrophoretic forms of AC may represent the toxic and non-toxic forms 
of AC observed by Rogel et a l (1989) as the AC protein expressed in E. coli was 
non-toxic.
Raptis et al. (1989) reported that exogenous CaM was capable of protecting the 
catalytic activity of AC against inactivation by trypsin but was unable to protect 
invasiveness. They proposed that two different domains on the same protein or on 
different proteins were responsible for each activity. Furthermore, they predicted that 
the penetration domain would have to be downstream (toward C-terminus) from the 
catalytic domain. Recently Bellalou et a l . (1990 b) were able to show the production 
of non-invasive AC by in-phase deletions of the 3'-end of CyaA. Truncated AC 
showed markedly reduced haemolytic activity and no invasive activity. Bellalou et al. 
(1990 b) proposed that the structural integrity of the full length protein (CyaA) was 
necessary for the toxin activity and that distinct structural determinants within the CyaA 
protein were involved in secretion, pore formation and entry of ACT into target cells.
Very recently, the haemolytic and invasive activities have been differentiated on 
the basis of inactivation with exogenous CaM. The invasive activity was found 
inhibited in the presence of CaM, while haemolytic activity was unaltered or potentiated
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(Rogel et al., 1991), again suggesting that two distinct domains or structural 
determinants are responsible for these two activities.
In the present study, it was observed that those extracts of B. pertussis , E. coli 
and other Bordetellae showing reduced or no 200 kDa in immunoblot profiles were 
less toxic or non- toxic as assesed by toxicity assays (which will be discussed later). 
These included, B. pertussis Tohama (wild-type), B. pertussis TnJ mutants BP349, 
BP353, B. parapertussis and E. coli expressing the cyaA gene . As evident from 
the data presented in the Results section, urea extracts of B. pertussis Tohama , and 
Tn5 mutant BP353 (FHA") were less toxic than B. pertussis 18323, B, pertussis 
BP357, and S. pertussis BP348 (pRMBl) in CL assays, although equal amounts of 
total protein were assayed. B. pertussis BP349 which showed only a faint 210 kDa 
and no 200 kDa was non-toxic in CL assays and BHK cell assays even if twice the 
normal level of protein was assayed. Similarly, extracts of E. coli H1469 (pRMB3) 
were non-toxic. B. parapertussis was also very weakly toxic.
Controversial data have been reported on the structural-functional relationship of 
B. pertussis AC. Both enzymic and toxic activities have been linked with a variety of 
molecular forms (Hanski and Farfel,1985; Shattuck and Storm, 1985; Kessin and 
Franke, 1986; Ladant,1986; Hewlett et al., 1989; Rogel et aL, 1989; Masure and 
Storm, 1989) depending on whether the AC has been extracted from the cells or 
culture supemates.
In the present study , a 50-45 kDa form was observed in culture supemates which 
reacted on immunoblots with both polyclonal and monoclonal AC antibodies and was 
assumed to be a degradation product. This form had AC enzyme activity and therefore 
presumably represents an N-terminal moiety of CyaA (Glaser et al., 1988). This form 
was further degraded after storage of culture supemate into lower MW forms ranging 
from 37-25 kDa. Characterization of the cell- associated ACT by immunoblotting 
revealed that ACT was synthesized as high MW 210 and 200 kDa holotoxin forms by 
B. pertussis and B. bronchiseptica and mainly as a 210 kDa form in B. parapertussis. 
However Bellalou et al. (1990 a) have reported the secretion of the 200 kDa form into 
culture supemates of B. pertussis under certain growth conditions. They grew B. 
pertussis in filter - sterilized SS medium with 2% BSA instead of the autoclaved 
medium which was used in the present study. Under the growth conditions provided 
during this study, the holotoxic ACT was not found in culture supemates even after 48 
h growth. .
When AC was expressed in E. coli (pRMB3) it was synthesized as a 210 kDa 
molecule . In E. coli (pRJVIB6 ) a few more bands, probably break -down products
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were observed along with the 210 kDa form.These results support the findings of 
Bellalou a/. (1990 a) that the cyaA gene product appears as a 200 kDa protein that 
corresponds to the major intracellular form of the AC and that those forms present in 
the culture supernate are proteolytic cleavage products of the holotoxin resulting in 
catalytically active fragments.
The MW of 210 and 200 kDa for AC is substantially larger than the the MW 
weight calculated from the deduced amino acid sequence (177 kDa) of the protein 
(Glaser et aL, 1988 a). The difference between calculated MW and the apparent MW 
of the protein may be due to post-translational modification or due to incomplete 
unfolding of the molecule in the solublizing buffer used for SDS-PAGE .
DETECTION OF AC BY CALMODULIN-AFFINITY PROBING.
Wolff et al. (1980) discovered that B. pertussiss ACT was stimulated by 
calmodulin (CaM) and the stimulation of cell- bound AC was 100-fold higher than the 
stimulation of AC recovered from culture supemates. AC is synthesized as a large 
precursor of 1706 amino acids (Glaser et al., 1988 a). Under the usual growth 
conditions the N-terminal moiety of this precursor is processed to low molecular 
weight forms of 43 to 50 kDa and secreted into the medium (Shattuck et al., 1985, 
Ladant et al., 1986). Glaser et al. (1989) showed that the N-terminal portion of this 43 
kDa (tryptic) fragment of ACT from 1-235/237 residues harbour the active, ATP 
binding site whereas the C-terminal region of this fragment from residues 
235/237-399 corresponds to the main CaM-binding domain of the enzyme. These 
data established the fact that AC is a CaM-sensitive protein and has a strong affinity 
for it. On the basis of this information, an alternate method for detection of AC on 
Western blots was devised by probing the AC with CaM.
The data presented in this study clearly demonstrate that although not as specific 
as monoclonal anti-AC antibodies, this method still has its advantages in that it is 
reproducible and that detection by Western blotting could be performed without the aid 
of anti-AC antibodies. This result is the first report on the detection of ACT with CaM 
providing direct evidence of the affinity of ACT with CaM.
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MICROPLATE ASSAY FOR DETERMINATION OF AC ENZYMIC 
ACTIVITY.
A microplate assay developed for the determination of AC enzymic activity from 
B. pertussis and E. coli showed a detection range from 4-32  micromol cAMP.
The principle of the assay is based on the cross-feeding of a cya defective mutant, E. 
coli G802 with cAMP to initiate the transcription of B-galactosidase which then 
hydrolyzes a chromogenic substrate in the medium, producing a blue colour. E. coli 
is able to use the disaccharide lactose as its sole carbon source provided that lactose can 
enter the cells and be broken down into its component saccharides i.e., glucose and 
galactose. The proteins that carry out these functions are specified by the structural 
genes of the lac operon (Gale, 1943). In the absence of lactose, the lac operon genes 
are not transcribed due to the presence of a 'repressor' which is attached to the operator 
site to block the transcription. When lactose is supplied, derepression occurs by 
binding of lactose to the repressor, resulting in production of B-galactosidase and 
permease for lactose. The mechanism is called metabolic induction and occurs in E. 
coli (Reznikoff, 1992). Another regulation mechanism 'catabolite repression' 
(Magasanik,.1961) is also active in E. coli. In the presence of glucose, production of 
enzymes by the lac operon is switched-off and efficient transcription is prevented even 
when lactose is present. RNA polymerase does not bind directly to the promoter unless 
a special protein factor called CAP (catabolite activator protein) and cAMP are present.
These two form a complex, CAP undergoes allosteric changes (Kumar, 1975) and 
binds to the promoter after which RNA-polymerase can recognize and bind to the 
promoter to initiate transcription (Pastan and Adhya, 1976). The strongest evidence of 
involvement of cAMP in catabolite repression is that mutants deficient in cya and cap 
are defective in AC and CAP and are unable to utilize certain carbohydrates (Perlman 
and Pastan, 1969). The ability can be restored in cya mutants by addition of exogenous 
c A A/IP or dibutyryl cAMP (Aono et al., 1979). cAMP uptake in E. coli occurs by 
facilitated diffusion (Goldenbaum and Hall, 1979).
The results show that this assay could be used for detection and semi-quantification 
of AC. Despite its narrow detection limits, a significant quantity of AC enzymic activity 
could be detected as is evident from the activity detected in CaM- affinity purified AC 
from B. pertussis BP348 (pRMBl). The microplate assay described here offers many 
advantages since it allows the analysis of many samples, is reproducible, simple to 
perform, and economic in requirements of time and chemicals. The assay does not 
require the use of radioisotopes and can be easily assessed by spectrophotometric
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means for quantification. Although not as sensitive as the Salomon assay, the 
microplate assay may be a good choice in future for the preliminary screening of 
samples for the presence of AC, including clinical specimens of pertussis and 
semi-quantification of AC enzymic activity from cell extracts, culture supemates, or 
purified preparations.
DETERMINATION OF AC TOXIC ACTIVITY BY DIFFERENT 
ASSAYS.
The purpose of this study was to devise a simple, reliable, convenient and safe 
assay for determination of toxic activity of ACT. Increased levels of intracellular 
cAMP have been reported to inhibit various phagocytic functions. Confer & Eaton 
(1982) reported that ACT entered mammalian cells such as polymorphonuclear 
leukocytes (PMNs), was activated by host cell calmodulin (CaM), and induced 
increased levels of intracellular cAMP which impaired the bactericidal functions of 
these cells. The fact that ACT penetration raises the intracellular cAMP concentration 
provided a sensitive assay for ACT. Several studies have reported that ACT increases 
the cAMP concentrations in a wide range of eukaryotic cells. It is because ACT has 
little target cell specificity (Hanski et al., 1985; Hewlett and Gordon, 1988). Target 
cells have included : monocytes, lymphocytes, mouse S49 lymphoma cells, isolated 
rat pituitary cells, CHO-cells, (Hewlett et al., 1985); HeLa 229 cells (Ewanowich, 
1989); J774 cells (Hewlett et al., 1989); red blood cells (Bellalou et al., 1990; Rogel et 
al., 1991) and mouse neuroblastoma cells (Masure et al., 1991).
The most extensively studied category of target cells is that of immune effector 
cells in which ACT has been found capable of inhibiting the activities involved in 
defences against microbes, such as : chemotaxis, phagocytosis, oxidative activity and 
killing (Confer & Eaton, 1982; Hewlett et al., 1983 a; Friedman et al., 1987 b; 
Pearson et al., 1987; Galgiani et al., 1988).
ACT also inhibited the cytotoxicity of non-phagocytic immune effector cells, e.g., 
natural killer (NK) cells (Hewlett et al, 1983 a). In cells in which cAMP is a positive 
signal, e.g., rat pituitary cells, ACT promoted the secretion of growth hormone 
(prolactin), luteinizing hormone and adrenocorticotropic hormone (Cronin et al., 
1986). The basis of determination of ACT in other cells is the measurement of the 
accumulation of intracellular cAMP. This involves the use of radioactive isotopes in 
the form of radiolabelled cAMP in a competitive binding assay (Gilman, 1970).The 
assay provides a standard and sensitive determination of ACT toxic activity , but the
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methodology involved is laborious and time-consuming. Moreover, involvement of 
radioactive isotopes make its use expensive and potentially hazardous and confined to 
authorized persons.
The data presented here have taken some of the other consequences of ACT toxin 
activity as parameters to measure the effect of the toxin on target cells, such as : 
elongation effect on CHO cells; haemolytic effect on red blood cells; arborization of 
baby hamster kidney cells (BHK cells) ; inhibition of nitroblue tétrazolium reduction by 
PMNs; and inhibition of the chemiluminescent response of PMNs to chemotactic 
stimuli.
CHO Cell Assay.
The elongation effect induced in CHO cells by cAMP has been shown with a 
number of toxins which either stimulate host cell AC or increase intracellular cAMP 
levels directly. The effect has been shown with heat labile enterotoxins of Vibrio 
cholerae and E. coli (Guerrant et a i, 1974; Merson et a i, 1979), cholera toxin (CT) 
and adenylate cyclase toxin (Hewlett et ai, 1983 b; Hewlett et a i, 1985). Pertussis 
toxin (PT) did not produce the elongation, but had a clustering effect on CHO cells 
(Hewlett et a i, 1983 b). The sensitivity and detection limits of this system for CT and 
PT have been reported to be < Ing/ml (Hewlett et ai, 1983 b).
The use of CHO cell elongation as a parameter to detect ACT with sensitivity and 
specificity was explored during this study. When ACT was used in high doses (200 
nmol cAMP/min/ml) no effect was observed. This agrees with the observations of 
Hewlett (personal communication) who also observed a similar effect with high doses 
of ACT . With lower doses, however, elongation was observed and the limit of 
detection was 12.5 nmol cAMP/min /ml enzymic activity. These data indicate that 
there may be a dissociation between cAlVIP accumulation elicited by ACT and 
morphological change in CHO cells and it may be assumed that at high levels of ACT, 
the cells may undergo a physiological stress due to depletion of ATP resulting in 
paralysis or dormancy of the cell functions, including shape-change. The elongation 
response may be used to monitor AC toxin at appropriate dilutions, but the assay did 
not show the sensitivity comparable to that reported for PT and CT. As far as the 
specificity was concerned, this assay was found satisfactory since no cluster pattern 
indicative of PT was observed with CaNl-affinity purified ACT. Furthermore, when 
crude extract of BP348 (AC ~,PT +) was tested, only a clustering effect was observed 
suggesting that the elongation effect shown in CHO cells by CaM - affinity purified
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AC was due to ACT.
The underlying mechanism involved in this elongation effect has not been fully 
elucidated. It has been recognized by membrane-membrane interaction studies that 
various membrane components of CHO cells change with cell density (Porter et al., 
1973). In a recent study, incubation of respiratory epithelial tissue with B. pertussis 
culture filtrate showed cytotoxic effects in the epithelial cells which produced 
mitochondrial swelling and cell surface cytoplasmic blebbing (Wilson et al., 1991). 
This effect could be due to ACT activity in the culture filtrates.
Although the CHO cell assay offered a specific assay for detection of AC, it was 
not found to be very sensitive and the effect was detectable only within a narrow 
range, since high doses did not induce elongation at all. Moreover, the assay required 
aseptic conditions and was found to be time-consuming, taking 16-24 h to observe the 
morphological changes. Above all, the results were recorded by microscopy which 
was purely subjective and likely to involve human bias in the scoring of results.
Haemolytic Assay.
ACT has been reported as a bi-functional protein exhibiting both CaM-sensitive 
ACT enzymic and haemolytic activities (Glaser et al., 1988 b; Bellalou et al., 1990 b; 
Rogel et al., 1991). A single Tn5 insertion mutation in the cya operon resulted in a 
mutant BP348, deficient in both AC enzymic and haemolytic activity (Weiss et at.,
1983). Both activities were restored when BP348 was complemented with plasmids 
carrying the complete cya operon (Brownlie et al., 1988), Sequence analysis of 
cyaA revealed a domain between residues 640 and 910, displaying a particularly high 
amino acid homology with an internal part of the alpha -haemolysin of E. coli (Glaser 
et ah, 1988 b).Bellalou et al. (1990 b) have recently shown that in-phase deletions in 
this region resulted in a mutant with markedly reduced haemolytic activity. Moreover, 
the mutant AC was completely devoid of invasive activity. These data indicate that 
the haemolytic activity has a direct impact on toxicity and that this activity could be 
used to determine the toxicity of ACT, RBCs are the most convenient cells for 
assaying cytolytic toxins because they are readily available, and contain a built-in 
marker in the form of haemoglobin (Bemheimer, 1988). Species of RBCs used in an 
assay might be of importance since human RBCs have been shown to be an excellent 
target for internalization of AC (Masure et al., 1991) but not for haemolysis (Rogel et 
a l, 1991).
The data presented in this study concerned an investigation of the haemolytic 
activity as an assay for toxicity of ACT. Haemolytic activity of ACT on sheep and
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rabbit RBCs was explored and sheep RBCs were found to be more sensitive. This 
does not agree with a recent study by Rogel et a/. (1991) who found rabbit RBCs more 
sensitive but the discrepancy may be explained by different assay conditions. 80% 
haemolytic activity was observed with a dose of 60 nmol cAMP/min/ml AC enzymic 
activity which is considerably less than that applied by Rogel et al. (1991). This 
difference may be due to the the difference in incubation times which was 1 2  h in the 
case of this study whereas Rogel et al. (1991) incubated cells for only 3h.
The haemolytic activity of ACT was blocked when it was incubated with 
monospecific anti-AC antiserum which agrees with the data of Rogel et al. (1991). 
Taken together, these findings suggest that haemolytic activity of ACT could be used as 
an assay for determination of toxic activities in B. pertussis ACT. However, in the 
case of ACT expressed and activated in E. coli, only a weak haemolytic activity was 
observed by Sebo et al. (1991). This activity was 5 times less than B. pertussis 
haemolytic activity which is already 100 times lower than that of E. coli alpha 
-haemolysin. (Bellalou et al., 1990 b).
BHK Cell Assay.
A variety of mammalian cells have been used to detect the toxic effects of B. 
pertussis ACT, but the morphological change as a parameter has been reported only in 
CHO cells (Hewlett et al., 1985).These cells, after intoxication with ACT, exhibit an 
elongation or stretching effect, thought to be due to the intracellular elevation of cAMP. 
An effect of elevated intracellular levels of cAMP in baby hamster kidney (BHK) cells 
has been observed by Dr. John Edwards, Department of Cell Biology , University of 
Glasgow. These cells are fibroblasts and, after incubation with exogenous dibutyryl 
cAMP, tend to change their shape from regular to dendritic (tree -like) forms. When 
the effect of ACT on these cells was assessed, a similar change in the BHK cells was 
observed, indicating the intoxication of these cells by ACT and suggesting an 
alternative assay for ACT. This effect was not seen with crude extracts of ACT- 
deficient Tn5 mutant BP348. This encouraging study suggests the specificity of this 
assay for ACT in a dose- dependent manner. Furthermore, this assay was not time 
consuming, required less time than the CHO cell assay and was found more reliable 
since unlike CHO cells assay, assessment was not purely subjective and the results 
were scored by computer analysis.
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Inhibition of Nitroblue Tétrazolium Reduction .
A series of redox reactions takes place in PMNs and monocytes during 
phagocytosis. These create increased consumption and stimulation of the hexose 
monophosphate shunt . Products of the reduction of oxygen include hydrogen 
peroxide and several highly reactive unstable intermediates of oxygen i.e., superoxide, 
singlet oxygen, and hydroxyl radical (Allen et al, 1972).
Nitroblue tétrazolium reduction (NBTR) is an indication of neutrophil superoxide 
production and can serve as a useful marker of the normal redox capabilities of the 
PMNs to convert NBT to a blue formazan derivative after stimulation with PM A, a 
stimulus which promotes a variety of leukocyte responses including degranulation, 
superoxide generation, and aggregation (DeChatelet et al., 1976). In the present 
study this stimulus was used because PT inhibits neutrophil response to fMLP but not 
to PMA (Becker et al., 1985; Schefcyk et al., 1985) and it thus made the assay 
suitable for both crude or purified ACT preparations. PMA was therefore selected to 
exclude the possibility of any effect PT may have had on the assay.
The microplate assay, described for the first time in this study for detecting ACT 
activity, allowed the analysis of toxic activity of ACT in many samples 
simultaneously, was reproducible and simple to perform. This assay did not require 
the use of radioisotopes and was able to be assessed visually. The suppression of 
NBT reduction by ACT presumably occurred by impairment of cell functions due to 
increased levels of intracellular cAMP . No decrease in viability of cells was observed 
in ACT - treated PMNs by the trypan blue dye exclusion test. Inhibition of leukocyte 
reduction of NBT after stimulation by a chemotactic peptide fMLP has been reported 
for the assay of pertussis toxin (Craig & Parton, 1988) and leukotoxin of P. 
haemolytica (Craig et al., 1990). The inhibition of nitroblue tétrazolium reduction test 
was simple to perform and rapid, but the sensitivity for ACT was low and 
furthermore, the results were scored subjectively. Spectrophotometric assesment of 
the results was difficult because of uneven settlement of the insoluble formazan 
particles in the microplate wells. However, for rapid screening of ACT activity either 
in crude or purified preparations, the NBTR-microplate assay was found quite 
suitable. Moreover, with correct choice of target cells, appropriate stimuli, and high 
doses of toxin, it is possible that this assay may be useful for screening other toxins 
which suppress PMNs functions.
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Chemilummescence Inhibition Assay.
Chemiluminescence (CL), or the emission of light by phagocytosing PMNs is 
believed to result from the generation of oxidative species i.e., superoxide, singlet 
oxygen, and hydrogen peroxide (Allen et al, 1972). It is an indirect measure of the 
bactericidal ability of phagocytes. Addition of chemical and enzymic inhibitors of 
these metabolites and the enzymes involved in their generation, causes a decrease in 
bactericidal activity of PMNs (Johnston et al, 1975) suggesting their importance in 
microbiocidal functions. The addition of the non-particulate stimulus, PMA, to 
resting human PMNs also results in metabolic events similar to those seen during 
phagocytosis (De Chatelet et al., 1976). Thus the alteration of neutrophil response to 
PMA may indicate an alteration of the normal neutrophil responses to infection.
The CL inhibitory effect of ACT on human macrophages (Confer & Eaton 
1982), neutrophils (Friedman et al., 1987 b) and monocytes (Pearson et al., 1987) has 
been reported. In fact, the inhibition of the CL response of PMA-induced human 
macrophages in the presence of crude urea extracts (Confer & Eaton, 1982) was the 
first report to reveal toxin activity of B. pertussis ACT. Another study by Friedman 
et al. (1987 b) demonstrated the CL-inhibitory effect of affinity-purified ACT on 
human neutrophils stimulated with heat-killed opsonized S. aureus.
The CL inhibition assay for detection of AC toxic activity applied in this study was 
found to be more sensitive than previously reported CL assays. It is evident from the 
data presented in this study that this assay was sensitive enough to detect as little as 
0.5 nmol cAMP/min/ml AC enzymic activity applied /vial.
PMA was used as a stimulus to avoid any possible interference by PT. PMA 
appears to exert its effects by activating the protein kinase C in target cells (Nishizuka,
1984). Interestingly, PT inhibits neutrophil response to fMLP, C5a, and leukotriene 
B4, but has no influence on neutrophil response to PMA (Becker et al., 1986). 
Moreover, fMLP-induced PMNs showed enhanced CL in the presence of other 
components of B. pertussis , such as FHA and LPS (Craig et al., 1988). However, 
because PMA is a carcinogen, its use could be substituted with fMLP when working 
with purified preparation of ACT in CL assays.
In the present work, the PMA-induced, CL response of rabbit PMNs was 
impaired by both crude and CaM-affinity purified ACT. This suggests that 
myeloperoxidase-dependent production of hydrogen peroxide was being inhibited 
since luminol-enhanced CL detects mainly this activity (Briheim et al., 1984).The 
minimum time to achieve clear inhibition of the CL response by crude ACT was 15
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mill. On incubation of PMNs with crude ACT for less than a 5 min, marked 
enhancement of response was observed. The summed levels of neutrophil CL 
generated in the presence of PMA and crude ACT was higher than the summed levels 
of neutrophils CL generated in the presence of PMA alone.This may indicate the 
enhancement of CL by FHA or LPS in the presence of PMA. The rough LPS of E. 
coli J5, and smooth LPS of E. coli 0111;B4 are reported to stimulate human 
neutrophil PMNs (Henricks et aL, 1983). LPS is also found to serve a role of priming 
and stimulation of neutrophils (Aida and Pabst, 1991).
On the other hand, affinity- purified ACT did not show a similar time course of 
activity .The inhibitory effect of purified ACT on PMA-induced neutrophils was 
evident within 5 min and no early enhancement of CL was seen. Hewlett et al (1989) 
reported that purified ACT entered CHO cells and started production of cAMP without 
any lag period and this was supported by the data here. Studies of Friedman et al. 
(1987 b) have shown a dose-dependent effect of ACT on human neutrophils. The 
present results revealed an interesting biphasic response to ACT, Dose response 
studies showed that purified ACT was able to suppress PMA-induced CL response at 
doses above 0.5 nmol cAMP /min /ml AC enzymic activity per vial. Doses of approx: 
0.05 -0.0005 nmol cAMP /min /ml AC enzymic activity per vial did not inhibit CL 
response. With lower doses, a significant stimulation of CL response was observed. 
This effect of ACT on CL response has not been reported previously but related 
effects have been reported with low doses of other RTX toxins.Since ACT shares 
amino acid sequence similarities with other RTX toxins (Glaser et ah, 1988 b), it 
could be proposed that ACT at subtoxic doses may produce changes in the target cell 
membrane which lead to their altered function. In the case of alpha-haemolysin of E. 
co li , which is the most extensively studied toxin among all the pore forming RTX 
toxins, cytolytic events are attributed to the rapid formation of cation selective channels 
in host cells that lead to osmotic lysis (Bhakdi et al., 1986). Apart from lysis there 
are data suggesting that it can probably cause more subtle effects by impairment of 
host-cell activities. A 14-fold increase in superoxide production has been reported 
with sublytic (picogram) doses of E. coli haemolysin in rat renal tubular cells (Keane 
et al., 1987). This supports the view that alteration of the cell functions of animal cells 
could occur upon exposure to subtoxic or sublytic doses of RTX toxins, including 
ACT. A similar effect at sublytic concentrations of E. coli alpha haemolysin has been 
reported recently by Bhakdi and Martin (1991). The stimulatory effect at subtoxic 
concentration of ACT in the CL réponse could possibly provide an extremely sensitive 
assay for the detection of very low concentrations of the toxin in purified preparations.
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The respiratory burst is a distinguishing property of phagocytes. It reflects the 
activation of events with the formation of products essential for the killing of 
microorganisms, but these products are also a cause of tissue damage and 
inflammation (Baggiolini and Wymann, 1990). It seems possible therefore, that at 
high doses, ACT impairs phagocytic functions and facilitates B. pertussis survival, 
and at lower doses, it may cause the respiratory burst on a massive scale in PMNs 
and other target cells which may lead to local tissue damage and inflammation, thereby 
ensuring proliferation of B. pertussis in respiratory epithelial cells.
In conclusion,the inhibition PMA-induced, luminol/DNDH- enhanced CL 
response of rabbit peritoneal neutrophils was found to be a sensitive assay for ACT 
toxicity . This assay detected AC toxin activity in crude and purified preparations. 
With crude AC , approx 50 % inhibition of CL was observed at 3.3 pg protein/ml 
whereas Friedman et al. (1987 b) found 50 % inhibition of CL at a dose of 36 pg /ml 
even when they used purified ACT. Purified AC in the present study detected a CL 
inhibitory effect down to 0.5 nmol cAMP/min/ml AC enzymic activity / vial and a 50 - 
60 % inhibition of CL was observed at dose of 5 nmol cAMP/min/ml AC enzymic 
activity /vial. This sensitivity may be achieved due to the assay conditions used in the 
present study. Although both PMA and heat-killed S. aureus initiate the respiratory 
burst, the PMA -induced CL response is totally dependent upon the presence of a 
suitable substrate e.g., luminol in the reaction medium to permit detection of the light 
emission (Westrick et al., 1980), although particulate stimulants such as zymosan or a 
bacterium itself may serve as the substrate for secondary light producing reactions 
(McPhiel et al., 1979). The use of a particulate stimulus also may results in a more 
strong enhancement of the burst and may last longer than the burst induced by the 
luminol and PMA.
Another important variable to consider is the PMNs. Friedman et al. (1987 b) 
used human neutrophils isolated from peripheral blood whereas in the present study, 
rabbit peritoneal neutrophils were used. It has been reported that PMNs from 
different species and different sources may differ in their response to stimuli.De 
Chatelet et al. (1975) showed superoxide formation by rabbit peritoneal neutrophils 
when incubated with opsonized zymosan but rabbit peritoneal macrophages did not 
generate measurable quantities of superoxide. PMNs from peripheral blood and 
peritoneal exudate may also differ in their responsiveness.Takamori and Yamashita 
(1980) have reported two-times higher generation of superoxide anion in peritoneal 
neutrophils than in blood neutrophils. Blood neutrophils were found more resistant to 
hypotonic lysis.Furthermore, the activity of the enzyme alkaline phosphatase, a 
speciflcic marker enzyme for granules of rabbit PMNs was about 1.5 times higher in
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peritoneal PMNs than in blood PMNs. Therefore, it seems reasonable to suggest that 
rabbit peritoneal PMNs may have a more sensitive response towards CL events 
induced with PMA than the blood PMNs. Thus the use of rabbit peritoneal neutrophils 
and PMA in the CL assay seems to have advantages over the use of peripheral blood 
neutrophils and S. aureus.
Rabbit peritoneal neutrophils are relatively easily obtainable, survive longer 
during storage at 4 °C and containment conditions are not required for their use, 
whereas human blood is potentionally hazardous and less stable. Moreover, the 
preparation may contain contaminating erythrocytes and other leukocytes if not 
properly prepared.On the other hand, rabbit peritoneal neutrophil preparation is 
relatively simple and gives > 90% neutrophils. Furthermore, the rabbit is susceptible 
to B. pertussis aerosol infection and constitutes a relevant model for the disease in 
humans (Ashworth et al., 1982). Therefore, rabbit neutrophils may also serve as a 
substitute for human neutrophils for the assays.
Detection o f AC Toxic Activity in Different Bordetella by CL Assay
Crude preparations of ACT from different Bordetella showed different 
CL-inhibition effects. Urea extracts from AC- negative strains showed stimulation 
rather than inhibition. Since urea extracts are crude preparations from the cells, they 
presumably contain other components of B. pertussis e.g., FHA, LPS which 
enhance the PMA-induced response of neutrophils. LPS and FHA have been reported 
to enhance the fMLP - induced CL response of rabbit peritoneal neutrophils by Craig 
et al. (1988). In preparations containing ACT however, the stimulatory response was 
overidden by the inhibitory effect.
One of the important points to come out of this study was the strain variation that 
occurred between different Bordetella species and among B. pertussis strains for the 
production of ACT. B. pertussis Tohama was not comparable to other wild-type 
strains for the production of cell-associated ACT as assessed by the inhibition effect 
of PMA-induced CL response of rabbit PMNs. Furthermore, this strain also showed 
weak reactivity on immunoblots with monoclonal anti-AC antibodies, and had 
reduced AC enzymic activity. One possible explanation could be that the production 
of ACT in this strain follows a different time course . Leusch et al. (1990) have 
reported the earlier production of cell-associated AC in the case of one strain in 
comparison with other strains of B. pertussis.
Tn5 mutants of B. pertussis deficient in a individual virulence factors (Weiss et 
al., 1983) were tested in the CL assay in an attempt to determine the impact of the
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presence and absence of these factors on AC toxic activities. The FHA mutant BP353 
showed reduced toxicity in CL assay like B. pertussis Tohama. This strain also 
displayed less prominent AC bands on immunoblots with monoclonal antibody and 
contained less enzymic activity than another Tn5 mutant BP357 (PT mutant ) or other 
wild-type strains used in this study. The lower enzymic activity in this strain has 
also been reported by Weiss et al. (1983) and Leusch et al. (1990) but reduced toxic 
activity has not been reported. This difference in ACT (cell-associated) production by 
this strain could possibly be explained in several ways as discussed previously.
In contrast, another Tn5 mutant BP357 (PT ") showed high level production of 
AC which was comparable to the recombinant strain B. pertussis BP348 (pRMBl) 
which was shown to produce 3-fold higher enzymic activity and 5-fold higher toxin 
activity when tested on S49 lymphoma cells (Brownlie et al., 1988). This behaviour 
of BP357 was noted in the immunoblot study, enzymic assay and CL assay, A 
possible reason for the high level expression of ACT in BP348 (pRMBl) is a gene 
dosage effect (Brownlie et al., 1988). High level expression of ACT in BP357 (PT 
■) may reflect mechanisms already discussed on page 144 .
Although PT is widely regarded as one of the major protective antigens of B. 
pertussis , it may also be responsible for some of the untoward effects of B. 
pertussis and pertussis whole-cell vaccine, Moreover, BP357 (PT ") has been found 
protective in mouse protection test (Olander et al., 1986). It is of interest to speculate if 
the enhanced level of ACT contributes to the protective capacity of this strain and, if 
so, then this strain might be an interesting vaccine candidate.
In order to determine the specificity of the assay for ACT , the influence of 
calmodulin and calcium on the CL-inhibition effect of ACT was determined. The data 
agree with previous reports. It has been demonstrated that addition of pM  CaM 
prevented the formation of cAMP catalyzed by partially purified AC in target cells 
(Shattuck and Storm, 1985). Rogel et al. (1989, 1991) have reported the CaM- 
mediated inhibition of purified ACT activity and shown that the inhibitory effect of 
CaM was dose- dependent. The effect has been attributed to the altered configuration 
of the N-terminus of ACT after binding with CaM which may than prevent the access 
of ACT to the target cell interior (Rogel et. al., 1991; Ehrman et al., 1991). Blocking 
effect however, seems to be target cell specific, depending upon the type and nature 
of the cells, since in Chinese hamster ovary (CHO) cells, accumulation of cAMP was 
unaffected when CaM was added (Gentile et al., 1990).
In the present study, this blocking effect of CaM for AC toxic activity was 
demonstrated by reduction of the CL-inhibition effect of ACT suggesting that the 
toxic effect was specifically caused by ACT.
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The role of calcium in the catalytic and invasive activities of ACT has been 
investigated by several workers. Masure et al. (1988) reported that calcium influenced 
several properties of ACT including its chromatographic behaviour, the Stokes radius 
of the enzyme, the mobility of catalytic activity on SDS-PAGE, and the effectiveness 
of ACT to elevate cAMP in target cells. Although not an obligatory requirement for the 
enzymic activity (Greenlee et al., 1988; Gentile et al., 1990), calcium has been 
reported as an essential feature and indispensible cofactor for the invasive activity of 
ACT (Gentile et al, 1990; Hewlett et al. 1990; 1991). Calcium might be involved in 
attachment of ACT to target cells since the presence of 11 tandemly-repeated 
sequences each consisting of 9 amino acids have been found responsible for the 
binding of E. coli haemolysin to the erythrocyte membrane and these sequences 
appear to bind calcium (Boehm et al., 1990). Similar sequences have been identified 
on B. pertussis ACT (Glaser et al., 1988 b). Hewlett et al. (1990 ;1991) have also 
shown that calcium binding caused a conformational change in ACT. The exposure 
of purified ACT to free calcium at concentrations between 1-10 pM. resulted in 
conformational alteration as viewed by negative staining and electron microscopy. The 
present study supports the findings of Hewlett et al.,{\99\) that at low concentrations 
of calcium, the toxic effect of ACT could not be detected and that increasing the 
calcium concentration caused a visible effect. The maximum effect of toxin was seen 
with 3 mM calcium / 10^ cells. The bi-modal response observed in the present study 
could be explained as the effect of ACT at sub-optimal and then optimal concentrations 
of calcium which could be those described by Hewlett e/ al. (1991) i.e., unfolding/ 
conformational changes and then penetration into the target cells.
Suppression o f CL Response o f Neutrophils by Live B. pertussis
Suppression of the CL response of rabbit peritoneal neutrophils with live 
opsonized B. pertussis BP348 (pRMBl) but not with the ACT deficient TnJ mutant 
BP348 suggests that this suppression was caused by ACT. Since the bacteria were 
coated with fresh rabbit serum so as to provide opsonins to facilitate phagocytosis 
(Allen, 1977) the possibility exists that the whole bacteria were ingested rather than 
the ACT being released from the bacteria and then taken up by the neutrophils. 
Furthermore, the slightly delayed time for the suppression of CL may be due to the 
time required for entry of the bacteria and their possible processing within the host or 
both.
Hewlett et al. (1988) found intoxication of J744 cells with B. pertussis but not 
with culture supemates. They suggested that cell to cell contact may have resulted in
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the accumulation of cAMP in these cells. Recently, Mouallem et a i  ( 1990) have 
shown the intoxication of CHO cells by B. pertussis Tohama. The entry of whole 
bacteria was revealed by transmission electron micrographs. Very recently, Bromberg 
et al. (1991) have suggested the intracellular appearance of B. pertussis in alveolar 
macrophages of patients with human immunodeficiency virus infection. Saulckonen et 
a/. (1991) have shown an integrin - mediated localization of B. pertussis within rabbit 
macrophages.
A similar interaction of human neutrophils with virulent and avirulent strains of 
Salmonella typhi were examined by Kossack <3/. (1981). They observed equivalent 
phagocytosis of the strains when quantitated by uptake of radiolabelled virulent and 
avirulent strains of S. typhi but found a decrease in postphagocytic PMN oxidative 
metabolism, by measuring oxygen consumption and by decline in chemiluminescence 
response, in those PMNs ingesting virulent S, typhi.
These studies suggest that B. pertussis whole cells may invade host cells of 
various types and induce increased intracellular cAMP. The present results show a 
time-dependent decline in CL response of rabbit peritoneal neutrophils indicating that 
the whole cell of B. pertussis may have entered the neutrophils via phagocytosis and 
caused the suppression of CL. This effect shown by AC -positive B. pertussis but not 
by the AC - negative B. pertussis has not been reported previously.
The results from different assays for determination of AC toxic activity are 
summarized in Table 20. Comparison shows that the CL assay appears to be more 
sensitive .
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Table 20 
Comparative Study of Toxicity Assays for B. pertussis ACT
Assay Detection limit 
Crude Purified
(/^g protein) (nmol cAMP/min/ml)
Advantages Disadvantages
NBTR 2 0 /
5x104
cells
50/
5x104
cells
Simple,rapid, 
economical
Qualitative, 
less sensitive
Haemolytic 2 0 /
2 x 1 0 8
cells
6.25/
2 x 1 0 8
cells
Simple,rapid,
economical,
quantitative
Less sensitive
CHO cell ND 12.5/
5x1 Q4 cells
Specific Laborious,time- 
consuming, 
narrow range, 
less sensitive.
BHKcell 75/
5xl04 cells
ND Specific,
quantitative?
Time-
consuming
CL 1 /
1 0 6  cells
0.5/
1 0 6  cells
Sensitive,
simple,rapid,
quantitative,
economical.
Stimulation by
undesirable
factors
NBTR= nitroblue tétrazolium reduction; CHO=chinese hamster ovary ; BHK= baby hamster 
kidney; CL = chemiluminiscence inhibition; ND= not determined
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DETECTION OF ANTIBODIES AGAINST AC IN HUMAN 
CONVALESCENT SERA OF PERTUSSIS PATIENTS.
The human antibody response to B. pertussis ACT after pertussis infection and 
immunization has been recently reported (Farfel et al. 1990, Arciniega et al., 1991). To 
gain a broader understanding of the human immune response to B. pertussis AC as a 
step towards determining a definite role of AC antibodies in protection, convalescent 
sera from adult individuals with culture-confirmed pertussis were examined. Although 
pertussis is mainly considered to be a disease of children it is becoming observed more 
frequently in adults (Linneman & Nasenberry, 1977), presumably due to waning 
immunity after vaccination.
Immunobiot analysis of convalescent sera from four patients of pertussis showed 
clearly the presence of anti-AC antibodies strongly recognizing both the native ACT in 
B, pertussis urea extract and cloned AC in E. coli on immunobiot profiles. It has 
been reported that FHA antibodies appear in sera of pertussis patients (Redd et a l, 
1988). Since FHA has a closely similar MW (220) kDa to ACT, the possibility is 
there that the recognized bands could represent FHA.To exclude this possibility, 
extracts of Tn5 mutant BP348 deficient in ACT (Weiss et al, 1983) were probed with 
the same sera but did not show the presence of high MW protein in these extracts, 
confirming that the antigen recognized by human sera was in fact ACT.
In a separate study of CL assays, these same human sera were found to neutralize 
the toxic effect of AC. This result contradicts the findings of Farfel et at. (1990) who 
reported that the post-pertussis infection sera did not neutralize the enzymic and 
penetrative ability of the AC. The studies of Brezin et al. (1987) showed that both AC 
enzymic activity neutralizing and non-neutralizing antibodies protected mice against 
infection with B. pertussis which suggests that the lack of neutralizing capacity may 
not indicate that these antibodies are insignificant. Raptis et al. (1989) however, 
reported that hyperimmune sera could neutralize B. pertussis AC activity. The data 
presented in this study therefore indicate that neutralizing antibodies are produced 
against ACT during the course of infection, and their presence in convalescent patients 
may reflect their role as protective antibodies. The presence of neutralizing antibodies 
against FT in whooping cough have been shown to be important in long term immunity 
against pertussis (Granstrom et al, 1985).
The differences in titre observed among the sera for recognition of B. pertussis 
AC on immunobiots may have been due to the timing of serum sampling or to the 
severity of the disease which could have been severe and prolonged in those cases 
where high titre AC antibodies were obtained.
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In a very recent study by Guiso et al. (1991), the antibodies in the mouse after 
active immunization with 200 IcDa AC holotoxin (ACT) appeared very early in 
pertussis, which suggests that AC antibodies may play a role against initial 
pathogenesis i.e., colonization , as has been proposed by Goodwin & Weiss (1990).
AC TRANSFERRED TO NITROCELLULOSE FOR USE AS AN 
IMMUNOGEN.
Highly specific (monospecific) antibody against ACT was prepared by using 
affinity-purified ACT (210 and 200 kDa ) , transferred to nitrocellulose and used as an 
immunogen in rabbits.
Antibodies have become a useful reagent for the identification, localization and 
purification of biologically interesting molecules (Knudsen, 1985). However their 
usefulness in providing reliable and creditable information depends upon their 
specificity. While monoclonal antibodies offer higher specificity, they sometimes can 
be difficult to produce because the procedure involved is expensive and time- 
consuming and requires well-equipped tissue culture facilities. Moreover, hybridoma 
cell lines are frequently unstable due to either chromosome loss or to tissue culture 
contamination (Coding, 1986).
An alternative is the production of polyclonal antibodies from antigen separated by 
SDS-PAGE, although the separated protein will contain both acrylamide and SDS, 
which may have detrimental consequences. However, transfer of SDS-PAGE- 
separated ACT to nitrocellulose in the present case, proved successful for raising 
monospecific antibodies against ACT. This antibody, although raised against denatured 
AC, was capable of neutralizing AC enzymic and toxic activities as assessed by 
Salomon assays and CL-assays showing that it was able to recognize epitopes in both 
native and denatured molecules. This makes the antibody useful for a variety of 
purposes e.g., passive protection tests against ACT and detection of ACT on 
immunobiots and ELISA.
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INTRANASAL PASSIVE PROTECTION TEST.
It is now well known, at least from animal studies, that ACT is one of the 
important virulence factors of B. pertussis because Weiss et a i (1983) showed by Tn5 
-induced mutagenesis, that a B. pertussis strain deficient in AC was avirulent in a 
mouse model, and virulence of this strain was restored when this mutant harboured a 
recombinant plasmid expressing ACT activity (Brownlie et a i, 1988). Recent reports 
further substantiated the role of AC in virulence as a colonizing factor (Goodwin & 
Weiss, 1990). Besides its role as a virulence factor, a protective role of ACT has also 
been elaborated since both these roles are interrelated. Brezin et aL (1987) and Guiso et 
a l . (1989) have reported an efficient protection of mice after passive immunization with 
monoclonal and polyclonal antibodies against ACT. A protective role of AC holotoxin 
(200 kDa) and its degradation product, 45 kDa AC, against colonization has recently 
been reported by Guiso et al. {\99l).
The results presented in this study support the previous findings in that groups of 
mice treated with monospecific anti-AC antibodies (MSI) were partially protected 
when compared with those which did not receive this treatment (controls). Increased 
lung weight and oedema was reduced by the use of antibody but lung pathology was 
still present although it was not very prominent. The lung consolidation may have 
been due to the other factors produced by B. pertussis such as LPS. The leukocyte 
count did not show any difference. Preston (1988) described this characterization of 
infection as a less reliable diagnostic guide since in many cases he found that true 
pertussis did not develop a significant increase in circulating lymphocytes.
The possibility that MSI may have a bactericidal effect on 18323 was clearly ruled 
out since the viable count performed before and after incubation with MSI showed 
almost equal c.f.u./ml as those in MSI untreated, control doses. Furthermore, 
recovery of B. pertussis 18323 from the infected lungs proved that the mice were 
infected with B. pertussis.
In conclusion, passively administered anti- B. pertussis ACT antibodies protected 
mice against B. pertussis 18323. The reason why a complete protection was not 
achieved may be due to the antibodies (MSI) used or that they were raised against 
denatured ACT. However, SDS-denatured ACT has been shown to renature under 
hydrophobic conditions (Masure & Storm, 1989). Some renaturation could have 
occured on removal of SDS. The other possibility could be the titre of antibody which 
may not have been high enough to neutralize the ACT produced by B. pertussis 
18323, which has been reported to produce three times more AC activity and be more 
virulent than other wild-type B. pertussis (Guiso et a l 1991) . The data presented in
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this study supports this view. In the present work this strain had approximately 10 
times more enzymic activity and a 70% increased toxic activity than B. pertussis 
Tohama.
The partial protection also reflects the role of other virulence factors of B. 
pertussis, since, of course, the MS 1 neutralized the effect of AC, but B. pertussis has 
other factors involved in colonization of the host. However, in combination with the 
other components proposed for acellular vaccines, e.g., FHA, FT, P-69, ACT may 
play a protective role against infection as suggested by Weiss et al. (1989) and Guiso et 
al. (1991).
IMMUNOBLOT STUDY OF RTX TOXINS
The immunobiot study of RTX toxins investigated a cross- reaction with 
monoclonal anti-AC antibodies . This study included Bordetella pertussis adenylate 
cyclas toxin (ACT), Pasteurella haemolytica leukotoxin (LktA), Actinohacillus 
actinomycetemcomitans leukotoxin (AktA), and E. coli alpha - haemolysin (HlyA). 
The E. coli alpha -haemolysin is the most thoroughly studied cytolysin. Genetic 
studies have revealed that haemolysins of the RTX family are encoded by an identical 
number of genes which are organized in an operon. The nucleotide sequences have 
shown a high degree of homology and, as a consequence, activation of the 
haemolysins,their secretion, and mode of action share similar mechanisms. These 
toxins contain tandemly-repeated amino acid sequences of 9 residues which are 
involved in the calcium- dependent binding of the cytolysin to target cells. The close 
amino acid homology of the C-terminal portion of CyaA with HlyA of haemolysin 
provides a model for the entry of CyaA into the target cell. It has been reported that E. 
coli HlyC can function in place of the equivalent protein from P. haemolytica to 
activate LktA expressed in E. coli (Forestier and Welch, 1990) .
In present study, these similarities were assesed by the immunobiot study. 
Monoclonal antibody raised against the holotoxin AC of B. pertussis seemed an 
appropriate tool to search for similarities between RTX toxins from different 
organisms.The immunlogical relatedness among RTX toxins has not been examined 
previously. The results suggest that the RTX toxins share common epitopes or 
antigenic determinants and the demonstration of a cross-reaction between ant-AC 
monoclonal 9D4 and the AktA may prove to be highly useful for the isolation and 
study of this recently described toxin. Further studies are required to determine what 
role this relatedness plays in the stmcture-function relationship and in the diagnosis of 
the disease since the possibility exists that the antibodies detected by serological tests
PART IV -  167 -  DISCUSSION
of patients sera may have been raised against, for example, Hly of E. coli present in 
the host. The genetic and immunological relatedness between RTX toxins indicate that 
these toxins might have a common evolutionary origin.
EXPRESSION OF CYA IN E. COLI
The gene {cyaA) encoding ACT has been shown to be part of an operon consisting 
of additional genes cyaB cyaD cyaE (Glaser et al., 1988 b) and cyaC (Barry et al., 
1991). Complementation studies have shown that cyaB, cyaD, cyaE are required for 
the secretion of ACT from B. pertussis (Glaser et al., 1988 b), and share a large 
degree of sequence similarity with hlyA, hlyB, and hlyD genes (Glaser et al., 1988 b). 
Like ACT, secretion of HlyA also needs HlyB and HlyD. Regarding the homology 
between E. coli HlyA and B. pertussis CyaA, export of CyaA from E. coli has 
been reported, although only 2% of total AC activity was released into the culture 
medium as compared to B. pertussis Tohama (Masure et al., 1990).
Previous studies from this laboratory have described the expression of the cyaA 
gene in E. coli harbouring plasmid pRMB3. Cell extracts from this strain showed AC 
enzymic activity which was stimulated in the presence of exogenous CaM (Brownlie et 
al., 1988). Further studies revealed a 200 kDa protein expressed in a protease- 
defective E. coli strain (H1469) harbouring plasmid pRMB3. This product had AC 
enzymic activity and was recognized by anti-R. pertussis ACT monoclonal antibodies 
(Rogel et al., 1989). Barry et al. (1991) reported that an additional gene, cyaC, was 
required for the activation of CyaA to its cell-invasive form in B. pertussis . Very 
recently, Sebo et al. (1991) were able to show the activation of CyaA in E. coli in the 
presence of cyaC from B. pertussis. In the present study, expression of cyaA in E. 
coli strain H1469, harbouring either plasmids pRMB3 or pRMB6  and/or double 
plasmids i.e., pRMB6  and a plasmid carrying C genes either from E. coli, P. vulgaris, 
or B. pertussis were examined for the production and activation of CyaA . The results 
obtained from the E. coli H1469 (pRMB3) showed enzymic activity equivalent to 
wild-type B. pertussis which reacted with anti-ACT polyclonal and monoclonal 
antibodies and post-infection human sera of pertussis. The protein was also detected by 
the CaM -affinity probing method for detection of CyaA. However the extracts from 
this strain were non-toxic in toxicity assays. This agrees with the previous reports by 
Brownlie et al. (1988) and Rogel et al .(1989).
Cloned C genes from other RTX toxins were introduced into E. coli on plasmids 
which resulted in the constructs: HI469 (pRMB6,pANN202); H I469 (pRMB6 , 
pKIMl); and H1469 (pRMB6 , pANGE3). These constructs revealed the production of
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210 kDa CyaA with AC enzymic activity comparable to wild-type B. pertussis which 
reacted with monoclonal and polyclonal anti-AC antibodies on immunobiots .AC toxic 
activity in CL assays of crude preparations was determined. There was a stimulatory 
factor present in crude preparations of these constructs which was possibly LPS . 
This was determined by treating the neutrophils with purified LPS which gave a similar 
enhancement of the CL response . Efforts to remove the LPS from these preparations 
by Detoxi -Gel chromatography also removed the toxic activity of the ACT since a 
50-60 % reduction in CL inhibition effect was observed in a urea extract of B. pertussis 
18323 after Detoxi-Gel treatment. The reason for this reduction remained unclear, 
Phenyl-sepharose chromatography was also not able to remove the stimulatory effect 
from these extracts.
CaM - agarose chromatography was performed and the dialysed eluate was assessed 
for the toxic effect on CL response, A low level of toxicity was observed in the purified 
AC from cloned constructs indicating the activation of cyaA in the presence of hlyC 
from E. coli and P. vulgaris and cyaC from B. pertussis . The level of activation 
by hlyC from P. vulgaris seemed to be higher than that by the hlyC from E. coli or 
cyaC from B. pertussis because only 51% inhibition of CL response was observed 
with the dose of enzymic activity which gave 99% inhibition when measured with the 
B. pertussis ACT. The low toxicity observed in E. coli - expressed ACT may be due 
either to the presence of stimulatory factor(s) which may not have been removed 
completely by CaM-affinity chromatography, or may reflect the low level production of 
activated CyaA. This may be due to a number of factors. It has been reported for E. coli 
haemolysin that an additional factor, cytosolic activating factor, is required for 
conversion of pro-toxin to activated toxin and that the HlyC alone cannot activate 
pro-HlyA to activated toxin (Hardie et al., 1991).The HlyC proteins in the absence of 
this factor, which has been identified as acyl carrier protein -like factor ( Issartel et al., 
1991) may not function properly with CyaA and CyaA may not function satisfactorily 
in E. coli as the activation process requires an acyl carrier protein as donor of a fatty 
acid molecule which is specific to B. pertussis . Both of these moieties may be different 
in E. coli from the equivalent components by B. pertussis. Sebo et al. (1991) also 
found less haemolytic activity in ACT, expressed and activated in E. coli.
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APPENDIX I: MEDIA
(i) Bordet-Gengou Medium (BG)
Bordet -Gengou agar base obtained from Difco was used in this study since the 
agar base obtained from Oxoid failed to show haemolytic colonies of B. pertussis . 
This was important from the point of view of selecting ACT + from the ACT " strains 
of B.pertussis . The base was prepared in 500 ml aliquots. Prior to autoclaving, the 
base was dissolved fully in distilled water containing 1% glycerol by heating at 90 
°C for 20 min in a steamer after which the dissolved agar was autoclaved at 121 °C 
for 15 min . At this stage the autoclaved agar was either stored or cooled to 56 "C in 
a water bath and used for pouring by adding 1 0 0  ml deflbrinated sheep blood tmder a 
laminar flow cabinet.
BG with kanamycin (40 qg/ml) was also used for selection of Tn5 mutants. BG 
with tetracycline (10 p,g/ml) was used for the recombinant strain B. pertussis BP348 
(pRMBl). The antibiotics were added to the agar base just before adding the blood 
and well mixed by rotation of the bottle to avoid frothing. Stock solutions of the 
antibiotics were filter-sterilized, using 0.45 q pore size Acrodisc syringe filter 
(Gelman).
(ii) Cyclodextrin Liquid Medium (CDL) g
Mono sodium glutamate 10.7
L-ProHne 0.24
NaCl 0.5
KH2PO4  0.5
MgCl2.6H2O 0.1
CaCl2  0 . 0 2
Tris 6.1
Cas amino Acids ' 0.5
MepCD 1.0
Contents were mixed in 700 ml distilled water and dissolved, pH was adjusted to 7.4 
with 2N HCl and the medium was autoclaved at 121“C for 15 min at 15 p.s.i.The 
volume was made up to 990 ml with distilled water.
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Supplement preparation fo r  1 litre CDL g
L-cysteine 0.04
Fe SO4  7 H2 O 0.01
Ascorbic acid 0.02
Niacin 0.004
Glutathione (reduced) 0.15
Contents were dissolved in 10 ml distilled water and filter- sterilized by passage 
through a 0.45 p. pore size Acrodisc syringe filter (Gelman) and added to 990 ml of 
the cooled autoclaved medium.
APPENDIX II: SODIUM DODECYL SULPHATE POLY
ACRYLAMIDE GEL ELECTROPHORESIS (SDS- PAGE). 
(i) Acrylamide/Bis
Acrylamide 30.0 g
N, N-methylene bis acrylamide 0.8 g
Distilled water 100 ml
(ii) Lower Gel Buffer (pH 8.8)
Tris 18.1 g
SDS 0.4 g
Distilled water 50.0 ml
The pH was adjusted to 8 . 8  with 2N HCl and the final volume made up to 100 ml 
with distilled water.
(iii) Upper Gel buffer (pH 6.8)
Tris 6.0 g
SDS 0.4 g
Distilled water 50.0 ml
The pH was adjusted to 6 . 8  with 2N HCl and the final volume made up to 100 ml
with distilled water.
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(iv) TEMED (Undiluted stock)
(v) Ammonium Persulphate Solution
A 10% solution was made up freshly (50 mg in 0,5 ml distilled water).
(vi) Solubilizing Buffer
Glycerol 10 ml
2-mercaptoethanol 5 ml
SDS 3 g
Bromophenol Blue 0.01 g
Upper buffer , lin 8  dilution of (iii) to 100 ml
(vii) Running Buffer (pH 8.3)
Tris 3.03 g
Glycine 14.4 g
SDS 1.0 g
Distilled water 1000 ml
(viii) Staining Solution
Coomassie Blue R 250 1.525 g
50% (v/v) methanol 454 ml
Glacial acetic acid 46 ml
(ix) Destaining Solution
Methanol 50 ml
Glacial Acetic Acid 75 ml
Distilled water 875 ml
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Slab Gel Preparation
(i) Lower (Separating) Gel 7.5% acrylamide
(0 . 8  mm )
Lower buffer 5 ml
Distilled water 1 0  ml
Acrylamide/Bis 5 ml
Ammonium persulphate solution lOOpl
TEMED 2 0 pl
(ii) Upper (Stacking) Gel 4.5% acrylamide
Upper gel buffer 2.5 ml
Distilled water 6  ml
Acrylamide/ Bis 1.5 ml
Ammonium persulphate solution 30pl
TEMED 2 0 pl
APPENDIX III: BUFFERS AND REAGENTS
NOTE: Deionized, distilled water was used to prepare all reagents.
(i) HEPES Buffered Saline (HBS)
NaCl 8 . 0  g
KCl 0.4 g
CaCl2 0.14 g
Glucose 1 . 0  g
HEPES 2.388 g
Ingredients were dissolved in 900 ml of water and the pH adjusted to 7.4 with 1
N NaOH. The volume was made up to 1 litre with water and the preparation was
autoclaved at 121 °C for 15 min. The divalent cation-free HEPES solution was
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prepared by the omission of the calcium.
(ii) Phosphate- Buffered Saline (Dulbecco A)
Phosphate-buffered saline tablets (Dulbecco A, pH 7.3, Oxoid) were used. Each 
tablet was added to 1 0 0  ml of distilled water and the solution was autoclaved at 
l i r e  for 15 min .
(iii) Immunoblotting/ Western Blotting 
Transfer B uffer
Tris 3.03 g
Glycine 14.4 g
2 0 % (v/v) methanol to 1 0 0 0  ml
Diaminobenzidine (DAB) substrate solution
3,3'- diaminobenzidine (DAB) 0.05 g
l%CoCl2 inH 2 0  2  ml
PBS (Dulbecco A ,pH 7.3, Oxiod) 98 ml
30 % H2 O2 , added immediately prior to use 0.1 ml
Caution: Handle DAB with care. It is a carcinogen
Electroblotting buffer (20 mM Tris! 150 mM glycine, pH  8)
Tris base (sigma) 15.5 g
Glycine 17.4 g
methanol 1 2 0 0  ml
DistiUed water to 6000 ml
Ponceau -5 solution
Ponceau- S 0.5 g
Glacial acetic acid 1.0 ml
Distilled water to 100 ml
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Horseradish peroxidase-antUIg conjugate
A variety of species-specific anti-Ig conjugates were purchased from Scottish 
Antibody Production Unit (SAPU). Diluted these as indicated by the manufacturers 
and stored frozen in 0.025 ml aliquots until use.
(iv) ELISA
Coating Buffer
Na2C03 1.59 g
NaHCOg 2.92 g
Reagents were dissolved in 1 litre of distilled water and kept at 4 °C. The pH of the 
solution was approximately 9.6.
Washing! Incubation Buffer
NaCl 8.0 g
KH2PO4  0 . 2  g
Na3HP04 1.15 g
KCl 0.2 g
All the ingredients were dissolved in 1 litre of distilled water. Tween 20 (0.5 ml) was 
then added to a final concentration of 0.05 %. The pH of the solution was 7.4.
Citrate-Phosphate B uffer
Solution A: 0.1 M citric acid 21.01 g
Solution B: 2M Na2HP0 4  28.3 1 g
of distilled water
To prepare a 0.15 M solution of citrate-phosphate pH 5,0, 49 ml of solution A and 51 
ml of solution B were added together just before use.
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OPD Substrate Solution
OPD (O-phenylenediamine, Sigma) 34 mg
Citrate phosphate buffer (pH5) to 100 ml
30 % H2 O2  (Sigma) 100 pi
(v) Iso- Electric Focusing 
Fixing solution
Trichloroacetic acid 57.5 g
Sulphosalicylic acid 17.25 g
Distilled water 500 ml
Staining solution
Coomassie Blue R 250 0.46 g
Destaining solution 400 ml
Filtered through Whatman paper 1.
Destaining solution
Ethanol 500 ml
Acetic acid 160 ml
Diluted with distilled water up to 2000 ml.
(vi) Reaction Mixture for Microplate Assay for AC Enzymic Activity
IMTris-HClpHS 300 pi
1 M MgCl2  50 pi
ATP (Sigma) 2.5 mg
1 M CaCl2 50 |xl
Calmodulin (bovine brain, Sigma) 2 pM
Make up to 5ml with distilled water
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